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"The great tragedy of Science - the slaying of a 
beautiful hypothesis by an ugly fact."
Thomas Henry Huxley (1825-1895), 
Ib.viii. Biogenesis and Abiogenesis.
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S u m m ary
There are two distinct biosynthetic pathways to the essential 
amino acid L-lysine (A). The diaminopimelate pathway to L -ly sin e  
(A) occurs in higher plants and bacteria whereas the a -a m in o a d ip a te  
pathway to L-lysine (A) operates in fungi and yeasts. This thesis is 
concerned with the first two steps in the diaminopimelate pathway 
to L-lysine (A), catalysed by dihydrodipicolinate synthase (DHDPS) 
and dihydrodipicolinate reductase (DHDPR). In particular, the 
synthesis of L-aspartic acid-p-sem ialdehyde (L-ASA) (C), a s u b s tr a te
of the first enzyme and the mechanism of formation of L-2,3- 
dihydrodipicolinate (L-2,3-DHDPA) (B), the product of the re a c tio n  
catalysed by DHDPS, was studied. In addition the synthesis of 
compounds which might be inhibitors of DHDPS was studied.
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L-Aspartic acid-p-semialdehyde (C) is an important 
intermediate in the biosynthesis of L-lysine (A), L-threonine and L- 
methionine. The trifluoroacetate salts of the L- and D-isomers of 
aspartic acid-p-semialdehyde were prepared from L- and D- 
allylglycine respectively. Our Biochemistry co-workers have isolated 
and purified DHDPS and have set up an assay system for this
enzyme. Using this assay system we confirmed that L-ASA (C) is a 
substrate for DHDPS whereas the D-isomer is not.
Having pure L-ASA (C) allowed us to carry out precise NMR 
spectroscopic experiments and biochemical experiments to 
investigate the mechanism of DHDPS. We confirmed that the product 
from the enzymic reaction is dipicolinic acid (D).
H 02C‘ kN
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Manipulation of the synthetic route to L-ASA (C) allowed us to 
prepare a range of aspartic acid-p-sem ialdehyde analogues and 
derivatives. Most o f these compounds were tested for p o te n tia l
inhibitor or substrate activity with DHDPS. In particular the
trifluoroacetate salt of DL-aspartic acid-p-sem ialdehyde methyl ester
hydrate (E) showed no substrate activity however, 14% inhibition 
was observed with this compound at 0.5 mM.
OH
HO
(E)
The other substrate of DHDPS in the diaminopimelate p a th w a y  
to L-lysine (A) is pyruvate (F). A range of pyruvate (F) and 
bromopyruvate derivatives were synthesised and tested as 
substrates or inhibitors of DHDPS. Methyl pyruvate has shown 
substrate activity with DHDPS. In general, the bromopyruvate 
derivatives were better inhibitors than the pyruvate derivatives.
A range of sulphur analogues of L-2,3-DHDPA (B) and L -2,3 ,4 ,5- 
tetrahydrodipicolinic acid (L-2,3,4,5-THDPA) (G) were synthesised
and tested for inhibitor activity with DHDPS. The 3,4-dihydro-1,4-
thiazines, in particular the diethyl ester (H) and its N- m e th y l
analogue (I), showed good inhibition at 0.1 mM with DHDPS. The 3 ,4- 
dihydro-2,2-dim ethyl-1,4-thiazine diester (J) showed the b e s t
inhibition with 20% at 0.1 mM. The 3,4-dihydro-1,4-thiazines were
1   ..................................
I prepared by reacting L-cysteine derivatives with ethyl
[ bromopyruvate in dichloromethane in the presence of triethylamine.
i
I*
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H
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The 1,3-thiazoles that were prepared showed very good 
inhibition with DHDPS. The diester (K) showed 21% inhibition at 
O.lmM with DHDPS. This compound was prepared by treatment of 
the mercapto-amide (L) with phosphorus pentasulphide in pyridine. 
The mercapto-amide (L) was prepared by treating L-cysteine methyl 
ester hydrochloride with ethyl oxalyl chloride in dichloromethane in 
the presence of triethylamine.
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C h a p te r  111 - L-Lvsine: An Essential Amino Acid.
In tro d u c tio n
Amino acids are found in living organisms in both their free
forms and bound by amide linkages in peptides and proteins. There
are approximately 20 different protein a-amino acids. The
composition of proteins varies widely. In some cases only a few  
amino acids constitute the bulk of the protein. However, more
typically, most of the amino acids are present. The structures of the
amino acids have all been determined following the c h a ra c te r isa tio n  
of glycine and leucine by Braconnet in 1820, with threonine being
the last to be isolated in pure form in 1925.1 *3 With the exception 
of glycine, they are all optically active and exist mainly in the L-
forms. An important member of this group of protein amino acids is
L-lysine (1). Its importance will be discussed in Section 1.1.
1.1. The Importance of L -Lvsine.
L-Lysine (1) is economically one of the most important amino
acids. It is an essential amino acid for human nutrition and i s
frequently the limiting amino acid in plant protein in terms of 
nutritional quality. Mammals lack the ability to make L-lysine (1 ) 
and so must consume it within their diet. Commercially, the largest 
amounts are produced by the bacteria Corynebacterium glut ami cum , 
Brevibacterium flavum and Brevibacterium la c to fe rm e n tu m .4 The 
production of L-lysine (1) will be discussed in more detail in Section
21.2. The biosynthesis of L-lysine (1) in bacteria and plants is 
incompletely understood. This will be discussed in Section 1.3. me so
-2,6-Diaminopimelic acid (28), an intermediate in the biosynthesis of 
L-lysine (1), is a building block for the cell wall cross-linking 
material of most bacteria. Enzyme inhibitors of lysine biosynthesis 
should therefore possess anti-bacterial and/or herbicidal activity 
without mammalian toxicity. The design of inhibitors will be 
discussed in more detail in Section 1.4 and Chapters 4, 5, 6 and 7.
The conversion of L-lysine (1) into alkaloids is an important
biological process which has been studied for many years. Alkaloids
are a diverse group of natural products containing nitrogen as part of 
a ring system and are found mainly in plants. They exhibit a wide 
range of biological activities. The isolation of large numbers of 
alkaloids has been accompanied by an increase in understanding of
their biological properties and their pharmacological, toxicological 
and ecological significance in nature. Experiments with isotopically
labelled precursors have helped us to understand the complex
manner in which alkaloids are biologically synthesised. More
importantly, understanding the biosynthesis of alkaloids, starting 
from simple amino acid precursors, has assisted the design of
biomimetic synthetic routes. In addition synthesis of analogues of 
biosynthetic intermediates may lead to inhibition o f particular
enzymes and hence these analogues may have useful biological
a c tiv ity .
There are two main classes of alkaloids which utilise L -ly sine
( 1) as the precursor, namely the piperidine alkaloids and th e
3quinolizidine alkaloids. Both these types of alkaloids occur in a 
limited number of plant families.
Many higher plants possess the necessary m etabolic pathways 
for the synthesis of piperidine alkaloids. In each case these alkaloids 
incorporate one or more piperidine rings. A typical piperidine 
alkaloid is pseudopelletierine (3), isolated from the bark of Punica  
granatum L. (p o m eg ra n a te ).5 Its probable metabolic pathway from 
L-lysine (1) via A-methylisopelletierine (2) is shown below (S c h e m e  
1 ).
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Scheme 1 : Pseudopelletierine biosynthesis.
4Quinolizidine alkaloids are sometimes known as the lupin 
alkaloids since they occur widely, but not exclusively, in species of 
the genus Lupinus from the plant family Fabaceae (fo rm e rly
Leguminosae). Their biosynthesis from L-lysine (1) starts with a 
decarboxylation in an analogous fashion to that of the pyrrolizidine 
alkaloids from ornithine .6 Thereafter the two biosynthetic pathways 
differ. The route to the pyrrolizidine alkaloids is via a later 
symmetrical interm ediate (C4-N-C4), whereas the formation of
quinolizidine alkaloids does not involve a corresponding C5-N-C5 
interm ediate. The most common quinolizidine alkaloid is sparteine 
(4). It has been isolated from many plant species including <Spartiu m  
scopar ium ,7 Sarothamnus scoparius,8 Lupinus l inden iancus9 and
Lupinus laxus R y d b .10 A particularly good 'biomimetic' total 
synthesis of this compound has been carried out by Van Tamelen 
(Schem e 2). Careful labelling studies by the groups of R obins1 1 and 
S p e n se r1 2 showed that there were equal levels of 13C-enrichment for 
6 carbon atoms after feeding [13C-15N ]- l,5 -d ia m in o p e n ta n e  
(cadaverine), and that there were two 13C-15N doublets. This 
confirmed that two moles of cadaverine are incorporated into the 
two outer rings of sparteine as shown in (4a) (Schem e 2). The s te p s  
by which 3 molecules of cadaverine form sparteine are not 
u n d e rs to o d .
L-Lysine (1) and L-arginine (5) play an important role in 
molecular interactions in biological systems because of their basic  
groups. It is well established that L-lysine (1) and L-arginine (5) are 
indispensable requirements for normal growth of m ic ro b es , 13-16 
p la n ts 17-19  and animals.2 0-22  Furthermore, an antagonistic role
o H N ^ |  Me A ' '
AM e * ^ 0
Mannich-type^ 
CH20 , AcOH
Hg(OAc)2
%ro
Wolff-Kishner
" ^ r e d n .
Sparteine (4) (4a)
Scheme 2
between these two amino acids has also been observed in living 
o rg a n ism s .2 3 ’24 Antagonism existing between L-lysine (1) and L- 
arginine (5) has been clearly illustrated by their effects on animal
6systems. Either oral or peritoneal administration of a large dosage of 
L-lysine (1) or L-arginine (5) has been found to produce a highly 
significant change in the growth of transplantable tumours in
while L-arginine (5) promoted the growth of the tumour. On the 
other hand, the D-enantiomers produced an opposite effect on tumor 
growth: D-lysine promoted and D-arginine inhibited this growth.
From the above considerations it is obvious that L-lysine (1)
plays a crucial role in nature. Hence, lysine biosynthesis in b o th  
micro-organisms and plant systems, and particularly its regulation, is 
o f considerable practical importance. There are two major pathways 
to L-lysine (1). Both the a-aminoadipate (AAA) and the 2,6-
diaminopimelate (DAP) pathways will be discussed in Section 1.3.
1.2. Production of L -Lvsine.
The remarkable progress in the technology of amino acid
production, based on biochemistry and genetics, has made the amino
acid industry of great importance for human life today. In 
particular, amino acids have many diverse uses in foods. They are
m ice .2 5 *2 6 Thus L-lysine (1) strongly inhibited the tumour growth
+
H *  
L-Arginine (5)
7largely responsible for the taste of many types of foods, including 
soy sauce, seafood, and cheese. Alanine and glycine are used as
sweeteners, for example, and synthetic mixtures of protein am in o  
acids are used in special diets, eg. a low phenylalanine amino acid 
mixture is used to prevent the mental retardation effects of 
phenylketonuria, a metabolic inability to degrade phenylalanine in
the normal way.
L-Lysine (1) is now produced by direct fermentation with 
auxotrophic and regulatory mutants and by enzymatic methods. The 
production of L-lysine and L-ornithine represents the first industrial 
utilisation of auxotrophs for amino acid production. The first r e p o r t  
describes lysine production by homoserine auxotrophs of 
Micrococcus glut amicus grown at suboptimal concentrations of th e  
required amino acids methionine and threonine .2 7
An enzymatic method for lysine production uses the yeast 
Cryptococcus laurentii, which hydrolyses a-am inocaprolactam , a
synthetic intermediate in the manufacture of nylon, to lysine.2 8 A 
strain of Achromobacter obae can racemise D - and L - a -a m in o ­
caprolactam, and cells of both organisms were combined in an 
efficient enzymatic process for lysine production2 9
1.3. Biosynthesis of L -Lvsine.
There are two distinct biosynthetic pathways for the synthesis 
of the essential amino acid L-lysine (1). In organisms such as 
Euglenoids, some Phycomycetes {eg. Chytridiales, Blastocladiales and 
Mucorales), as well as yeasts and higher fungi such as Ascomycetes
and Basidiomyces, L-lysine (1) is synthesised via the intermediate a- 
aminoadipic acid (12) derived from 2-oxoglutarate (6) and acetyl 
coenzymeA (acetyl CoA) (Scheme 3). In bacteria, some
Phycomycetes {eg. Hypochytriales, Suprolegniales and Leptomytales) 
and higher plants the pathway is characterised by the condensation 
of L-aspartic acid-p-sem ialdehyde (21) and pyruvate (22) and the 
formation of the interm ediate m e 5 0 -2 ,6 -diam inopim elate (28)3 0
(Schem e 4).
The a-Aminoadipate (AAA) Pathway to L -Lvsine.
a-Aminoadipate (12), a-ketoadipate (11) and a -k e to g lu ta ra te  
(6) have long been known as products of lysine catabolism in 
a n im als .3 1 *32 Proof that these compounds are part of a biosynthetic 
cycle to produce L-lysine (1) came from studies of lysine mutants, 
which cannot make lysine for themselves but can produce lysine 
when their growth media are supplemented with the above 
compounds. These studies led to the establishment of the following 
biosynthetic pathway (Schem e 3).
There are nine enzymes involved in the pathway and most of 
them have been isolated and reasonably well characterised. The 
starting substrate is 2-oxoglutarate (6) which is a product of the 
Krebs cycle.3 3 This is condensed with acetyl CoA to form 
homocitrate (7). The reaction is catalysed by homocitrate 
sy n th a se .3 4 The next reaction in the pathway is the conversion of 
homocitrate (7) into homoaconitate (8) catalysed by the enzyme
9O
h o 2c  c o 2h  
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Homocitrate
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Acetyl-CoA
h o 2c
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c o 2h  
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C 02H
HO,C COoH
O
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NH,
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H
Saccharopine 
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CO,H H / c ° 2 C ^
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Scheme 3 : a-Aminoadipate Pathway
H CO 2
L-Lysme (1)
1 0
homocitrate dehydratase. This enzyme has not yet been isolated. 
Homoaconitate (8) is then hydrolysed to homoisocitrate (9) catalysed 
by homoaconitate hydratase .3 5
The next step in the process involves the reduction o f
homoisocitrate (9) to a-ketoadipate (11) via the proposed 
intermediate oxaloglutarate (10). This step is catalysed by
hom oisocitrate  dehydrogenase3 6 and needs the coenzyme 
Nicotinamide Adenine Dinucleotide (NAD) for the reaction to take
place. The reaction is believed to proceed via oxaloglutarate (10), 
which is an enzyme bound intermediate. Whilst bound to the
enzyme decarboxylation occurs to give the product, a -k e to a d ip a te
(11). This is then converted into a-aminoadipate (12) via th e  
enzyme am inoadipate am inotransferase3 7 with glutamate as the
amino group donor. Pyridoxal phosphate is used as a cofactor during 
the transam ination.
The processes detailed so far take place within the
mitochondria of the organism and all the enzymes used are found in 
the mitochondria. However the last three steps of the process take
place in the cytoplasm. This means that a-am inoadipate (12) must 
be transported from the mitrochondria to the cytoplasm to be finally 
converted into L-lysine (1).
The pathway to L-lysine (1) continues with the conversion of 
a-am inoadipate (12) into a-am inoadipate sem ialdehyde (13) 
catalysed by aminoadipate semialdehyde dehydrogenase .3 8 ’39 T he  
enzyme is cocatalysed by Nicotinamide Adenine D inucleo tide  
Phosphate (NADPH) and Adenosine Triphosphate (ATP) and the
reaction is believed to happen in two stages. The first step involves
11
the conversion of a-aminoadipate (12) into 5 -adeny  1 -a -a m in o a d ip a te  
catalysed by ATP. In the second step the above enzyme bound 
intermediate is converted into a-am inoadipate sem ialdehyde (13)
co-catalysed by NADPH.
The synthesis of L-lysine (1) from a -a m in o a d ip a te
semialdehyde (13) is carried out in two steps which invove first of 
all the condensation of a-am inoadipate semialdehyde (13) with 
glutamate (15) followed by reduction to form saccharopine (14) in 
the presence of NADPH. This step is catalysed by saccharopine 
dehydrogenase •{glutamate form ing).4 0 The final step in the pathway 
involves the conversion of saccharopine (14) into L-lysine (1) and a- 
ketoglutarate (6) using saccharopine dehydrogenase (lysine
fo rm in g )4 0 in the presence of NAD. It is known that this enzyme has 
a very ordered mechanism in which NAD and saccharopine (14) b o th  
bind to the enzyme and L-lysine (1), a-ketoglutarate (6) and NADH
are released in that order. The a-aminoadipate pathway to L -ly sine  
(1) will not be discussed any further in this thesis.
The Diaminopimelate (DAP1 Pathway to L -L vsine.
The use of radioactive precursors of lysine and intermediates
of the proposed pathway have confirmed that the synthesis of L- 
lysine (1) in bacteria is via m e j 0-2 ,6 -diam inopim elate (28).41-43
The first two enzymes of the pathway, aspartate kinase and
aspartate semialdehyde dehydrogenase, are common to the synthesis 
of threonine (16), isoleucine (17) and methionine (18) (Schem e 4).
1 2
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These three are known as the aspartate family of amino acids.
Aspartate kinase catalyses the formation of aspartyl phosphate (20) 
from aspartic acid (19). It has been detected in a variety of plant
tissues including maize,4 4 »45 pea,4 6 barley,4 7 >4 8 w h e a t,4 9 ’50
sp in a ch 5 1 and carrot.5 2 ’53 Aspartate semialdehyde dehydrogenase 
catalyses the conversion of aspartyl phosphate (20) into aspartic
acid-P-semialdehyde (21). This enzyme has been shown to be 
present in pea5 4 and a range of maize tissues.5 5
A further seven unique enzyme catalysed reactions are
required for the synthesis of L-lysine (1) from pyruvate (22) and L-
aspartic acid-P-semialdehyde (21) (Scheme 5). These e n zy m es  
have been characterised in Escherichia coli. However, only e n zy m es  
catalysing the first two and last two steps have been isolated from
plants and characterised.
Dihydrodipicolinate Synthase (DHDPS) catalyses the 
condensation of L-aspartic acid-p-semialdehyde (21) with p y ru v a te
(22) to give L-2,3-dihydrodipicolinic acid (23). The rea c tio n  
presumably proceeds in several steps. Carbon-carbon bond
formation must occur between the aldehyde group of L-aspartic acid- 
p-semialdehyde (21) and the methyl carbon of pyruvate (22) with 
loss of the elements of water. Imine formation also takes place with
the loss of a second mole of the elements of water. DHDPS has been
isolated from bacteria, such as E. coli,5 6 and from plant systems, such 
as maize4 5 and wheat.5 7 The second stage in the biosynthesis is the 
NADPH dependent reduction of L-2,3-dihydropicolinic acid (23) 
to L-2,3,4,5-tetrahydrodipicolinic acid (24) catalysed b y
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dihydrodipicolinate reductase (DHDPR). DHDPR has been isolated 
from maize.5 8
Enzymes which catalyse the next three steps in the pathway
have not been isolated from plants, but have been isolated from
micro-organism s. The NADPH dependent reduction of L-2,3- 
dihydrodipicolinic acid (2) to L-2,3,4,5-tetrahydrodipicolinic acid (2 4 ) 
is followed by succinylation of the amino group with succinyl CoA.
This reaction is catalysed by tetrahydrodipicolinate succinylase 
(THDPS). Succinylation serves to protect the amino group of (24)
during the synthesis of LL-2,6-diam inopim elate (27). The N -succiny l 
intermediate (25) is aminated at the exposition in an amino 
transferase reaction with glutamate as the amino group donor. The
enzyme which catalyses this step is succinyl diam inopim elate 
transferase. Desuccinylation of N-succinyl diaminopimelic acid (26) 
with succinyl diaminopimelate desuccinylase results in the formation 
of LL-2,6-diaminopimelic acid (27). This is epimerised to m e so- 2,6- 
diam inopimelic acid (28) catalysed by diaminopimelate epimerase.
Finally decarboxylation at the D-centre of m e5 0 -2 ,6 -d iam in o p im elic  
acid (28) gives L-lysine (1). Diaminopimelate decarboxylase has 
been detected in E. coli,5 9 and in maize6 0 and wheat germ.6 1»6 2
An unusual enzyme, /ne jp -d iam inop im ela te  dehydrogenase, 
has been detected in maize.6 3 It seems in maize that there could be
an alternative biosynthetic route which bypasses several stages of 
the proposed pathway and directly converts L-2,3,4,5- 
tetrahydrodipicolinic acid (24) into m es  0-2 ,6-diam inopim elate (28). 
The diaminopimelate pathway to L-lysine (1) is discussed in more
detail in Chapter 2.
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The enzymic reactions that we have investigated are the 
dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate 
reductase (DHDPR) steps of the diaminopimelate pathway to L -ly sine  
(1) found in bacteria.
1.4. Design of Inhibitors of the DAP Pathway to L-Lvsine.
we.y0-2,6-Diaminopimelic acid (28) is a building block of the 
peptidoglycan of most Gram-negative as well as Gram-positive 
bacteria. It is introduced into this network as part of the cross- 
linking moiety between polysaccharide fibres.6 4 *65
Inhibitors of peptidoglycan biosynthesis such as (3-lactams,4 5 
fosfom ycin  6 6 D -cycloserine,6 7 L -alanyl-L-am inophosphonic acid6 8 
and vancomycin, for instance, have powerful antibiotic p ro p e rtie s . 
Hence, the enzymes of peptidoglycan processing appear to be good 
targets for the rational design of new antibacterial agents.6 6 The 
absence of the peptidoglycan network in mammals also implies that 
such an approach to inhibitors of the DAP pathway to L-lysine (1) 
should provide selective toxicity against bacteria.
It is noteworthy that LL-2,6-DAP (27), m eso -2 ,6-DAP (28) a n d  
L-lysine (1) are biosynthetically closely related (Schem e 5) as 
lysine is formed from LL-2,6-DAP by epimerisation followed by 
decarboxylation of m e so- 2,6-DAP (28).6 4 *69 Hence, potential
inhibitors of the DAP pathway to L-lysine (1) should have 
antibacterial properties with no mammalian toxicity. It is a ssu m e d  
that the DAP pathway to lysine in plants is analogous to the enzymic
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production of lysine in bacteria. Therefore, inhibitors may be 
produced which have antibacterial and/or herbicidal activity.
The synthesis of L-aspartic acid-p-semialdehyde (21) was f i r s t
reported by Black and Wright in 1955.7 0 In Chapter 3 we report an
improved synthesis of this starting substrate. Mechanistic studies 
carried out using this compound and biological results obtained doing 
this work will also be discussed in Chapter 3. Analogues of L-
aspartic acid-P-sem ialdehyde (21) have been synthesised and tested 
as inhibitors of DHDP Synthase. This will be discussed in Chapter 4. 
Derivatives of pyruvate (22) have been prepared. The interesting 
test results that they showed will be discussed in Chapter 5.
The first synthesis of the proposed intermediate L-2,3,4,5-
tetrahydrodipicolinic acid (24) was achieved within our group by Dr. 
L. Couper. This will be discussed in Chapter 2. Analogues of L-
2 ,3 ,4 ,5-tetrahydrodip icolin ic  acid (24) and L -2 ,3 -d ih y d ro d ip ico lin ic  
acid (23) with an additional heteroatom in the ring, namely 1,4-
thiazines (29) and 1,3-thiazoles (30), have been synthesised. Their 
preparation and test results will be discussed in Chapters 6 and 7
re sp e c tiv e ly .
(29) (30)
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C h ap te r F21 - The D iam inopim elate (DAP) Pathw ay to L-
L v s in e .
In tro d u c tio n
The diaminopimelate (DAP) pathway of lysine biosynthesis has 
been mainly studied in bacteria and is also considered to be the 
major pathway operating in higher plants. Among the se v en  
enzymes of Escherichia coli involved in the DAP pathway from L- 
aspartic acid-p-semialdehyde (21) to L-lysine (1), only four of them 
have been identified in plants. In this Chapter reported studies on 
each of the enzymes of the DAP pathway in bacteria and in higher 
plants will be reviewed. This will include a discussion on enzyme 
isolation and purification, mechanistic studies carried out on each 
particular enzymic step, and compounds which have been 
synthesised and tested as substrates or inhibitors for individual 
en zy m es.
2.1 D ihydrodipicolinate Synthase.
Dihydrodipicolinate synthase (DHDPS) catalyses the 
condensation of pyruvic acid (22) and L-aspartic acid-p- 
semialdehyde (21) to form L-2,3-dihydrodipicolinic acid (23). It is a 
branch point enzyme in the aspartate family of amino acids 
(Schem e 4), which leads to L-lysine (1) via 7 enzymic steps and the
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interm ediate m e so  -2,6-DAP (28). DHDPS has been detected in a
broad range of species and tissues.4 5 ’71
In bacteria DHDPS is subjected to two different types of control: 
the E. coli DAP pathway is characterised by a lysine feedback 
inhibition of DHDPS, while Bacillus species have a lysine insensitive 
form of DHDPS.7 2 ’73 DHDPS has been purified 5000-fold from crude 
extracts of E. coli W? 4 The enzyme has been shown to be
homogenous by polyacrylamide gel electrophoresis and bears a
negative charge in the pH range 6.0 to 9.2. Its molecular weight was 
determined as 134,000 daltons.
All plant DHDPS enzymes characterised at the regulatory level 
belong to the lysine sensitive type. The plant enzyme has been
detected in chloroplasts of spinach leaves and is presumed, as are th e  
other enzymes of the plant DAP pathway, to be active only in such 
o rg an e lle s .7 5 ’76 There are four reports which focus on higher plant 
DHDPS. The enzyme was first demonstrated by Cheshire a n d
M iflin45 in 1975 using maize seedlings as the source of the en zy m e.
The spinach leaf DHDPS was partially purified and characterised in
1981 by Wallsgrove and Mazelis.7 7 They succeeded in producing a 
fraction of the enzyme from spinach leaves that was purified 87-fold 
and had a specific activity of 836 units mg- 1 protein.
Wheat DHDPS, in a semi-pure form, was more recently used to 
investigate the kinetics and .the inhibitory features of DHDPS.5 2 The 
enzyme was purified about 5100-fold from suspension cultured cells
of wheat (Triticum aestivum  var. Chinese Spring). The enzyme has 
an average molecular weight of 123,000 daltons as determined by
gel filtration and exhibited maximum activity at pH 8.0.
2 0
The most recent isolation of the enzyme was from N icotiana  
s y lv e s tr is  by Ghislain et al? 8 The synthase was localised in the
chloroplasts and identified as a soluble stromal enzyme by enzymatic 
and immunological methods. It has been purified and c h a ra c te r ise d  
and the molecular weight of the enzyme was shown to be 164,000 
daltons by an electrophoretic method. By carrying out isotopic 
labelling experiments with 14C-pyruvate, the enzyme was shown to
be composed of four identical sub-units of 38,500 daltons.
2.2 Mechanism of Dihydrodipicolinate Synthase.
The sequence of steps in the mechanism of formation of L-2,3- 
dihydrodipicolinic acid (L-2,3-DHDPA) (23) from L-aspartic acid -0 - 
semialdehyde (21) and pyruvate (22) has not yet been fully
established. Pyruvate binds to the enzyme via an amino group on
the lysine.57*74 One possible mechanism is a C-C bond formation
between the aldehyde group of (21) and the methyl carbon of (22) in 
an addition reaction to give the enzyme bound intermediate (31). 
This would be followed by ring closure to give 4 -h y d ro x y -L -2 ,3 ,4 ,5 - 
THDPA (34). Loss of a mole of the elements of water gives the
enzymic product (23) (Schem e 6). An alternative mechanism could
be first of all the formation of the imine intermediate (32). This 
would be followed by a ring closing addition step to give 4-hydroxy-
L-2,3,4,5-THDPA (34). As before, the loss of a mole of the elements 
of water would give the enzymic product (23) (Schem e 7).
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Kinetic studies carried out by Schedlarski and Gilvarg7 4 on
DHDPS isolated from E. coli suggest that the enzyme functions in C-C
bond formation by first of all forming an imine linkage with
pyruvate (22). They have shown that there is irreversible loss of
enzymatic activity upon the addition of sodium borohydride only in
the presence of pyruvate (22). This suggests that the formation of a 
Schiffs base intermediate between DHDPS and pyruvate (22) ta k e s
place in the enzymic reaction. Moreover they have established b y
chromatographic and electrophoretic methods that the Schiffs base is
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between the carbonyl group of pyruvate (22) and an e-amino group
of a lysine group attached to the protein.
From kinetic studies caried out on DHDPS isolated from wheat
suspension cultures, Kumpaisal et aF 7 have proposed that the
reaction proceeds in a 'ping-pong' mechanism. First of all pyruvate
(22) binds to the enzyme to form a Schiffs base (Km 11.76 mM). Km 
is the Michaelis constant. This is the * dissociation constant of th e
enzyme-substrate complex. Water is then released, followed by 
binding of L-aspartic acid-p-sem ialdehyde (21) (Km 0.88 mM).
F o o tn o te  ;
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Nucleophilic attack of the pyruvyl enamine on the L-aspartic acid-p- 
sem ialdehyde aldehyde group could then take place to give 
intermediate (31). The mechanism of DHDPS will be d isc u sse d
further in Chapters 3 and 4.
The product of the enzymatic reaction catalysed by DHDPS was
found to be very labile, severely limiting efforts for its thorough
characterisation. It has been suggested that the proposed product, L-
2,3-DHDPA (23), would be expected to be in equilibrium with L -2,5- 
dihydrodipicolinic acid (33) and 4-hydroxy-L-2,3,4,5-THDPA (3 4 ) 
(Schem e 8).7 4 It is not clear which of these compounds is the
immediate product of the enzymatic reaction.
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2.3. Inhibition of Dihydrodipicolinate Synthase.
The DHDPS enzyme from N. sylvestris, isolated by Ghislain e t 
a l,7 8 is strongly inhibited by lysine with an ID50 of 15 pM. The ID50 
value denotes the dose of inhibitor required to produce 50% 
inhibition. S -(2-A m inoethy l)-L -cysteine and yhydroxylysine, tw o
* /Is l#f\<\ as r O  - K/ij .
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lysine analogues, were found to be only weak inhibitors. An 
analogue of pyruvate (22 ), 2 -oxobutyrate, competitively inhibited
the enzyme and was found to act at the level of the pyruvate-
binding site.
With DHDPS isolated from wheat c u ltu re s 5 1 allosteric inhibition
was observed with increasing concentrations of L-lysine (1) and its
structural analogues, including //* reo-4-hydroxy-L -lysine and S-(  2-
am inoethyl)-L -cysteine, with respective ID50 values o f 51, 141 a n d
288 mM. These amino acids were competitive inhibitors with
respect to L-aspartic acid-P-semialdehyde (21) and n o n -c o m p e titv e
inhibitors with respect to pyruvate (22). The wheat enzyme was
*
also inhibited by Zn2+, Cd2+ and Hg2+ and also by sulphydryl 
inhibitors such as /?-(hydroxym ercuri)benzoic acid and p -  
ch lorom ercuribenzenesulphonic acid.
Within our group at Glasgow, Borthwick1 21 has tested 
analogues of L-2,3-DHDPA (23) and L-2,3,4,5-THDPA (24) on DHDPS 
isolated from E. coli. These compounds, which include dipicolinic acid 
(36) analogues, chelidamic acid (35) analogues and piperidine-2,6- 
dicarboxylic acid (37) analogues, were synthesised by Dr. L. Couper.
Chelidamic acid (35) and its N -substituted analogues showed 
good inhibition of DHDPS at low concentrations. N -M eth y lch e lid am ic  
acid showed the best inhibition, 63% was observed at 0.1 mM. The 
diesters of chelidamic acid and their N -substituted analogues also 
showed good inhibition.
Dipicolinic acid (36) showed significant inhibition of DHDPS at 
0.5 mM, as did some its analogues. Changing the diacid to a diester, a 
dicyano, a diimidate or a ditetrazole derivative had little effect on
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the amount of inhibition. Poor inhibition was observed with the fu lly  
saturated piperidine-2,6-dicarboxylic acid (37) analogues. However 
piperid-4-one-2,6-dicarboxylic acid and its N-m ethyl derivative 
showed good inhibition.
Compounds with only one carboxyl group such as pipecolinic 
acid, proline and picolinic acid and their analogues showed little or 
no inhibition of DHDPS, showing the importance of two carboxy lic  
acid groups in binding to the active site of the enzyme.
O
COoH
(35)
Inactivation of Wheat DHDPS by 3-Bromopyruvate.8 0
3-Bromopyruvate was first introduced by Meloche7 9 as an 
active site directed alkylating reagent and has proved to be quite 
versatile in labelling pyruvate binding sites of many enzymes.8 0 
Kumpaisal et al*  1 have studied the inhibitory effects of 3- 
bromopyruvate on DHDPS isolated from wheat cultures. The a ssa y  
system they used was developed by Yugari and Gilvarg5 6 and 
involved o-aminobenzaldehyde. The chromophore of the product 
formed from L-2,3-DHDPA (23) and 0 -am inobenzaldehyde w a s  
observed by its spectrophotomeric absorbance at 540 nm.
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They have shown that 3-bromopyruvate inhibits wheat DHDPS 
considerably at 1 mM. Kinetic studies have shown that this 
compound inhibits in a competitive manner with respect to pyruvic 
acid (22) and in a non-competitive manner with respect to L -asp a rtic  
acid-(3-semialdehyde (21). The calculated Ki for 3-bromopyruvate 
was 1.88 mM. Ki is the dissociation constant of the non-productive 
enzym e-inhibitor complex.
From the results of Kumpaisal et al. it appears that 3- 
bromopyruvate inactivates DHDPS by alkylating nucleophilic amino 
acid residues at or near the active site. The competitive type o f  
inhibition with respect to pyruvate and the protection by pyruvate 
against inactivation indicate that reacting groups at or near the
pyruvate-binding site of DHDPS are modified by 3-bromopyruvate.
The pseudo first order kinetics observed for the initial 
inactivation with 3-bromopyruvate is consistent with a two s te p
binding process. The first process is probably a rapid, reversible 
Schiffs base formation between the enzyme and the inhibitor, 
followed by a slow, irreversible alkylation step. The Km of pyruvate 
(11.8 mM) is considerably larger than the Ki of 3-bromopyruvate 
(1.8 mM). The electron withdrawing bromine in 3-brom opyruvate 
promotes Schiffs base formation between the amino group of an
amino acid residue of the enzyme and the carbonyl carbon of 3-
bromopyruvate, resulting in a higher affinity of 3 -b ro m o p y ru v a te  
than of pyruvate.
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2.4. Biosynthesis of Dipicolinic Acid (36) in Bacillus subtilis.
In 1966 Bach and Gilvarg8 2 demonstrated that cell free
extracts prepared from sporulating cultures of Bacillus m e g a te r iu m
can carry out the net synthesis of dipicolinic acid (DPA) (36) from
pyruvate (22) and L-aspartic acid-p-semialdehyde (21). Subsequent
results on DPA (36) formation in spore forming bacteria have
suggested that the reaction leading to the synthesis of DPA (36) from
l -2,3-DHDPA (23), which is the reaction product of DHDP Synthase in
E. coli,s 6 occurs as a branch of the pathway for lysine biosynthesis i n
b a c te r ia 8385 (Schem e 9).
It is difficult to demonstrate the conversion of L-2,3-DHDPA
(23) into DPA (36) as an isolated reaction, since the substrate is
extremely unstable. It has not been confirmed whether the
*
conversion is an enzymic process or just spontaneous air oxidation of 
L-2,3-DHDPA (23).
The chemical synthesis of DPA (36) from oxaloacetic acid and 
L-aspartic acid-P-sem ialdehyde (21) was investigated by Kimura in 
1 9 7 3 .8 6 This work will be discussed in more detail in Chapter 3.
2.5. D ihydrodipicolinate Reductase.
The enzyme dihydrodipicolinate reductase (DHDPR) catalyses a 
pyridine nucleotide linked reduction of L-2,3-dihydrodipicolinic ac id
(23) to L-2,3,4,5-tetrahydrodipicolinic acid (24) in the DAP pathway 
to L-lysine (1) (Schem e 9).
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The enzyme was first described by Farkas and Gilvarg in 1965 
from E. co//.89 More recently, Tamir and Gilvarg8 7 modified their 
procedure by carrying out additional purification steps which led to a 
preparation of this enzyme from E. coli that was homogeneous as 
judged by sedimentation pattern and gel filtration and was at least
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95% pure as judged by gel electrophoresis. The molecular weight 
was found to be 110,000 daltons; the Km value obtained for L-2,3- 
DHDPA (23) was 9.0 pM, and the pH optimum for the reaction was
7.0 with either NADH or NADPH as the co-catalyst.
DHDPR has also been isolated and partially purified by Tyagi e t  
al.5 8 from three week old maize kernels. The crude maize extract 
and the partially purified enzyme were assayed for DHDPR by their 
ability to restore the capability of crude extracts of a mutant E. coli t o 
synthesise m e s o -2,6-diam inopim elate (28) from L-aspartic acid-(3- 
semialdehyde (21) and pyruvate (22). In a study of its properties, 
the Km value obtained for l-2,3-DHDPA (23) was 0.43 mM and for
NADPH the Km was 46 pM. The enzyme had a pH optimum close to
7.0 and was much more temperature labile than the bacterial 
enzyme. Its molecular weight was 80,000 daltons.
2.6. Mechanism of Dihvdrodipicolinic Reductase.
L-2.3-Dihvdrodipicolinic Acid (23)
The substrate for this enzymic step is the proposed product o f
DHDP Synthase, L-2,3-DHDPA (23). As previously mentioned, th is  
product is very labile and is immediately oxidised by either an
enzymic or a chemical process to dipicolinic acid (DPA) (36) and, as 
such, the purification and characterisation of L-2,3-DHDPA (23) has 
proved very difficult. Kimura8 6 suggested that L-2,3-DHDPA (23) 
might exist in equilibrium with L-2,5-DHDPA (33) and 4-hydroxy-L-
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2,3,4,5-THDPA (34) (Schem e 8). Theoretically it is also possible for 
L-2,3-DHDPA (23) to exist as an open chain compound. It has not
been established which is the true physiological substrate of the 
reductase enzyme although it has been assumed to be l -2,3-DHDPA
(23).
For the studies carried out on maize DHDPR,53 l-2,3-DHDPA
(23) was synthesised by the condensation of L-aspartic acid-P- 
semialdehyde (21) with oxaloacetic acid in alkali. The reaction was 
accompanied by evolution of a stoichiometric amount of CO2. L -2,3- 
DHDPA (23) was partially purified and isolated as the barium salt. 
The compound was stored in water at -80 °C due to its instability at
room temperature at neutral pH. As such, only freshly synthesised 
compound was used in the enzyme assays. This reaction will be 
discussed further in Chapter 3.
Mechanism of Formation of L-2.3.4.5-Tetrahvdrodipicolinic Acid (24).
The enzymes that catalyse hydride transfer reactions have
been shown to fold into two distinct domains with cofactor in one
domain and substrate in the other. When a substrate is reduced the
hydride anion is transferred from the nicotinamide ring of NADPH to 
produce NADP+. The reduced co-enzyme has a prochiral centre and
the process is stereospecific. The hydride anion attacks at the 4- 
position of L-2,3-DHDPA (23) (Schem e 10). It has not yet been 
established whether the enzyme donates the p ro -S  or the p ro -R
hydrogen of its co-factor NADPH.
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Scheme 10
L-2.3.4.5-Tetrahydrodipicolinic Acid (24).
L-2,3,4,5-THDPA (24) is the second intermediate on the DAP 
pathway to L-lysine (1). It is formed from the NADPH dependent 
reduction of L-2,3-DHDPA (23) catalysed by DHDPR. There have b e e n  
several syntheses claimed of this intermediate.
S h ap sh ak 8 8 reported the synthesis of d-2,3,4,5-THDPA b y 
treatment of /we$0-2,6-diaminopimelic acid (28) with L-amino acid 
oxidase isolated from Neurospora crassa. There was no chemical or 
spectroscopic evidence given for the product he made.
Farkas and Gilvarg8 9 investigated the enzymic reduction of L-
2,3-DHDPA (23) to L-2,3,4,5-THDPA (24). DHDPR was isolated from 
E. coli and partially purified. Reduction of the enzymic reaction 
product (24) with sodium borohydride gave p ip e r id in e -2 ,6 -
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dicarboxylic acid (37). This was characterised by comparison of its 
Rf value with authentic piperidine-2,6-dicarboxylic acid. The so lv e n t 
system used was methanol-water-pyridine (8:1:1). The Rf v a lu e s  
were identical.
Kimura and Sasakawa9 0 reported the formation of DPA (36) 
and l-2,3,4,5-THDPA (24) on cyclisation of aa'-dioxopim elic acid (38) 
with ammonia. Since the reaction rate was not affected by the 
presence or absence of oxygen, they assumed that the presumed 
initial product, 1,4-dihydrodipicolinic acid (39), d isproportionated to 
DPA (36) and L-2,3,4,5-THDPA (24) (Schem e 11). The products 
were identified by UV absorption (DPA at 270 nm) and by colour 
reactions with ninhydrin and 0 -am inobenzaldehyde (L-2,3,4,5- 
THDPA).
The potassium salt of L-2,3,4,5-THDPA (24) has been prepared 
by the elimination of /7-toluenesulphinic acid from the N- 
toluenesulphonyl derivative of dimethyl A M o sy l-c /j-p ip e rid in e -2 ,6 - 
dicarboxylate (42) by one of my co-workers Dr. L. Couper ( S c h e m e
Dimethyl 7V -tosyl-c/s-piperidine-2,6-dicarboxylate (42) was 
synthesised from dimethyl c/\s-piperidine-2,6-dicarboxylate (41) b y  
stirring it overnight in pyridine with toluenesulphonyl
0 2C  JN+  C O 2H
H2
(37)
1 2 ).9 1
NH,
H 02C O O ^ c O jH  
(38)
xx0 2C N+ C 02H
h 2
(39)
Scheme 11
3 3
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ja"02C N ' CQ2H 
H
L-2,3,4,5-THDPA
(24)
0 2C N. C 02H 
H
DPA (36)
jO.M e02C N C 02Me M e02C ' N ^ C 0 2Me 
(4°) (4i)
jO l jO lK+ 0,C  N CO,K+ K+ 0 , C N C 0 , K +
H
(43)
H
L-2,3,4,5-THDPA
(24)
I
.,,Gk + o 2c  n
Hn
c o c o 2 k
(44)
n .Me02C N C 02Me 
Ts 
(42)
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chloride. Hydrogenation of dimethyl dipicolinate (40) gave (41) in 
good yield. Dimethyl dipicolinate (40) was made from dipicolinic
acid (36) by heating at reflux in methanol and conc. sulphuric acid.
The elimination was carried out using potassium f-butoxide in 
dichloromethane at room temperature. The ester groups were
simultaneously cleaved during the reaction. Purification was 
achieved by stirring the reaction product in distilled water with the 
weak anion exchanger Amberlite 1R-45 (hydroxide form) for 2 4 
hours to remove p-toluenesulphinic acid. *H and 13C-NMR data
indicated that L-2,3,4,5-THDPA (24) exists in solution in e q u ilib riu m  
with the corresponding enamine (43) and an open chain form (44).
THDPA (24) was shown to be unstable at neutral or acidic pH.9 1
2.7. Inhibition of Dihydrodipicolinate Reductase.
The DHDPR enzyme isolated from E. coli by Tamir and Gilvarg8 7 was 
inhibited by DPA (36). It was found to be a com petitive inhib itor 
with the substrate with a Ki value of 1 mM. a-Picolinic acid (45) and 
isophthalic acid (46) were also found to be inhibitors of the reaction.
The latter was also shown to be competitive with the substrate with
a Ki of 15 mM. The high affinity and competitive nature of the
inhibition shown by DPA (36) and to a lesser extent, isophthalic acid
(46) strongly suggests that a cyclic form of the substrate binds to the 
active site on the enzyme.
With the plant DHDPR isolated from maize by Tyagi et al.,5 8 oc- 
picolinic acid (45), L-pipecolic acid (47), isophthalic acid (46) and
3 5
(45) (46)
isocinchomeronic acid (48) all inhibited the enzyme activity. These 
compounds all have similar structures to L-2,3-DHDPA (23) ( T a b le  
1 ).
INHIBITOR % INHIBITION
20 mM 10 mM 5 mM 1.5 mM
24 4 8 0
23 30 0 0
a-Picolinic Acid (45) 
L-Pipecolic Acid (47)
.Oo 2c  n ;
Ho
Isophthalic Acid (46) 
Isocinchomeronic Acid (48)
c o 2hjcr
0 2C Nf 
H
Dipicolinic Acid (36)
44 20 0
50
100
Tabte i
Dipicolinic acid (36) was by far the most potent inhibitor that 
they tested. It was a competitive inhibitor with a Ki value of 0.9
3 6
mM. This is analogous to the inhibition shown by DPA (36) on 
bacterial DHDPR. Similar to the conclusion reached with b a c te r ia l 
DHDPR, competitive inhibition of the reductase reaction by DPA (3 6 ) 
suggests that the substrate for this enzyme is in the ring form rather 
than the open chain form.
2.8. Succinvl CoArTetrahvdrodipicolinate A T-Succinvltransferase.
Succinyl CoA:Tetrahydrodipicolinate A/r-S u c c in y ltra n s fe ra se  
(Succinyl CoA:THDPS) catalyses the AT-succinylation of L-2,3,4,5- 
THDPA (24) by succinyl coenzyme A to form L -2 -(su cc in y lam in o )-6 - 
oxopimelic acid (25) (Schem e 13). Succinylation serves to protect 
the amino group during the synthesis of L L -2 ,6 -d iam in o p im ela te  
(27). Either acetyl CoA or succinyl CoA can be used for the acylation 
step used in protection in micro-organisms.
, \ ' C 0 2'  Tetrahydrodipicolinate 
v /V-Succinyftransferase H O 2C(CH^)20 O N H — C " iC 0 2
Succinyl CoA CoASH
(25)(24)
Scheme 13
Succinyl CoArTHDPS was first isolated from E. coli by Gilvarg in 
1 9 6 19 2 and more recently, enzyme activity has been demonstrated 
in B re v ib a c te r iu m  by Tosaka and Takinami.9 3 However, the
3 7
isolation, physical characterisation and initial kinetic studies of this
enzyme have only relatively recently been described by Simms et al. 
in 1984.9 4
2.9. Mechanism of Succinyl CoA:Tetrahydrodipicolinate N-
Succinv l tran s fe ra se .
In 1986 Gilvarg et al.9 5 studied analogues of L-2,3,4,5-THDPA
(24) for their ability to act as substrates or inhibitors of the 
succinylase. From the results obtained and studies on the 
interactions of these compounds at the active site of the enzyme they 
were able to draw certain conclusions concerning the catalytic 
mechanism of the enzyme and the structural requirements of the
catalytic site. From these conclusions they proposed a s te reo c h em ic a l 
model for the succinylation of L-2,3,4,5-THDPA (24) (Schem e 14). 
This involves the succinylase enzyme first binding L-2,3,4,5-THDPA
(24). This is followed by the hydration of the imine group where 
water adds to the double bond cis  to the C-2 carboxyl group to give
2-hydroxyp iperid ine-2 ,6 -d icarboxy lic  acid (49) in which the two 
carboxyl groups are tra n s  to each other. The hydrated product (4 9 ) 
is then succinylated to give (50). This is followed by ring opening to 
give the acyclic product L-2-(succinylam ino)-6-oxopim elic acid (51).
The carboxyl groups are the primary ligands involved in the 
binding of L-2,3,4,5-THDPA (24) to the succinylase enzyme. The
hydration of the imine occurs enzymically, but the enzyme does not 
necessarily catalyse ring opening. Opening of the ring may occur in a
3 8
concerted manner during or after succinylation. It is also possible
that ring opening occurs after dissociation of the succinylated THDPA
(50) from the enzyme.
In aqueous solution, l-2,3,4,5-THDPA (24) can exist in a
number of forms which are shown in Schem e 15. In Section 2.10
2 i COO-
o o c - ^ ^ S o -  + H* °  o o c ' ^ \
L-2,3,4,5-THDPA H
(24) (49)
^-Succinyl CoA 
^CoA SH
COO' COO
'00C' T ^
0OCCH2CH2" CO l X X X S f B r %  iH
(51) (50)
Scheme 14
certain acyclic analogues of L-2,3,4,5-THDPA (24) will be shown to be 
substrates for the succinylase enzyme and, as such, it is reasonable to  
postulate that the open chain form (53) of l-2,3,4,5-THDPA could be 
the true substrate of the enzyme. Gilvarg et a l9 5 however, have 
proved that this is not the case. They carried out experiments to 
measure the spontaneous rate of ring opening of l-2 ,3 ,4 ,5 -T H D PA
(24) using 2,4,6-trinitrobenzenesulphonic acid as a trapping agent fo r  
primary amines. Their results showed that the non-enzymatic rate 
of ring opening is insignificant compared to the enzyme-catalysed
3 9
rate of succinylation. Hence, the acyclic form of L-2,3,4,5-THDPA
(53) is unlikely to be the true enzyme substrate although it 
undoubtedly exists in aqueous solution, but only as a small fraction 
of the total THDPA.
..Cl'0 2C N. C 02H 
H2 
(52)
0 2c " C o ^  CO,H
(53)
, n~ 0 £ ' N+ C 02H 
H
(24)
-R>0 +h 2o
.ac o 2h~02C N+ 'OH
h2
(49)
Scheme 15
2.10. Inhibition of Succinyl CoA:Tetrahydrodipicolinate N-
S u cc in v ltran sfe rase .
As previously mentioned, inhibitor and substrate studies have
been carried out on succinyl CoA:THDPS by Gilvarg et al.9 5 In the 
succinylase enzyme assay, transfer of the succinyl group from
succinyl CoA was followed by measuring the appearance of the free 
sulphydryl group of CoASH with 5,5’-dithiobis-2-nitrobenzoic acid 
(DTNB, Ellman's reagent). The enzyme assay contained 100 m M
4 0
potassium phosphate, 0.5 mM DTNB, L-2,3,4,5-THDPA (24) and the 
succinylase enzyme. Compounds were tested initially at 5 mM. The 
reaction was started with the addition of succinyl CoA and was 
followed by looking at the spectrophotomeric absorbance at 412 nm. 
The compounds which were tested could be split into 2 categories: 
acyclic and cyclic analogues of L-2,3,4,5-THDPA (24).
Acyclic Analogues of L-2.3.4.5-THDPA,
DL-2-Aminopimelic acid was previously found by Simms96 to  
be both a substrate and an inhibitor of succinyl CoArTHDPS. Gilvarg 
et a l 9 5 investigated this further by resolving the racemic mixture of 
DL-2-aminopimelic acid and testing the enantiomers separately. L -2- 
Aminopimelic acid (54) was found to be a good substrate and sh o w ed  
a Vmax similar to the natural substrate, L-2,3,4,5-THDPA (24), but
had a Km approximately 50-fold higher. D-2-Aminopimelic acid was 
not a substrate of the succinylase, showing that stereochemistry a t 
the a-carbon is important in determining substrate activity. 
However, D-2-aminopimelic acid was a competitive inhibitor of the 
enzyme with respect to L-2,3,4,5-THDPA (24) with a Ki value of 0.76 
mM .
Related acyclic compounds were also tested for inhibitor 
activity in the succinylase assay. Increasing the chain length of (54) 
by one methylene group as in DL-2-aminosuberic acid or by
4 1
HOoCAH
(54)
\C 02-
NH*
decreasing by one methylene group as in DL-2-aminoadipic acid 
resulted in neither inhibition nor substrate activity. Substituting a 
sulphur for a methylene as in L-2-amino-4-thiaadipic acid gave a
high Ki value of 125 mM and little, if any, substrate activity. DL- 2- 
Aminothiapimelic acid gave a Ki of 1.1 mM, similar to the Ki for (54). 
Close investigation of this compound also revealed that it had a low 
level of substrate activity. 2-Oxopimelic acid was a weak inhibitor. 
However, both enantiomers of 2-hydroxypimelic acid had better 
affinity for the enzyme than the corresponding enantiomers of (54),
although L-2-hydroxypimelic acid did not have any substrate 
activity. L-2- Amino-D-6-hydroxypimelic acid was found to be a 
better substrate than (54). DL-2,6-Dihydroxypimelic acid was a 
relatively good inhibitor with a lower Ki value than (54).
Cyclic Analogues of L-2.3.4.5-THDPA.
A number of cyclic compounds were also tested on succiny l 
CoA:THDPS. Only one was found to be a substrate, namely 3,4-
d ih y d ro -2 tf-l,4 -th iaz in e-3 ,5 -d ica rb o x y lic  acid (DHT) (55). This 
compound had a Vm^about one-half of that of the natural substrate 
L-2,3,4,5-THDPA (24). Its Km was slightly higher than L- 2-
aminopimelic acid (54). This can be explained by the fact that only
the enamine tautomeric form of DHT (56) (Schem e 1 6 )  was
4 2
observed in the *H NMR spectrum of the disodium salt in aqueous
solution. Hence, the high Km of DHT (55) may be explained because
the imine form, which is used as a substrate of the succinylase,
makes up only a small fraction of the total DHT.
Xs!
'0 2C  N + C O jH  '0 2C  N f C O jH
H  H 2
(55) (56)
Scheme 16
Other cyclic compounds were found to be inhibitors and are 
listed in Table 2. When compared to L-2,3,4,5-THDPA (24),
compounds containing fully unsaturated rings (eg. pyridine, benzene 
and pyran analogues) were all weak inhibitors with Ki values at least
50-fold higher than the Km for L-2,3,4,5-THDPA (24).
Fully saturated rings (eg. piperidine, tetrahydropyran,
cyclohexane and tetrahydrothiopyran analogues) were also weak 
inhibitors. A notable feature of these compounds is that trans-  
isomers are better inhibitors than the corresponding cis-com pounds. 
As was found with the acyclic compounds, placing a hydroxy group 
alpha to the carboxyl group greatly enhanced the inhibition. The 
best inhibition was shown by 2 -h y d ro x y te tra h y d ro p y ra n -2 ,6 -
dicarboxylic acid (57). This was a competitive inhibitor with respect 
to l -2,3,4,5-THDPA (24) with a Ki value of 0.06 pM.
4 3
STRUCTURE X NAME K i ( p M )nH02C X ^ O O jH N Dipicolinic Acid 12,800CH Benzene-2,6-dicarboxylic Acid 8,500
jO lH0 2c  c r x o 2H
Pyran-2,6-dicarboxylic 
Acid
1,800
o
AHO2C X CO2H
NH Chelidamic Add 2,600
0 Chelidonic Add 3,100
HO2Cx' ^ j r v 0 O2H
NH
0
tram- Kperidine-2,6-dicarboxylic 
Acid
mzw-Tetrahydropyran-2,6- 
dicarboxylic Add
2,000
680
NH
0
c/5- Piperidine-2,6-dicarboxylic 
Acid
ris-Tetrahy dropyran-2,6- 
dicarboxylic Add
63,000
3,900
H0 2C ^ ^ ^ C 0 2H 
Y °  OH
Y =  H (57) 2-Hydroxytetrahydropyran-
2.6-dicarboxylic Acid
Y *  OH 2,6-Dihydroxytetrahydropyran-
2.6-dicarboxylic Add
0.06
0.20
H02cJ 3 ^ C02H
OH
/ram-2-Hydroxycyclohexane- 
2,6-dicarboxylic Add
c/5-2-Hydroxycyclohexane- 
2,6-dicarboxylic Add
5,600
12,000
Table 2
2.11. TV-Succinvl Diaminopimelate Aminotransferase.
4 4
TV-Succinyl diaminopimelate am inotransferase catalyses the 
conversion of L-2-(succinylamino)-6-oxopimelic acid (25) into L- 2- 
(succinylamino)-6-aminopimelic acid (26). The succinylated 
intermediate is aminated at the e-position with glutamate as the 
amino group donor (Schem e 17).
H
.x\'C 0 2
H 02C(CH2)2C0NH ^  S S d a t e  H 02C(CH2)2C0NH
o
h o 2c \
^  . aminotransferase
P  /  ------T5— =\ ------ ► H-
(a l2>3
(25) Glutamate a-Ketoglutarate C02"
(26)
Scheme 17
TV-Succinyl DAP aminotransferase has been isolated from E. coli 
and has been partially purified and characterised by Peterofsky and 
G ilvarg.9 7 The aminotransferase is pyridoxal phosphate dependent 
and like most pyridoxal dependent enzymes the aminotransferase is 
inhibited by hydroxylamine. Treatment of the enzyme at 0 °C with 
0.05 M hydroxylamine causes an inhibition of 95%.
2.12. A-Succinvl Diaminopimelate Desuccinvlase.
A-Succinyl diaminopimelate desuccinylase catalyses the 
formation of LL-2,6-diaminopimelic acid (27) by the desuccinylation 
of L-2-(succinylamino)-6-aminopimelic acid (26) (Schem e 18).
The enzyme was detected in E. coli by Gilvarg9 8 and has been 
partially purified by Kindler and Gilvarg.9 9 The enzyme requires
Co2+ for activity.
H02C(CH2)2C0NH-
H-
(CI 2^)3
A-Succinyl 
diaminopimelate 
desuccinylase
H*N-
H-
C 02"
(26)
(CI *2)3
Scheme 18
co2~
(27)
2.13. LL-Diaminopimelate Epimerase.
Several variations of m e so-  2,6-DAP (28) biosynthesis exist in 
different bacterial strains.1 0 0 Most bacteria (and higher plants) 
convert LL-2,6-DAP (27) into the meso-iorm  (28) catalysed by l l -  
diam inopim elate ep im erase,101-103 but some bacteria, such a s  
Bacillus sphaer icu s , bypass the LL-form (27) by directly converting 
L-2,3,4,5-THDPA (24) into me so-  2,6-DAP (28) using me so-
4 6
diam inopim elate dehydrogenase (Schem e 19).100,1 04-106 meso-  
Diaminopimelate dehydrogenase will be discussed in Section 2.15.
L-2,3,4,5-THDPA
(24)
LL-DAP (27)
Epimerase
Dehydrogenase
Decarboxylase
NH
meso-DAP (28) L-Lysine (1)
Scheme 19
LL-Diaminopimelate epimerase was detected over 30 years ago 
in E. colit but was only recently purified and fully characterised by 
modification of the method of Wiseman and Nichols.1 01 A 
purification of 2500-fold was achieved in overall 31% yield. T he 
purified LL-DAP epimerase had a specific activity of 35 units mg- *. 
It exists as an active monomer of molecular weight 34,000 daltons 
and requires no co-factor and no metal. Tyagi and co-workers1 0 2 
have isolated LL-diaminopimelate epimerase from two to three week 
old maize leaves.
The mechanism of LL-DAP epimerase resembles that of proline 
ra c e m a se .107 It uses an active site thiol group in the deprotonation-
4 7
protonation process of diaminopimelate epimerisation. Therefore,
some anionic character might be expected to develop at the a -c a rb o n  
centre and hence, the carbon framework at that site should be planar 
in the transition state (Schem e 20).
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2.14. Inhibition of LL-Diaminopimelate Epimerase.
Lam et a/.108 investigated the interaction of analogues of m esa-
2.6-DAP (28) with diaminopimelate epimerase from E. coli. T he
analogues which were tested for enzyme activity are shown in 
Schem e 21. A coupled enzyme assay was used to measure the
amount of inhibition. The conversion of LL-2,6-DAP (27) into m esa-
2.6-DAP (28) by the epimerase was measured by further
transformation of m e s a - 2,6-DAP (28) into L-2,3,4,5-THDPA (24) by
4 8
excess m eso -D AP dehydrogenase with formation of NADPH. NADPH 
formation was followed by observing the absorbance at 340 nm.
h 3n  n h 3
X = SO *(59) R -N H  ((62)X = S02 (60) R -N H 2 (62)
a. 2R, 6S c. 2S, 6S
b. 2S, 6R d. 2R, 6R
CMX ^  ^  ,CO-
RN
M  ^  H2N
(63)
R = H (64) 
R = Me (65)
Scheme 21
None of the DAP analogues tested irreversibly inactivated the 
epimerase. /we.y0-Lanthionine (58ab) and LL-lanthionine (58c) were 
both good competitive inhibitors with Ki values of 0.67 mM and 0.42 
mM respectively. The corresponding DD-isomer (58d) was at least 20 
times less effective as an inhibitor. This is in accord with the 
stereochemical requirements of the enzyme for its n a tu ra l  
su b s tra te s .
The LL- and DD-isomers of both lanthionine sulphoxides (59c 
and 59d) and lanthionine sulphones (60c and 60d) showed no 
detectable effects on the epimerase, but their corresponding me so-
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isomers (59ab and 60ab) were very weak competitive inhibitors 
with respective Ki values of 11 mM and 21 mM. The reduced 
activity of the lanthionine sulphoxides and sulphones could be due to 
electronic effects or to changes in the overall geometry.
A-Hydroxydiaminopimelate (61) proved to be an extremely 
potent competitive inhibitor with a Ki value of 5.6 pM for the 
mixture of isomers. The reason for this extremely good inhibition is 
unknown, but it may be that elimination of water from (61) occurs to 
generate an a-imine bound to the enzyme as a planar transition state 
analogue (Schem e 22). This could then be attacked by the active 
site thiol at the a-carbon in a reversible fashion.
N-Aminodiaminopimelic acid (62) was a less effective 
competitive inhibitor with a Ki value of 2.9 mM. This may be due to 
the inability of the terminal hydrazine amino group to leave through 
elimination. 4-Methylenediaminopimelic acid (63) was found to be 
a non-competitive inhibitor with a Ki value of 0.95 mM. Neither (64) 
or (65) showed any significant inhibition of the epimerase.
2.15. m es  o-D iam inopim elate D ehydrogenase.
/we$0-Diaminopimelate (DAP) dehydrogenase catalyses th e  
direct conversion of L-2,3,4,5-THDPA (24) into me so-  2,6-DAP (28) in 
one enzymatic step. The reaction is reversible and is co-catalysed by
B,1
HoN
HO
/ H H2NT-
b 2
(61)
HO - 
B2
Scheme 22
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NADPH and ammonia. It has been described as a reductive 
transamination reaction (Schem e 23).
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In 1976, Misono and co-w orkers109  demonstrated m e s o - D AP 
dehydrogenase activity in Bacillus sphaericus. This work w a s  
further extended in 1983 by White1 10 and was extensively studied
5 1
by Misono and co-workers.105’109’111 They purified the enzyme to 
homogeneity. SDS-polyacrylamide gel electrophoresis showed the 
enzyme to consist of two identical subunits, each with a molecular 
weight of 41,000 daltons. The enzyme showed maximum activity at 
pH 10.5. The occurrence of me so- DAP dehydrogenase has also b e e n  
described for a few other bacterial species.1 05 It is worth noting 
that the enzyme has not been detected in E. coli.
In plant systems, Wenko et al.1 12 have isolated and purified
m e  5 0-DAP dehydrogenase from Glycine max  embryos. Maximum
enzyme activity was observed at pH 8.0. From p re lim in a ry
molecular weight determinations the enzyme was found to have no
/
subunit structure and had an apparent molecular weight of 67,000 
d a lto n s.
The mechanism of m e so-DAP dehydrogenase has not yet b e e n  
fully established. Careful studies by Misono and Soda1 05 on the 
dehydrogenase from B. sphaericus showed that it donates the 4-pro-  
S hydrogen of its co-factor NADPH to the substrate in the reductive 
reaction and is highly specific for the m e  so-  isomer of DAP. In the 
active site of the dehydrogenase there is a non-essential thiol 
g ro u p 113  and a tryptophan residue .105  Product inhibition studies 
indicated that the sequence of addition of substrates in the oxidative 
deamination is NADP+ followed by m e so-  2,6-DAP (28) and that the 
order of release of products is ammonia, then L-2,3,4,5-THDPA (24) 
and finally NADPH.
5 2
2.16. Inhibition of m gS0-P iam inopim elate  Dehydrogenase.
Lam et a /.108 tested analogues of me s o -  2,6-diam inopim elic ac id  
(28) for substrate and inhibitor activity on the dehydrogenase 
enzyme from B. sphaericus.1 0 5 The dehydrogenase assay system 
monitored NADPH formation spectrophotomerically at 340 nm.
From substrate studies they found that the enzyme is
stereospecific for /we 5 0-isomers and barely accommodates 
substituents on the carbon chain. m e so- Lanthionine (58ab) was a 
poor substrate (Km 5.8 mM) compared to m e  so-  2,6-DAP (28) (Km 1.1
mM), with a relative Vmax 1% of that observed for the natural
substrate. The sulphoxide (59) and the sulphone (60) of lanthionine 
were even poorer substrates. However, the m e s 0-isomers of N- 
hydroxy- (61ab), AT-amino- (62ab) and 4-m ethylenediam inopim elic 
acid (63ab) were found to be good substrates of the dehydrogenase 
en zy m e.
The sulphoxides (59c and d), sulphones (60c and d) and D D -
lanthionine (58d) showed very slight competitive inhibition. L L -  
Lanthionine (58c) is a weak non-competitive inhibitor with respect
to m e s 0-2 ,6-DAP (28) with a Ki of 38 mM.
2.17. me so  -D iam inopim elate Decarboxylase
m e s o -Diaminopimelate (DAP) decarboxylase catalyses the final 
step in the synthesis of L - lysine (1) by the pyridoxal phosphate
5 3
dependent decarboxylation of me so  -2,6-DAP (28) exclusively at the 
D-centre to give L-lysine (1) (Schem e 24).62>114 The enzyme is 
highly specific for the meso-isomer,  and the DD- and LL-isomers o f
2,6-DAP are neither substrates nor effective inhibitors. m e so- DAP 
decarboxylase is the only pyridoxal dependent a -d e c a rb o x y la se  
known to act on a D-amino acid.
me s o -  DAP decarboxlase has been studied in bacteria6 9 »115 and 
in higher plants,5 9 - 6 1 »116 where it is localised solely in the 
c h lo ro p la s ts .7 5 White and Kelly1 1 7 have purified the enzyme from & 
coli and have shown that it has a native molecular weight of 200,000 
daltons as calculated from its sedimentation coefficient.
The molecular weight of the enzyme in higher plants varies 
between 75,000 daltons for wheat germ6 1 and 85,000 daltons for 
maize endosperm .6 0 Estimates of the Km for me s o -  2,6-DAP (28)
vary between 0.1 and 0.3 mM. The wheat enzyme was extracted 
from a wheat germ acetone powder in 50 mM potassium phosphate 
buffer (pH 7.0). The enzyme had a specific activity of 283 pkat mg" 1
C 02'
+ co2
H3N- H
meso-Diaminopimelatey 
decarboxylase HH
co2
meso-2,6-DAP (28)
(CH2)4NH2 
L-Lysine (1)
Scheme 24
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protein. A particularly rich source of the maize enzyme came from
maize endosperm harvested 28 days after pollination. A fte r  
purification this enzyme had a specific activity of 783 nkat mg’ 1
protein. (Katal is the SI Unit of enzyme activity and is the amount of
enzyme that converts 1 micromole of substrate into product per 
second. It is an inconveniently large unit and is used much less than 
the international ’unit' of enzyme activity.)
2.18. Mechanism of m e so  -D iam inopim elate Decarboxylase
Kelland et al.6 2 carried out a detailed analysis of this plant
enzyme mechanism by two-dim ensional *H-13C heteronuclear NMR 
shift correlation spectroscopy with 2H decoupling. From their results
they proposed that the mechanism of m e s o -  DAP decarboxylase in
plants was comparable to the known mechanism operating in Bacillus
sph a er icu s69 (Schem e 25).
During decarboxylation of a-am ino acids by pyridoxal
phosphate-dependent decarboxylases the bond between the a-
carbon and the carboxyl carbon of the substrate is expected to be
nearly perpendicular to the plane of the cofactor’s conjugated tt-
sy s te m .1 18-120
The first step in the mechanism is the formation of the Schiffs 
base (66) between the co-factor and m e s o - 2,6-DAP (28) ( S c h e m e  
2 5 ). Addition of m e so  -2,6-DAP (28) gives the imine (67). The
carboxyl group is t r a n s -antiparallel with the imine. Carbon dioxide is
then lost to give the intermediate (68). The co-factor essentially
5 5
H -N , Overall reaction
H
H3N—^ -R  + ENZ+ Hn - e n z
H -K
N -¥ -H -
/  COo-
(67)
-CO
H -N
Scheme 25
stores the electrons of the cleaved bond until protonation from the 
solvent can occur to give (69). The resulting imine (69) is then
5 6
hydrolysed to give L-lysine (1). All pyridoxal phosphate dependent 
a-decarboxylases proceed with retention of configuration except for
m e s o -DAP decarboxylase which shows inversion .6 2 *69
2.19. Inhibition of mg j o -Diam inopim elate Decarboxylase.
With higher plant me so  -DAP decarboxylase Mazelis and 
C revelling6 1 and Sodek6 0 have shown that at concentrations up to 1 
mM lysine has little effect on enzyme activity. At 20 mM however, 
lysine inhibited the wheat germ me so  -DAP • decarboxylase by 60%. It 
is unlikely that inhibition at this high concentration would indicate 
any physiological feedback regulation.
Vederas et al.1 2 2 have synthesized and tested analogues of 
m e so  -2,6-DAP (28) for enzyme activity with m e so -D A P
decarboxylase from Bacillus sphaericus1 2 3 and from wheat germ 
( Triticum vulgaris).6 1 Enzyme activity was assayed by measuring 
the release of 14CX>2 from [1,7-14C]-DAP.6 2 Rates of 14OC>2 p ro d u c tio n  
were analysed by the statistical method of Wilkinson.1 2 4
There are two potential modes of inhibition of pyridoxal 
phosphate-dependent a-decarboxylases, ^-elimination and N-
modification. Both will be discussed below.
6-E lim ina tion
Substrate analogues which have a leaving group attached to a 
p-carbon of the a-amino acid can undergo elimination to generate an
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electron-deficient conjugated system (70) (Schem e 26). 
Stereoelectronic considerations for elimination reactions125 r e q u ir e  
that the bond between the p-carbon and its attached leaving group 
must be aligned nearly perpendicular to the plane of the conjugated 
co-factor-inhibitor complex. The leaving group may be above or 
below this plane, depending on the side chain R.1 2 6
H -
-CO
H -
H -N
(70)
Scheme 26
The electron-deficient conjugated system is highly reactive and 
is prone to attack by nucleophilic species at the p-carbon or at C-4 of 
the co-factor.1 27 »128 This would result in direct covalent attachment
5 8
of the co-factor-inhibitor complex to a group in the enzyme active 
site, and as such, would result in irreversible loss of enzyme activity.
a-Difluoromethyldiaminopimelate was expected to be a potent 
inhibitor due to extensive precedent with other pyridoxal p h o sp h a te -  
dependent a-decarboxylases. However, Vederas et al.111 found n o
irreversible or even strong competitive inhibition. This suggested 
that a-difluoromethyldiam inopim elate cannot bind to the enzyme 
active site. Apparently both plant and bacterial me s o -  DAP 
decarboxylases enforce the stringent stereochemical requirement for 
the DL-isomer of the substrate by a 'tight-fit' in the region 
surrounding the a-carbon and do not permit replacement of th e a -H  
by a larger group.
To solve this problem, Vederas et al.122 investigated the
elimination of a group 'X' at the p-carbon of the side chain (S c h e m e  
27). The sulphoxides (59) and sulphones (60) were investigated 
because a number o f pyridoxal phosphate-catalysed p -e lim in a tio n s  
o f sulphur-containing groups are known1 2 9 ’130 and the parent 
m e s  o -lanthionine (58) is decarboxylated by me s o -  DAP
decarboxylase. The LL- (59 and 60c) and me so  -isomers (59 and
60ab) of lanthionine sulphoxide and sulphone are competitive 
inhibitors but did not show inactivation of the decarboxylase. T h e
sulphoxides were found to be better inhibitors than sulphones,
possibly due to secondary binding of the sulphoxide functionality.
5 9
H - K
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^ -M o d if ica tion
An alternative approach to inhibition of the decarboxylase is 
modification of the substrate nitrogen. Cooper and Griffiths1 31 have 
observed that N-hydroxyglutam ate irreversibly  inhibits pyridoxal 
phosphate-dependent g lu tam ate decarboxylase.
N -hydroxydiam inopim elate was tested for inhibition of m eso -  
DAP decarboxylase by Vederas et al.111 They found it to be a good  
competitive inhibitor o f both the wheat germ and the bacterial
6 0
enzyme. However the compound showed no irreversible
in ac tiv a tio n .
N -A m inodiam inopim elate has been found to have inhibition 
constants in the range 1-2 pM with a pyridoxal p h o s p h a te -d e p e n d e n t 
histid ine decarboxylase1 3 2 and with aspartate am inotransferase .1 3 3 
With m eso-D A P decarboxylase this compound was found to be a good 
competitive inhibitor with a Ki of 100 pM for the bacterial enzyme
and a Ki of 84 pM for the wheat germ enzyme.
Conclusion
The diaminopimelate pathway to L-lysine (1) has b e e n
reasonably well studied in bacteria. However, in higher plants the 
pathway is not completely understood. In bacteria all seven 
enzymes of the pathway have been isolated and characterised. In 
higher plants only four of the enzymes have been isolated. Although 
the main intermediates in the pathway, in both bacteria and plants, 
have been established, the mechanisms and stereochemistry of some 
of the steps are not fully understood.
The synthesis and testing of potential inhibitors has b e e n  
carried out in some detail for the latter enzymes in the pathway.
However, very few inhibitor studies have been undertaken for th e
earlier steps in the pathway, particularly the first and second steps, 
catalysed by DHDPS and DHDPR.
The syntheses of two important intermediates in the p a th w a y , 
L-2,3-DHDPA and L-2,3,4,5-THDPA, have been attempted by many
6 1
groups. However, the purification and characterisation of these
intermediates has proved very difficult due to their instabiltiy.
The synthesis of the starting substrate in the pathway, L- 
aspartic acid-(3-semialdehyde, has been carried out by Black and 
Wright.
6 2
Chapter f31 - Synthesis of L-Aspartic Acid-8-sem ialdehvde and
A nalogues.
In tro d u c tio n
L-Aspartic acid-p-semialdehyde (21a) is an im portant 
intermediate in the biosynthesis of L-lysine (1), L-threonine (16) and 
L-methionine (18) (Schem e 4). The biosynthesis of L -th re o n in e  
(16) and L-methionine (18) proceeds v ia  L-homoserine after
reduction of L-aspartic acid-p-sem ialdehyde (21a) catalysed by
hom oserine dehydrogenase .1 34- 1 36 Furthermore, in the DAP 
pathway to L-lysine (1) (Schem e 5), which occurs in bacteria and 
higher plants, the most intriguing step is the condensation of L- 
aspartic acid-P-semialdehyde (21a) with pyruvate (22) catalysed b y 
DHDP Synthase to give L-2,3-DHDPA (23). Further enzyme catalysed 
reactions of L-2,3-DHDPA (23) lead to L-lysine (1).
L-Aspartic acid-P-sem ialdehyde (21a) is derived
biosynthetically from L-aspartic acid (19) (Schem e 4 ) v ia  L -a sp a rtic
acid-p-phosphate (20). Formation of L-aspartic ac id -P -p h o sp h a te
(20) from L-aspartic acid (19) is catalysed by aspartate kinase.4 4 - 5 3  
Aspartate sem ialdehyde dehydrogenase catalyses the pyridine
nucleotide reduction of L-aspartic acid-p-phosphate to give L- 
aspartic acid-P-sem ialdehyde (21a).5 4 >55
L-Aspartic acid-p-semialdehyde (21a) has also become an 
increasingly im portant synthetic interm ediate .1 3 7 The a ld e h y d e
function provides a useful handle for manipulation, and this allows 
access into a range of polyfunctional non-protein and unnatural
amino acids. The use of L-aspartic acid-p-semialdehyde (21a) as a
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synthetic intermediate will be discussed in more detail in Sections 
3.3 and 3.6.
The first reported chemical synthesis of L-aspartic acid-P- 
semialdehyde (21a) was by Black and Wright in 1955.7 0 However, 
very little chemical evidence was provided for the compound. In 
this chapter there will be described a brief selection of synthetic 
methods and the use of protecting groups in a-am ino acid synthesis. 
The Black and Wright synthesis of L-aspartic ac id -p -sem ia ld eh y d e  
(21a) will be reviewed followed by a discussion on our improved 
synthesis of this compound and biochemical results obtained with L- 
aspartic acid-P-sem ialdehyde (21a). Finally, the synthesis of 
analogues of L-aspartic acid-P-semialdehyde (21a) will be discussed 
along with the test data obtained on DHDP Synthase with these 
com pounds.
3.1. a-Amino Acid Synthesis.
The synthesis, resolution and physiochemical characterisation 
of a-amino acids and their derivatives continue to be areas of highly 
active research. There are many well established and, more re c e n tly , 
newer methods for the synthesis of a-am ino acids.1 38- 1 4 0 These can 
be grouped into three main categories: alkylation of glycine
derivatives; condensation and substitution reactions in which th e  
amino- or carboxyl-function is introduced to complete the synthesis; 
and lastly rearrangement reactions. Each of these synthetic 
strategies will be briefly discussed in this section.
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Asymmetric synthesis of a-amino acids is undergoing 
considerable development and several successful methods have been 
e s ta b l is h e d .1 41 However, asymmetric synthesis of a-am ino acids
will not be discussed in this section. The use of a-am ino acids as
starting materials for the synthesis of other a-amino acids is an
increasingly important technique. Examples of this strategy will be 
shown in the Black and W rig h t7 0 synthesis, and in our modified
synthesis of L-aspartic acid-p-semialdehyde in Sections 3.2 and 3.3
re sp e c tiv e ly .
Alkvlation of Glycine Derivatives to give a-Amino Acids.
Alkylation of acetamidomalonate esters and other N- 
acylam inom alonates remains the most frequently chosen route to a-
amino acids with side chains which can withstand the hydrolysis s te p  
involved at the end of the synthesis (Schem e 28).
A typical procedure from diethyl acetam idom alonate (71)
involves reaction of the alkyl halide with it to give the crystalline
alkylated malonate (72). This is hydrolysed with refluxing dilute
aqueous sodium hydroxide. Excess alkali is removed with a strong
cation exchange resin. This brings about hydrolysis to the malonic 
acid, which is decarboxylated by boiling in water.
Another well documented alkylating method for the synthesis
of a-amino acids is alkylation of benzylidene glycine ester (73), a
Schiffs base. However, overalkylation problems arise with this
method giving mixtures of mono- and di-alkylated products. The
yields of these reactions are not very good.
R \  ,0 
N-Chfe-CL -
R4  ^ R2
R \  , 0  
N—CHR3—C' -
R* R:
"►H3N -C H R 3- C 0 2-
H
I
A cN H -C -C O o E t
I
C 0 2Et
(71)
.  A cN H -C -C O p E t
C 0 2Et
(72)
Scheme 28
PhC H=N CH ^-C02R
(73)
Condensation and Substitution Reactions to give g-Amino Acids.
The Strecker synthesis (Schem e 29) is a well established
condensation reaction yielding a-am inoalkanenitriles (75) which, on
hydrolysis, give the corresponding a-amino acid. There are many
variations of the Strecker synthesis and the yields are variable.1 4 2
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R— CHO  ► R— CH -------» -R —CH -► R—CH
SCN VCN nC02-
(74) (75)
Scheme 29
The first step in the Strecker synthesis involves the formation 
of the cyanohydrin (74) from the aldehyde using sodium cyanide, 
acetic acid and methanol. The aminonitrile (75) is formed from the 
cyanohydrin (74) by treatment with ammonium hydroxide and 
ammonium chloride. Hydrolysis of the aminonitrile (75) with 10M 
HC1 gives the a-am ino acid.
Substitution reactions leading to a-amino acids, which have 
been used over many years, are based on the easy availability of a- 
halogeno-alkanoic acids and a-hydroxy- or epoxy-alkanoic acids. 
The introduction of the nitrogen function can either be as the free 
amino group using ammonia to give the a-amino acid, or if an amine 
is used, N-alkylated a-amino acids can be prepared.
Rearrangement Reactions leading to a-Amino Acids.
The Curtius, Hofmann and Schmidt rearrangements1423  have 
all been used for the synthesis of a-amino acids v ia  the 
corresponding isocyanate (Schem e 30). However, these
rearrangement reactions are now only rarely used for this purpose in
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view of the availability of efficient, more convenient, alternative 
general methods for amino acid synthesis.
C'-O
h 2n Hofmann
Br2
O•t
r — a
Schmidt OH
C:0
NH
Br
-  *
N'
R— C.
O
NHNH2 
Curtius
NaN02, HCI
\ ^ rN = N = N '
-N2 heat
R— N = C = 0  ^  ► R—N—C = 0
Isocyanate
Scheme 3Q
Protecting Groups in q-Amino Acid Synthesis.
Protecting groups are of paramount importance in a-amino a c id  
synthesis. Temporary protection of the a-amino group and of the a - 
carboxyl group eliminates the dipolar character o f the starting 
zwitterionic amino acids. This allows the synthesis of a-am ino acids 
to be carried out in organic solvents, and not under more difficult 
aqueous conditions. The protecting group must fulfil a number of 
requirements. It must react selectively in good yield to give a
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protected substrate that is stable to the conditions used in the rest of 
the planned synthesis. The protecting group must also be selectively 
removed in good yield by readily available reagents which do not 
attack the rest of the molecule. Finally, the protecting group sh o u ld  
have a minimum of additional functionality to avoid further sites of
reac tio n .
The protecting groups which have been mainly used in our 
amino acid synthesis are the f-butoxycarbonyl (BOC) group and the
benzyloxycarbonyl or carboxybenzyl (CBZ) group for ^ -p ro te c t io n  
and the f-butyl and benzyl esters for protecting the carboxyl group. 
These protecting groups meet all of the above requirements.
There are many reagents available for the formation and
removal of the widely used BOC group. The two most com m on 
reagents for putting on the BOC group are d i-f-bu ty l dicarbonate1 4 3 
and 2 -(f-b u to x y c a rb o n y lo x y im in o )-2 -p h e n y la c e to n itr ile 1 4 4 under 
basic conditions. The yields vary between 70 and 95%. The 
mechanisms for putting on the BOC group using both these reagents 
are shown in Schem e 31.
Removal of the BOC group is carried out under mild acidic 
conditions. The most common method of removal is stirring the 
protected compound in trifluoroacetic acid at room temperature for
one hour (Schem e 32).1 45 Thiophenol is sometimes used with 
trifluoroacetic acid to act as a scavenger for f-butyl cations. This 
prevents possible alkylation of the deprotected product.
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f-Butyl esters are stable under mild basic conditions and are
very popular for the protection of the carboxyl group. There are 
several reagents used to form r-butyl esters. The most common 
procedure used is isobutylene and conc. sulphuric acid at room
temperature for one day.1 4 6
f-Butyl esters are cleaved under similar conditions to the BOC
group and so the BOC/f-butyl ester protecting groups for a -a m in o
*
7 0
acid synthesis are commonly used together since they can be both 
removed in one synthetic step.
r 1 On  > s . ••
c —o-
R
CF3CO2H
-----------
H
R1 i>v+ ° '
r2 - n " c \ 2 7
r 1
d 2^ N H 2 CF3C0 2-
R
+ CO2
CF3 CO2 H
R
+ « £ >  ♦
Scheme 32
The CBZ group is widely used in peptide synthesis since it can 
easily be removed by catalytic hydrogenolysis.1 47 It is usually put 
on using benzyl chloroformate under basic conditions (Schem e 33).
Benzyl esters are easily prepared using benzyl bromide in 
d im e th y lfo rm a m id e .1 4 9 They are cleaved under the same catalytic 
hydrogenolysis conditions as the CBZ group and so the CBZ/benzyl 
ester protecting groups for a-am ino acid synthesis are commonly 
used together since, like the BOC/r-butyl ester protecting groups, 
they can both be removed in one synthetic step.
7 1
CIT C -O C H 2Ph
Oii
0 'N a+
O N a+ + NaCI + NaHC03
Scheme 33
3.2. Black and Wright Synthesis of L-Aspartic Acid-6-se m ia ld e h v d e .
Black and Wright reported the first synthesis of the s e p a ra te  
enantiomers o f aspartic acid-P-semialdehyde (21) from DL-
allylglycine (76) (Schem e 34 ).7 0 Resolution was achieved by 
enantioselective enzymic hydrolysis of the //-acetyl derivatives of 
DL-allylglycine. N -Acetyl-DL-allylglycine (77) was prepared from DL- 
allylglycine (76) by Sorrenson's method using 2M sodium h y d ro x id e  
and acetic anhydride. Hydrolysis of N -acetyl-D L-allylglycine (77) 
using hog kidney acylase gave L-allylglycine (76a) and unchanged N- 
acetyl-D -allylglycine (77b). L-,4llylglycine (76a) crystallised on 
cooling. N -Acetyl-D-allylglycine (77b) was hydrolysed by heating at 
reflux in 2M hydrochloric acid to give D-allylglycine (76b). Upon 
ozonolysis of D- (76b) and L-allylglycine (76a), D- (21b) and L- 
aspartic acid-p-sem ialdehyde (21a) were formed. Only the L -iso m er 
(21a) was found to be a substrate of DHDP Synthase. Black and 
Wright found that L-aspartic acid-P-sem ialdehyde (21a) was 
reasonably stable in acid solution at 0 °C. However it deteriorated 
rapidly in neutral solution or in the dry state. Attempts by them to
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dry the acid solution of L-aspartic acid-p-semialdehyde (21a) by 
evaporation at low temperatures also resulted in substantial losses of 
the enzymatically reactive compound.
NHo+
(CH3CCO2O,
NaOH
NH-COCH3
C 0 2H
NHq+
Hog kidney 
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'  CO,- +
H
(76a)
0 3> IM HQ
NH3+cr  
0 HCv— c o 2h
H
(21a)
Scheme 34
c o 2h
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2M HCI, 
reflux
c o 2h
'  NH3+Cr
H
(76b)
0 3, IM HQ
c o 2h
o h c ^ 4 -  NH^+c r  
H
(21b)
Black and Wright found that the usual aldehyde derivatives d id  
not form readily with this substance and hence, the identity of L-
7 3
aspartic acid-p-semialdehyde (21a) rested largely on the fact that it 
could be converted into L-homoserine. This enzymic process was 
catalysed by hom oserine dehydrogenase.134-136
When the Black and Wright procedure was repeated by us, i.e. 
ozonolysis of DL-allylglycine (76) in IM HC1 at 0 °C, we found that DL- 
aspartic acid-p-sem ialdehyde (21) was formed, along with a mixture 
of other products. To identify these products the reaction was 
repeated in D2O and DC1 and followed by lU NMR spectroscopy. 
There were signals present which were consistent with the presence 
of DL-aspartic acid-p-semialdehyde (21), formaldehyde (78) and DL- 
aspartic acid (19) (Schem e 35). DL-Aspartic acid (19) is 
presumably formed by oxidation of DL-aspartic ac id -p -sem ia ld e h y d e
(21). No aldehyde proton was observed in the NMR spectrum 
therefore the aldehyde probably exists as the hydrate.
(21)
+ H2C=0 
(78)
(76)
Scheme 35
(19)
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I o n - e x c h a n g e  c o l u m n  c h r o m a t o g r a p h y  w a s  a t t e m p t e d  t o  p u r i f y
t h e  m i x t u r e .  H o w e v e r  t h e  c o n c e n t r a t i o n  o f  D L - a s p a r t i c  a c i d - p -
s e m i a l d e h y d e  ( 2 1 )  w a s  f o u n d  t o  b e  l e s s  a f t e r  i o n - e x c h a n g e
c h r o m a t o g r a p h y .  T h i s  i s  p r o b a b l y  d u e  t o  t h e  i n s t a b i l i t y  o f  D L -  
a s p a r t i c  a c i d - p - s e m i a l d e h y d e  ( 2 1 )  a t  r o o m  t e m p e r a t u r e .
The concentration of DL-aspartic acid-p-semialdehyde (21) in 
the acid solution mixture was calculated by converting D L -aspartic
acid-P-sem ialdehyde (21) into DL-homoserine catalysed by 
hom oserine dehydrogenase .1 3 4 - 1 36 This work was carried out by 
Emma Borthwick in the Biochemistry Dept, at Glasgow University.
The enzyme activity was monitored by the decrease in absorbance at 
340 nm due to the oxidation of NADPH to NADP+. The change in
concentration of NADPH during the reaction could be calculated.
Since 1 mole of NADPH reacts with 1 mole of L-aspartic acid-p-
semialdehyde (21a), the concentration of L-aspartic acid-p- 
semialdehyde (21a) is equivalent to the change in concentration o f
NADPH. The concentration of the solution prepared under similar 
conditions with different batches of material was between 0.3 M 
and 0.4 M.
A possible mechanism of formation and decomposition of the
ozonide is shown in Schem e 36. The secondary ozonide (79)
decomposes as it is formed in the acidic solution. The mechanism of 
decomposition involves hydrolytic cleavage of the ether linkage of
(79) followed by decomposition to the aldehyde and formaldehyde.
Aspartic acid-p-semialdehyde (21) and formaldehyde (78) can then 
be further oxidised to aspartic acid and formic acid by hydrogen 
p e ro x id e .
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3.3. Modified Synthesis of L-Aspartic Acid-6-se m ia ld e h v d e .
In order to study the mechanism of DHDP Synthase and to 
carry out precise kinetic and inhibitor studies with this enzyme we 
required a synthesis of pure L-aspartic acid-P-sem ialdehyde (21a). 
We also required to make L-aspartic acid-p-semialdehyde (21a) in a 
protected form which was easy to handle, could be stored for long 
periods of time, and the protecting groups could be easily removed 
under mild reaction conditions in one synthetic step.
O u r  i n i t i a l  s t r a t e g y  w a s  t o  s t a r t  w i t h  t h e  n a t u r a l l y  o c c u r r i n g  
a m i n o  a c i d  D L - h o m o s e r i n e .  D o u b l e  p r o t e c t i o n  a t  t h e  a - a m i n o  a n d  a -  
c a r b o x y l  g r o u p s  f o l l o w e d  b y  o x i d a t i o n  o f  t h e  p r i m a r y  h y d r o x y l  g r o u p  
t o  t h e  a l d e h y d e  w o u l d  g i v e  p r o t e c t e d  D L - a s p a r t i c  a c i d - p -  
s e m i a l d e h y d e  d e r i v a t i v e s .  P u r i f i c a t i o n  c o u l d  b e  c a r r i e d  o u t  a t  t h i s  
s t a g e .  F i n a l l y  c a r e f u l  d e p r o t e c t i o n  w o u l d  g i v e  t h e  d e s i r e d  D L -  
a s p a r t i c  a c i d - p - s e m i a l d e h y d e  ( 2 1 ) .
The oxidation of the primary hydroxyl group of DL-ho mo se r in e  
analogues has been reported in the literature by several groups. 
Ramsamy et a /.149  carried out the oxidation of N -/-b u to x y ca rb o n y l-  
L-homoserine /-butyl ester to give N -/-b u to x y c a rb o n y l-L -a sp a rtic  
acid-P-sem ialdehyde /-butyl ester using a chromium (VI) trioxide- 
pyridine complex in methylene chloride .1 5 0 These compounds were 
intermediates in the synthesis of N - /-b  u toxy  carbon  y l-L -a- 
aminoadipic acid l-/-butyl 6 -ethyl diester (80), a suitably p ro te c te d  
amino acid for use in peptide synthesis. Keith and co-w orkers used 
the same oxidising conditions to prepare V -c a rb o x y b e n zy l-L -a sp a rtic
7 7
acid-P-semialdehyde benzyl ester from its homoserine analogue in 
the total synthesis of the naturally occurring amino acid
rhizobitoxine (81).151
Baldwin and Flinn1 3 7 prepared N -f-b u to x y ca rb o n y l-L -a sp a rtic  
acid-P-sem ialdehyde p-methoxybenzyl ester from its h o m o se rin e  
analogue using pyridinium chlorochromate and sodium acetate in 
methylene chloride .152  This protected aspartic ac id -p -sem ia ldehyde  
derivative was further converted into the more complex amino acids, 
L-2-aminohept-4,6-dienoic acid (82) and 2*S',4/?,5S-2-amino-4,5,6- 
trihydroxyhexanoic acid (83).
B O C -N H
C 02Et
(81)
(80)
(83)
Unfortunately when we tried to prepare N -r-b u to x y carb o n y l- 
DL-homoserine (84), the first intermediate in our proposed synthetic 
pathway to AT-r-butoxycarbonyl-DL-aspartic acid-p-sem ialdehyde t-
7 8
butyl ester, the reaction yields were low and TLC analysis showed 
two strong spots. and 13C NMR and IR spectroscopic analysis
showed that we had a 50/50 mixture of the desired product (84) and 
the lactone (85) (Schem e 37). The !H NMR spectrum had two f- 
butoxycarbonyl signals, there were 3 carbonyl absorption bands in 
the IR spectrum: 1777 (lactone), 1725 (acid) and 1705 (broad)
(carbamate) and the 13C NMR spectrum had double the expected 
amount of signals. Ozinskas and Rosenthal1 5 3 have previously 
prepared the lactone (85) in their synthesis of L-calanine and y- 
functional 2-aminobutyric acid derivatives. A variety of conditions 
using di-f-butyl dicarbonate and 2 - ( f -b u to x y c a rb o n y lo x y im in o )-2- 
phenylacetonitrile were tried with no better results. At this stage it 
was decided to abandon homoserine as the starting material and go 
back to allylglycine and modify the Black and Wright method.
DL-Allylglycine (76) was converted into its f-butyl ester using 
2-methylpropene and sulphuric acid (Schem e 38).1 43 The product
butoxycarbonyl (BOC) derivative (87) was prepared in 90% yield by 
treatment of (86) with d i-f-buty l dicarbonate under basic 
co n d itio n s .1 6 3 The doubly protected material (87) was subjected to
c o 2h
(84)
O
(85)
Scheme 37
was precipitated as the hydrochloride salt (86). The N -t-
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ozonolysis at -78 °C in methylene chloride and the ozonide w as
decomposed with triethylamine to give the protected aspartic acid-p- 
semialdehyde derivative (88). The mechanism of ozonide
decomposition is shown in Schem e 39. Purification of (88) was
carried out using flash column chromatography and elution w ith
ether to give a clear oil in 80% yield.
1 .Isobutylene, c.H2S04 
CH2C12, -78°C
2. Ether / HCl(g)
NH3 C1-
C 02t-Bu 
(86) [3 3 %]
NaHC03, NaCl, 
(B0C)20 ,
c h 2ci2 / h 2o ,
reflux, 2h.
NHC02t-Bu I.O3, CH2C12,-78°C 
0 HC ^ A C0  ,_Bu \ n t j N  (2eq), -78 - 0°C
[80%] (88)
TFA, CH2C12 
room temp., lh
NHC02t-Bu
C 02t-Bu 
[90%]
OH NH3 CF3C 02
c o 2h
[74%]
Overall yield: 17%
Scheme 38
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The L-isomer of N -f-butoxycarbonylaspartic  acid-p- 
semialdehyde t-butyl ester had identical spectroscopic data to the 
aldehyde prepared by Ramsamy and co-workers149 from oxidation 
of iV -f-butoxycarbonyl-L -hom oserine f-butyl ester using a chromium 
trioxide-pyridine com plex.
Et3N ~Nx^
 CC^t-Bu
J  ^  NH-CO^t-Bu
O
Secondary ozonide
EfeN.
o
NH-COfet-Bu 
C 02t-Bu
EtoN+— O' + H2C =0 + OHC
NH-CO^t-Bu
COpt-Bu 
(88)
Scheme ,39
Deprotection of the BOC group and the f-butyl ester was carried 
out in one step by stirring (88) in trifluoroacetic acid in methylene
chloride for one hour at room temperature under a nitrogen
atmosphere. Removal of the solvent in vacuo gave a yellow oily 
residue which solidified giving a light yellow solid when ether was 
added. The yield was 74% and the solid had mp 64-66 °C. and
13C NMR data indicated that the product exists as a hydrate (91), i.e.
no aldehyde proton was observed and there was a double doublet at 
5h 5.1 for the 4-H and a signal 6c  89.4 for C-4. The NMR spectrum 
of (89) is shown in F igu re  1. The product has correct
8 1
V-H
Fj g URfi. 1 : 1 H  NMR SPECTRUM OF ASPARTIC ACID-6-SEMIALDEHYDE HYDRATE.
TRIFLUQ.&.QACETATE SALT,
microanalysis and accurate mass data. It exists as the
trifluoroacetate salt. This material is stable for several months if 
kept dry under a nitrogen atmosphere at 0 °C
This synthesis was repeated for D - (76b) and L -ally lg lycine 
(76a). The L-isomer of aspartic acid-p-semialdehyde hydrate (89a) 
had [aId1 6 +3 .33° and mp 63-64 °C, whereas the D-isomer (89b) had 
[o c ]d 16 -3 .J 5 °  and mp 63-65 °C. The CD spectrum of D- (89b) and L - 
aspartic acid-P-semialdehyde hydrate (89a) were mirror images 
(F igu re  2). The D-isomer had Ae -1.0 at 202 nm. This is in
8 2
a g r e e m e n t  w i t h  t h e  g e n e r a l  r u l e  t h a t  a l i p h a t i c  D * a m i n o  a c i d s  g i v e  
n e g a t i v e  CD c u r v e s  a r o u n d  203 n m ,  a n d  v i c e - v e r s a  f o r  L - a m i n o  a c i d s .
KL tnm]
L - a s p a r t a t a  a e m l - a l e a h y c a  1mm ( O . S m g / m l )
190 .0 sso.o
• 3: ■ —  O - a a p a r t a t a  a a m l a l d a h y d a .  0 .  l e m.  O . e s m g / m l
F 1 0 U R E - 2 : CP  C V R V E S .Q F .P -  AND. L tA SPA R T IC .  A C IP rg r -S E M lA L P E H Y P K*
The overall yield of formation o f DL-aspartic acid-p- 
semialdehyde hydrate (89) from DL-allylglycine (76) was 17%. The 
reason for this low overall yield is the poor yield of the first step in 
the synthesis, namely formation of the f-butyl ester o f a lly lg ly c in e  
(86) using isobutylene and conc. sulphuric acid. This step was 
repeated several times under various different reaction conditions, 
but no yield higher than 33% was obtained. The low yield is 
presumably due to formation of isobutylene polymers. These remain
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in the organic solvent when the /-butyl ester is precipitated as the 
hydrochloride salt.
To overcome this problem it was decided to change slightly the 
synthesis by replacing the /-butyl ester with the anisyl (p- 
methoxybenzyl) ester (Schem e 40).154
(BOC),Q, KHCO,,
H,07d*oxan
NHC02t-Bu 1.0* CHjCl* -78°C
[75%] (92)
C0 2CH2-C6H4-0 Me (2eq), -78 - 0°C
TFA, CH2C12 
room temp., 2h
OH NH3 CF3C 02
[79%]
NH-C02t-Bu
c o 2 k +
(90) [91%]
MeO-C6H4-CH2Br, 
DMF, room temp.
NHC02t-Bu
C 02CHr C6H 4 ^  
[79%]
Overall yield: 42%
Scheme 40
This ester was put on in 79% yield giving an overall yield o f  
formation of DL-aspartic acid-p-sem ialdehyde hydrate (89) of 42%.
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The /?-methoxybenzyl ester can also be easily removed by treatment 
with trifluoroacetic acid .1 5 6
The potassium salt of N -r-butoxycarbonyl-D L-allylglycine (90 ) 
was prepared in 91% yield from DL-allylglycine (76) using di-r- b u ty l 
dicarbonate and potassium bicarbonate in a water/dioxan mixture. 
This procedure was used by Baldwin et al. to prepare the potassium 
salt of A f-r-bu toxycarbony l-L -hom oserine .1 5 7 Compound (90) was 
converted into the p-m ethoxybenzyl ester (91) in 79% yield using p-  
methoxybenzyl bromide in DMF. The same ozonolysis procedure was 
used as before to give the aldehyde (92). The L-isomer of this 
aldehyde has already been prepared by Baldwin and Flinn1 3 7 as an 
intermediate in their total syntheses of the more complex amino 
acids (82) and (83).
Deprotection was carried out in one step by stirring (92) i n 
trifluoroacetic acid for two hours to give the hydrate of the 
trifluoroacetate salt of DL-aspartic acid-p-semialdehyde (89). This 
product had identical physical properties and spectroscopic data to 
those formed from the synthesis using the r-butyl ester.
3.4. Biochemical Results with L-Aspartic Acid-6-sem ialdehvde and
P v ru v a te .
DHDP Synthase.
DHDP Synthase used in our biochemical experim ents was
purified and over expressed from E. coli.1 21 This work was
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undertaken by Emma Borthwick (Biochemistry Dept., University of 
Glasgow). The E. coli strain MV1190 (Rec A~) was transformed by
pDA2 to produce an overexpressing strain for DHDP Synthase. pDA2, 
a pUC9 derived plasmid containing the gene encoding for DHDP 
Synthase, was obtained from Dr. P. Stragier in Paris. The specific 
activity of DHDP Synthase from the over-expressed strain is 52 
un i t s / mg .
A homogeneous sample of DHDP Synthase was analysed by 
electrospray mass spectrometry (ESMS) by Andrea Schneier and Dr. 
C. Abell (University of Cambridge).15 7a A molecular mass of 31 
272.3 Da (eleven determinations) was obtained for the enzyme. The 
electrospray mass spectrum of DHDP Synthase is shown in F igu re  3.
Results Miss calculated from seven] ESMS 31273.2
Smoothed spectrum of DHDPA synthue
Component analysis
31274.1
unmodified DHDPA synthai*
?;»»» ;i7»> ;:<»«__;nf«.
FIGURE 3 : ELECTROSPRAY MASS SPECTROMETRY OF DHDP SYNTHASE.
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The E. coli DHDP Synthase has previously been sequenced and 
the mass calculated as 31 372.3. The difference between the mass 
calculated and that observed is within the resolution of the VG BioQ
mass spectrometer (0 . 1%).
The molecular mass of 31 272.3 is taken as correct for all
subsequent studies of DHDP Synthase. The masses of all enzyme- 
substrate complexes analysed by ESMS are based on this mass.
L-Aspartic A cid -|3 -sem ialdehyde
The trifiuoroacetate salts of DL- (89) and L-aspartic acid-P- 
semialdehyde hydrate (89a) were shown to act as substrates for the 
DHDP Synthase reaction. The D-isomer (89b) did not act as a 
substrate. This is in agreement with the results obtained by Black 
and W right.7 0
The D L -  (89) and L-isomers (89a) were also shown to be 
substrates for homoserine d e h y d ro g e n a se 1 3 4 " 136 by incubation with 
the enzyme and observation of the disappearance of NADPH. The D -  
isomer (89b) did not act as a substrate. Homoserine d e h y d ro g e n a se
was partially purified using the method of Bachi and Cohen,1 5 5
Schiffs Base Formation Between DHDP Synthase and Pvruvate.
One of my co-workers, Susanne Connell, has shown that there is  
irreversible loss of enzymatic activity of DHDP Synthase upon the 
addition of sodium borohydride only in the presence of pyruvate
(22). This suggests that the formation of a Schiffs base intermediate
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between DHDPS and pyruvate (22) takes place in the enzymatic
reaction. This is in agreement with the results reported by 
Schedlarski and Gilvarg7 4 and by Kumpaisal et al. 5 7
Andrea Schneier and Dr. C. Abell (University of Cambridge)157®
have obtained direct evidence for Schiffs Base Formation Between
DHDP Synthase and Pyruvate (22). A sample of ca ta ly tic a lly  
active DHDP Synthase was incubated with pyruvate (22) for five 
minutes at 0 °C. Sodium borohydride was then added, resulting in 8 5 
% inactivation of the enzyme.
ESMS of this sample (Figure 4) showed a single protein species, 
indicating that all the active sites were modified and confirm ing that 
the tetrameric enzyme does not exhibit half-sites reactivity. The 
molecular mass of the protein, 31 347.1 (4 determ inations)
corresponds to that o f the reduced Schiffs base with pyruvate and 
DHDP Synthase. The calculated molecular mass of this species is 31 
345.4. The ESMS of DHDP Synthase, pyruvate and borohydride is
shown in F igu re  4.
Component analysis of DHDPA synthase + pyruvate + BH4*
j T s m  1 3 1 2 0 a  . a i i a a  1 a i i a a  '  s t f a q  J 32« i »
FIGURE 4 : ELECTROSPRAY MASS SPECTROMETRY OF DHDP SYNTHASE + PYRUVATE +
BOROHYDRIDE.
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An identical sample of DHDP Synthase was treated with sodium 
borohydride in the absence of pyruvate (22). No loss of e n zy m e  
activity was observed and the ESMS analysis showed on ly  
unm odified enzyme.
Similar studies were carried out in which DHDP Synthase was 
incubated with L-aspartic acid-P-sem ialdehyde hydrate (89a). 
However, no loss of enzymatic activity was observed upon the 
addition of sodium borohydride and the ESMS of the sample showed 
only unmodified DHDP Synthase. This suggests that there is no 
Schiffs formation base between DHDPS and L-aspartic acid -p - 
semialdehyde hydrate (89a) in the enzymic reaction.
Further work must be carried out using ESMS to investigate the
mechanism of formation of l -2,3-DHDPA (23).
Standard Assay System , for DHDP Synthase.
B orthw ick1 21 set up a standard assay screen for DHDP 
Synthase by monitoring the rate of formation of dipicolinic acid (36) 
at 270 nm. The product of the reaction* in vivo, is L-2,3-DHDPA (23)
which is unstable and could not be the product absorbing at 270 nm.
L-2,3-DHDPA (23) is oxidised in air to DPA (36) which absorbs at 270 
nm (Schem e 9). This assay has enabled us to test analogues of both 
substrates, L-aspartic a cid-p-sem ialdehyde hydrate (89a) and 
pyruvate (22), and the pathway intermediates L-2,3-DHDPA (23) a n d  
L-2,3,4,5-THDPA (24) for substrate or inhibitor activity.
The standard 1 ml assay consisted of 100 mM imidazole buffer, 
1 mM L-aspartic acid-P-semialdehyde (89a), 1 mM pyruvate (22)
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and 16 units of DHDP Synthase. Three concentrations of compound 
were studied, 1 mM* 0.5 mM and 0.1 mM, unless other dilutions w e re  
required. Each result shown is an average over three assay runs.
The level of inhibition was measured by a percentage of the 
standard rate as shown in the following equation and graph :
- — * x 100 = Inhibition (%) a
aW>fKart
a = rate of standard assay
x = rate  of assay plus compound
tune
Significant inhibition was taken to be about \0% inhibition at 
0.5 mM of the compound being tested. All test data obtained is 
shown in Section 6.4 - Experimental Chapter. Due to the lack of time 
no Ki or Km values for any of the compounds tested have been 
o b ta in ed .
3.5. NMR Spectroscopic Studies.
Our Biochemistry co-workers have shown that by incubating L- 
aspartic acid-p-semialdehyde hydrate (89a) and pyruvate (22) with
9 0
DHDP Synthase and following the reaction by UV spectroscopy the
product obtained has a UV spectrum with Amax at 270 nm.
To identify the absorbing species a portion of the assay so lu tion
was freeze dried, dissolved in D2O and a *H NMR spectrum at 200 
MHz was run at room temperature. The spectrum was very noisy 
and several impurities were present. A strong singlet at 5 7.95 ppm 
corresponded to DPA (36). The standard *H NMR spectrum of DPA 
(36) is a singlet at 5 8.35 ppm. The difference in 5 may be due to pH 
differences. Further study of this product from the enzymic reaction
in an NMR spectrometer with higher field strength would be
desirable to see if  splitting of the signal can be observed.
A similar non-enzymic reaction between DL-aspartic acid-0- 
semialdehyde hydrate (89a) and oxaloacetic acid under basic
conditions in D2O was followed by *H NMR spectroscopy (S c h e m e  
4 1 ) .
The product from this reaction was DPA (36) (singlet 5 8,35
ppm) after a period of two hours via some intermediate which has a 
vinyl signal at 6 5.47 ppm. This intermediate signal was fo rm ed
instantaneously then slowly disappeared as the aromatic (DPA)
signal increased over the two hour period. A 13C NMR spectrum of 
the reaction product was consistent with the authentic 13C NMR 
spectrum of DPA (36), i.e. there were 4 signals at 5c 127.7 (C-3 and
-5), 139.4 (C-4), 148.2 (C-2 and - 6) and 165.6 (2 x acid groups).
Unfortunately due to lack of time this interesting result was not
studied further.
9 1
OH
OH C 02H NaOD/D20
h o 2c ^ n h 3+ c f 3c o 2- O ^ c OpH
(89) Oxaloacetic acid
d o 2c '  ' n * ^ c o 2d
DL-2.3-DHDPA (23)
ir
DOaC ^ "N '^ C O a D  
DPA (36)
Scheme 41
3.6. Synthesis and Test Results of Analogues of L-Aspartic Acid-B-
ssmial riefrytis.,..
Analogues of DL-aspartic acid-p-sem ialdehyde hydrate (89) 
have been synthesised and preliminary testing for substrate or 
inhibitor activity on DHDP Synthase has been carried out.
DL-Allylglycine (76) and the intermediates in the synthetic 
pathway to DL-aspartic acid-p-sem ialdehyde hydrate (89) ( S c h e m e  
3 8 ), DL-allylglycine /-butyl ester hydrochloride (86), dl-JV-/- 
butoxycarbonylally lglycine /-butyl ester (87) and DL-N-t- 
bu toxycarbonylaspartic  acid-P-sem ialdehyde /-butyl ester (88) h a v e
9 2
been tested for inhibitor activity. DL-Allylglycine (76) showed poor 
inhibition (14% at 1 mM) and compounds (86), (87) and (88) showed 
no inhibition.
Trifluoroacetate Saif of DL-Aspartic Acid-fl-semialdehyde M ethyl
Ester Hydrate.
The trifluoroacetate salt of the methyl ester of DL-aspartic acid- 
p-semialdehyde hydrate (93) was prepared . in a similar manner to 
DL-aspartic acid-P-semialdehyde (89) (Schem e 42), starting fro m
DL-allylglycine (76). The overall yield of formation was 40%.
DL-Allylglycine methyl ester hydrochloride (94) was prepared 
in 91% yield by stirring DL-allylglycine (76) in methanol and flushing 
the solution with HC1 gas at 0 °C. Protection of the nitrogen using di-
r-butyldicarbonate gave (95). Ozonolysis was carried out as before
to give the aldehyde (96).
However problems arose with the deprotection of (96). U n d e r
the same conditions as before, using trifluoroacetic acid at ro o m  
temperature a yellow syrup was obtained which proved to be the 
lactone (97) by NMR and IR analysis, i.e. no methyl ester signal 
was observed in the *H NMR spectrum and the IR spectrum had a 
Umax at 1770 cm-1- To solve this problem the deprotection was 
carried out with the same reagents at -78 °C. Removal of the
solvent in vacuo gave a yellow solid in 60% yield which was shown 
by spectroscopic analysis to be the methyl ester (93), i.e. there was a
9 3
singlet at Sh 3.63 and a signal at 6c 171.3 for the methyl ester and 
the IR spectrum had a um ax at 1750 cm-1.
MeOH, HCl(g), 
0°C
N H 3+C1‘
'C 0 2Me 
(94) [91%]
NaHC03, NaCl, 
(B0C)20 ,
c h 2ci2 / h 2o ,
reflux, 2h.
NHC02t-Bu
o h c ^ X
175 %] (96)
C 02Me
1.03, CHjQj, -78°C 
2.EUN (2eq), -78 - 0°C 4 ?
(95)
NHC02t-Bu 
C O ^
[98%]
TFA, CH2C12 
-78°C, lh
OH NH3 CF3C 02 
[60%] (93)
Overall yield: 40%
HO''
Scheme 42
NH3+ CF3C 0 2‘
(97)
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When tested as a substrate, no rate was observed for the 
methyl ester (93), but, 14% inhibition was found at 0.5 mM.
Similarly D L-A -f-butoxycarbonylaspartic a c id -P -se m ia ld e h y d e  
methyl ester (96) showed 5% inhibition at 0.5 mM.
D L - A T - F o r m y l - .  D L - N - A c e t v l -  a n d  D L - N - T r i f l u o r o a c e t v l - a s p a r t i c  a c i d -
6 - s e m i a l d e h v d e  H y d r a t e s .
The same synthetic route was used to form the N- am i do 
analogues DL-A-formyl- (98) and D L-N -trifluoroacetylaspartic acid-p- 
semialdehyde hydrates (100) (Schem e 43). The f-butyl ester (86) 
has been previously described. The A-formyl- (101) and N- 
trifluoroacetyl amides (103) were prepared in 98% and 36% yields 
using formic acid and trifluoroacetic acid respectively with the
coupling agent, l-(3 -d im eth y lam in o p ro p y l)-3 -e th y l carb o d iim id e .1 58 
This is a particularly good coupling agent to use as the resultant urea 
compound can be easily removed as the acid salt of the amine by
washing the reaction mixture with 5% aqueous citric acid in the 
work-up. The mechanism for the coupling reaction is shown in  
Schem e 44.
Ozonolysis of the trifluoroacetyl amide (103) gave the aldehyde
(106) in 54% yield. However, with the ozonolysis of the N -fo rm y l
amide (101) under the same conditions and the same reductive 
work-up using two equivalents of triethylamine at -78 °C no 
aldehyde was formed. Instead, spectroscopic analysis showed that 
the ozonide (107) had been isolated in 14% yield, i.e. the *H and 13C
(76) (86)
NH-CO-CH3 ^
COoH C.H2SO4
(109)
0 - 0
COot-Bu
NH-CHO 
0-0 (
^ ~ ~ X " C 0 2H 
°  (108) I54%l
RC02 H, CH2CI2 , 
Et-N=C=N-(CH2)3-NMe2 .HCI> 
N-methyl morpholine
NH-CO-R R = H (101) j980/oj
R = Me (102) [47%J 
C 0 2 t-Bu R = CF3  ( 1 03) [36%l
NH-CHO NH-CO-R
OHC
R = H (104) [43%] 
R = Me (105) [57%] 
C 0 2 t-Bu R = CF3  ( 1 06) [5 4 %]
OH NH-CO-R 
H 0/ ^ ' X ^ C 0 2H
R = H (98) [80%]
R = Me (99) [22%]
R = CF3 (100) [6 8 %]
Scheme. 43
NMR spectra showed no aldehyde signals. The 13C NMR spectrum
had signals at 5c 67.3 ppm for C-5 and 5c 91.2 ppm for C-4 ( F ig u r e
5 ). There was no possibility of this product being starting material
(101) because the expected signals for C-5 and C-4, at 5c 118.9 and
131.9 respectively, were not observed in the 13C NMR spectrum.
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H+
Et-N=C=N— (CHyr-NMej.HCI
o
/ r H+
H {
■ + ~  Et-N ^C =N — (CHgJj-NMez-HCI
Co
R— ,
0  O-H
C 0 2 t-Bu
N-Methyl
morpholine
NH3+cr
COpt-Bu
H H
■C 
II 
O
Et—N - -N — (CI-yj-NMeg.HCI
NH-CO-R
C 0 2 t-Bu
O
HO R
Scheme 44
To solve this problem, the reductive work-up was changed to
four equivalents of triethylamine at room temperature. This gave 
the desired aldehyde (104) in 57% yield. Compounds (104), (106)
and (107) were all deprotected by stirring in trifluoroacetic acid and
dichloromethane at room temperature for one hour to give the 
products (98), (100) and (108) in 80%, 68% and 54% yields
respectively. The IR spectra of (98) and (100) showed Umax at 1665 
and 1655 cm-1 respectively for the amide carbonyl bands.
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FIGURE 5.
TV-Acetyl-DL-allylglycine r-butyl ester (102) was prepared from  
the commercially available N -ace ty l -DL-allylglycine (109) using 
isobutylene as previously described. Purification was achieved on a 
silica gel column eluting with 15% ethyl acetate in hexane to give a 
clear oil in 47% yield. Ozonolysis followed by deprotection gave first 
of all the aldehyde (105) in 57% yield, i.e. there was a signal at 5h 
9.68 for the aldehyde proton and a signal at 6c 199.4 for C-4, and 
then the desired product (99) in 72% yield.
Unfortunately due to lack of time only D L -N -form ylaspartic  
acid-p-sem ialdehyde hydrate (98), DL-AT-formylaspartic acid-p- 
semialdehyde r-butyl ester (104) and DL-N-formylaspartic acid-p- 
semialdehyde ozonide r-butyl ester (107) have been tested for 
inhibitor activity. Compounds (98) and (104) both showed poor
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activity with approximately 10% inhibition at 1 mM. The ozonide
(107) showed no inhibition.
D L - A s p a r t i c  A c i d - B - s e m i a l d e h v d e  D i m e t h y l  A c e t a l .
Acylation of DL-allylglycine (76) with benzyl chloroformate 
yielded the corresponding N-protected amino acid (110) in 71% yield 
(Schem e 45). Treatment of (110) with benzyl bromide in 
dimethylformamide at room temperature gave an 84% yield of N- 
carboxybenzyl-D L-allylglycine benzyl ester (1 1 1 ).148 Ozonolysis of 
(111) in dichloromethane at -78 °C led. to the aspartic acid-P- 
semialdehyde derivative (112) in 58% yield. The corresponding 
dimethyl acetal (113) was formed in 82% yield upon heating the 
aldehyde (112) in methanol/trimethyl orthoform ate solution at 
reflux temperature for two h o u rs .159 Catalytic reduction of (113) 
gave DL-aspartic acid-p-sem ialdehyde dimethyl acetal in 58%
y ie ld .160 The overall yield from DL-allylglycine was 16%.
The L-isomers of the protected dimethyl acetal (113) and the 
aspartic acid-p-sem ialdehyde derivative (112) have been previously 
prepared by Keith et al.1 51 in their total synthesis o f the naturally 
occurring amino acid rhizobitoxine (81). They started with L- 
homoserine and used the same protecting groups to give N- 
carboxybenzyl-L -hom oserine benzyl ester. Oxidation of this 
protected homoserine derivative with chromium trioxide-pyridine 
co m p lex 150 in dichloromethane gave the aldehyde (112). The 
corresponding dimethyl acetal (113) was formed in essentially
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NH,
PhCH.COCl,
2M NaOH
NHC02CH2Ph
C 02H
(110) [71%]
0 ^ 003 , MeOH, 
BzBr, DMF
OH
NHC02CH2Ph 1.0 3, CH2C12, -78°C NHC02CH2Ph
[58%] (112)
C 02CH2Ph 2 .B 3N (2eq), -78 - 0°C C 02CH2Ph
p-TsOH, CH(OMe)3, 
MeOH
OMe NHC02CH2Ph
J L  X  
[82%] (113)
M eO‘
(HI) [84%]
Scheme 45
OMe NH3+
M e O ^ — ^ C 0 2-
(114) [58% ]
Overall yield: 16%
quantitative yield upon heating the aldehyde (112) in 
m ethanol/trimethyl orthoformate solution at reflux temperature in 
the presence of a catalytic amount of ammonium chloride.
The compounds prepared by Keith et al.1 51 had identical 
spectroscopic and physical data to the aldehyde (112) and the 
dimethyl acetal (113) prepared in our synthesis of DL-aspartic acid- 
P-semialdehyde dimethyl acetal (114). Unfortunately, due to lack of 
time (114) has not been tested for substrate or inhibitor activity.
1 0 0
T r i f l u o r o a c e t a t e  S a l t  o f  D L - A s p a r t i c  a c i d - 6 - s e m i a l d e h v d e  O x i m e .
Reaction of N -r-butoxycarbonylaspartic a c id -P -se m ia ld e h y d e  
(88) with hydroxylamine hydrochloride and triethylamine in 
dichloromethane gave a 2 : 1 mixture of the Z- (115) and E- oxime 
(116) in 73% yield (Schem e 46). The *H NMR spectrum showed a 
doublet of doublets at 5h 6.80 for 4-H (Z-isomer) and at 5h 7.39 for 
4'-H {E-isomer). The Z-isomer (115) 4-H is shielded by the lone pair
on the adjacent nitrogen and, as expected, comes at a lower chemical 
shift than that of the £ -isomer (116) 4'-H.
Deprotection of (115) and (116) using trifluoroacetic acid as 
previously described gave the Z- (117) and the E-isomer (118) of the 
desired product in 69% yield. The oximes have not been yet tested 
for inhibitor activity.
Trifluoroacetate Salt of DL-2-Amino-4-oxopentanoic Acid and DL-2-
A m ino-4-epoxypentanoic Acid.
Treatment of a solution of (88) in ethyl acetate with a solution
of diazomethane in ether gave a mixture of the methyl ketone (119)
and the epoxide (120) in 77% and 8% yields respectively ( S c h e m e
4 6) .* 6 1 Separation was achieved on a silica gel column eluting with 
50% ether in hexane. The *H NMR spectrum of (119) had a singlet at 
5h 2.17 for the methyl ketone, and a signal at 6c 206.6 C-4 in the 13C 
NMR spectrum. The !H NMR spectrum of (120) had a multiplet at 6h
C 0 2H 
[80% ] (1 2 1 )
I
TFA, CH2 CI2  
room temp.
NH-C02 t-Bu
C 0 2 t-Bu
[77% ] (119)
D'
(120)
NH-C02t-Bu
C 0 2 t-Bu
[8%]
OHC
CH2 N2 1 ether, 
EtOAc, 0°C
NH-COgt-Bu
C 0 2 t-Bu
(88)
HONH2 .HCI, Et3N, 
CH2CI2
H NH-CO^t-Bu
r r i  ,  n , , H° vN
OH P )  2 
(115)
C 0 2 t-Bu
H NH-C02 t-Bu 
2 i-Bu
[73% ] (E) 1 
(116)
TFA, CH2CI2 , 
room temp.
h n h 3 + c f 3 c o 2- h n h 3 + c f 3 c o 2-
+ HOs
N " v  'C 0 2H 
OH (Z) 2
(117)
N C 0 2 t-Bu
[69% ]
(E) 1 
(118)
Scheme 46
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2.45-2.63 for the protons at C-5 and at 6 h  2.91-3.00 for the p ro to n s  
at C-4. The 13C NMR spectrum had signals at 6c 48.1 for C-5 and 6c
49.8 for C-4.
The mechanism of the reaction of the aldehyde (88) with 
diazomethane involves attack at the aldehyde carbon to give the 
intermediate (122) (Schem e 47). This compound can either lose 
nitrogen to form the epoxide (120) or hydrogen can migrate with the 
loss of nitrogen to give the methyl ketone (119).
N=N=CH 2
Scheme 47
Deprotection of the methyl ketone (119). was easily carried out
using trifluoroacetic acid to give the trifluoroacetate salt of d l - 2 -
amino-4-oxopentanoic acid (121) in 80% yield. However, there was
not enough material to carry out the deprotection of the epoxide
N =
£ 0 /  NH-CQ>t-Bu 
H ^ ^ ^ C 0 5t-Bu
a ,b 
CHg— N^N 
^  NH-COgt-Bu
(122) COzt-Bu
(88)
O NH-CCy-Bu NH-COjt-Bu
C 0 2 t-Bu c o 2t-
(119) (1 2 0 )
Bu
103
(120). It was decided to prepare 2-amino-4,5-epoxypentanoic acid 
(124) by an alternative route.
Treatment of DL-N-carboxybenzylallylglycine benzyl ester
(111), previously described in the synthesis of DL-aspartic acid-p- 
sem ialdehyde dimethyl acetal (114), with a solution of m -  
chloroperbenzoic acid in dichloromethane at 0 °C followed by 
bringing the pH of the reaction to 8 with Na2HPC>4 buffer and stirring 
at room temperature for three hours gave the epoxide (123) in 76% 
yield (Schem e 48).1 6 2 There was a doublet of doublets at 5h 2.69
for the 5b-H in the !H NMR spectrum. The coupling constants were J
4.8 Hz and J  2.6 Hz. There was a doublet of doublets at 5h 2.69 for 
the 5a-H with coupling constants J  8.7 Hz and J  4.8 Hz and a m u ltip le t  
at 5h 2.88-3.02 for the 4-H. The 13C NMR spectrum had signals at 6c 
46.7 for C-5 and 6c 48.9 for C-4. Catalytic hydrogenolysis of (123)
COaCHgPh
NH-COgCHjPh
(76)
(112)
H2, Pd-C,
I ^ ----------------- U
I Ia O U  / A /^L J 1 1
m-CPBA, CH2 CI2 , 
Na2HP04
7
H NH-CO^CH2Ph
c o 2-. MeOH/AcOH & COjjCHgPh5
[63%J (124) (123) [76% ]
Scheme 48
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gave the desired epoxide (124) in 63% yield. The methyl ketone
(121) showed no inhibition at 1 mM. The epoxide (124) has not yet 
been tested for inhibitor activity.
Conclusion.
L-Aspartic acid-p-semialdehyde (21a) is an im portant
intermediate in the biosynthesis of L-lysine (1), L-threonine (16) and 
L-methionine (18). It has also become an important intermediate in
the synthesis of more complex non-protein and unnatural amino
acids.
The first synthesis of L-aspartic acid-p-sem ialdehyde (21a) 
was reported in 1955 by Black and Wright.7 0 This is the only
reported chemical synthesis of this compound. We now report an 
improved synthetic route to both the pure L - (89a) and D - iso m e rs  
(89b) of the trifluoroacetate salt of aspartic ac id -p -sem ia ld eh y d e  
hydrate starting from the commercially available amino acid
allylglycine (76). It appears as a light yellow solid and can be stored 
at 0 °C for several months.
Having L-aspartic acid-P-semialdehyde hydrate (89a) in pure
form has enabled us to set up a more accurate and reliable assay 
system to carry out kinetic studies on potential substrates o r
inhibitors of DHDP Synthase. Using this assay system we have 
confirmed that L-aspartic acid-p-sem ialdehyde hydrate (89a) is a 
substrate for the enzyme and that the D-isomer (89b) is not. We 
have also shown that L-aspartic acid-p-sem ialdehyde hydrate (89a)
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does not form a Schiffs base with DHDP Synthase in the enzyme
reaction whereas, as previously reported in the literature, pyruvate
(22) does. Having pure L-aspartic acid-P-sem ialdehyde hydrate
(89a) has also allowed us to carry out precise NMR spectroscopic
experiments to investigate the mechanism of DHDP Synthase. We
have confirmed that the product which can be isolated after carrying
out the enzymic reaction is DPA (36).
Manipulation of the synthetic route to DL-aspartic acid-p-
semialdehyde hydrate (89) has allowed us to prepare a range of
aspartic acid-p- sem ialdehyde analogues and derivatives. Most of 
these compounds have been tested for potential inhibitor or
substrate activity.
3.7. Future Work.
Accurate kinetic studies to get reliable Ki values should be
carried out with compounds which are showing at least 10%
inhibition at 0.5 mM. It must also be determined if the inhibition is 
com petitive or non-com petitive.
Using NMR spectroscopy to look at the mechanism of DHDP
Synthase is important to establish the structures of in te rm e d ia te s  
which are formed during the enzymatic reaction. Identification of
enzyme interm ediates will help in proposing synthetic targets which
may have useful enzymic activity. More NMR spectroscopic 
experiments are required at low temperatures under oxygen free 
conditions. This may slow down the enzymic reaction, thus giving
more time to identify the enzyme intermediates.
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From the test data which we already have it appears that 
substitution at the nitrogen group, as in the A-amido aspartic acid-p- 
semialdehyde analogues, does not lead to any inhibition. However, 
the methyl ester (92) showed slight inhibition and as such, larger 
ester groups should be investigated. Aldehyde derivatives should be 
p re p a re d .
The gem -difluoro analogue (125) would be an interesting
compound to test for activity. This could be prepared from (112) 
using diethylam inosulphur trifluoride (DAST)1 62 to give the
protected g e wi-difluoro compound (126). Catalytic hydrogenolysis
should give the desired product (125) (Schem e 49).
N H - C Q ^ P h  DASTCH2C|2
OHCv i   ►
COjCHgPh 
(112)
Scheme 49
The enol ether (127) would also be an interesting compound to 
test for substrate or inhibitor activity on DHDP Synthase. The
protected enol ether (128) has already been prepared by Keith e t  
a /.151 from the dimethyl acetal (113) (Schem e 50).
F N H -C aC H oPh
X  X
COaCH-Ph
(126)
't
(125)
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Treatment of acetal (113) with acetic anhydride and dry 
cationic exchange resin at 50 °C afforded the more labile h em iace ta l 
ester (129). Pyrolysis of this compound under reduced pressure at 
180 °C gave a mixture of the trans-  and c/j-enol ether (128).
Finally substitution at C-3 of DL-aspartic a c id -P -se m ia ld e h y d e  
hydrate (89) has not yet been considered. This might be possible 
starting from the enol ether (128). DL-3-M ethylaspartic acid-P- 
sem ialdehyde (130) and DL-3-fluoroaspartic a c id -p -sem ia ld e h y d e  
(131) would be interesting targets.
OMe COgCHgPh
NHCQ>CH2Ph
OMe COgCHjPh
(CHaCOJaO,
CH3 COOcation-exchange
resin NHCOoCHoPh
(113) (129)
180°C
c o 2- COaCHaPh
NH3+ NHCOaCHaPh
(127) (128)
Scheme 50
(130) (131)
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C h ap te r f41 - Synthesis of D erivatives of P v ru v a te  and
B r o m o n v r u  v a te .
In tro d u c tio n
All cells have the capacity to metabolise glucose (132) from the 
photosynthesis of carbon dioxide and water. Glucose (132) is by far 
the most important sugar. It can be converted into adenosine 
triphosphate (ATP), as well as small organic molecules which are the
building blocks of other biosynthetic pathways. In the absence of
oxygen, glucose (132) is converted into pyruvate (22) (Schem e 51), 
via a process known as glycolysis; but in the presence of oxygen,
glucose (132) may be completely oxidised to carbon dioxide v ia  the
citric acid cycle,1 6 4 with concomitant production of ATP. The 
products of the citric acid cycle are simple keto-acids, dicarboxylic
acids, carbon dioxide and most important of all ATP. The simple
keto-acids react with ammonia or its equivalent to produce aliphatic 
amino acids.
A product o f glycolysis, pyruvate (22), can be fu r th e r
converted into acetylcoenzyme A, which is of pivotal importance fo r 
both primary and secondary metabolism. Acetylcoenzyme A may be
used as a building block for the biosynthesis of fatty acids a n d
polyketides which can be further coverted into triglycerides, 
polyphenols, polyacetylenes, prostaglandins and macrocyclic
antibiotics. It can also be used a£ a building block for the
biosynthesis of isoprenoids. Pyruvate (22) may also enter the
C 0 2  + HzO hu (photosynthesis^
CH2OH
OH
Ho N fOH
OH
D-Glucose (132)
1 10
+ Other Sugars
CHo
II
C -O P
O O'
Phosphoenol pyruvate
CB
C = 0
Aliphatic amino 
acidsPyruvate (22)
CITRIC
ACID
CYCLE
CO;
Polyketides
and
Isoprenoids
Prostaglandins
Triglycerides Scheme 51
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citric acid cycle to combine with oxaloacetate to produce citrate and 
other keto-acids such as a-ketoglutarate, which can be converted 
into glutamate and other amino acids.
As previously mentioned, pyruvate (22) and the products of 
the citric acid cycle can be converted into aliphatic amino acids, 
which are the building blocks for peptides, proteins, alkaloids and 
penicillins. One such example of pyruvate (22) being converted into 
an aliphatic amino acid is the DAP pathway to L-lysine (1). Pyruvate
(22) and L-aspartic acid-p-sem ialdehyde (21a) are the two
substrates involved in this pathway. DHDP Synthase catalyses the
condensation of pyruvate (22) with L-aspartic a c id -p -se m ia ld e h y d e  
(21a) to give L-2,3-DHDPA (23). A further six enzyme catalysed
reactions of L-2,3-DHDPA (23) lead to L-lysine (1) (Schem e 5).
The sequence of steps in the mechanism of formation of L-2,3-
DHDPA (23) from pyruvate (22) and L-aspartic a c id -p -se m ia ld e h y d e
(21a) has not yet been fully established. However, Schedlarski and
G ilvarg7 4 and Kumpaisal et al.5 7 have shown that the enzyme 
functions in carbon-carbon bond formation by first of all forming an 
imine linkage with pyruvate (22), i.e. DHDP Synthase forms a Schiffs
base intermediate with pyruvate (22) in the enzymic reaction.
In this Chapter a range of pyruvate and b ro m o p y ru v a te  
analogues have been synthesised and tested for either substrate or 
inhibitor activity with DHDP Synthase. The results obtained with
these compounds will be discussed at the end of each section.
4.1. Synthesis o f Pyruvate Derivatives.
A number of imine and hydrazine derivatives o f pyruvate (22) 
and methyl pyruvate have been synthesised and tested with DHDP
S yn thase .
The oxime (133), methyloxime (134), semicarbazone (135),
thiosemicarbazone (136) and methyl hydrazinocarboxylate (137)
derivatives of methyl pyruvate were all prepared under the same 
reaction conditions in 38%, 17%, 11%, 60% and 69% yields
respectively (Schem e 52), i.e. a solution of methyl pyruvate in 
dichloromethane was added to a solution of the respective amine 
hydrochloride in water and the two-phase mixture was rapidly
stirred for 24 hours. Extraction of the resultant m ixture with 
dichloromethane, followed by drying and concentration gave the
desired products.
Thiosemicarbazide was prepared in 47% yield by h e a tin g  
ammonium thiocyanate and hydrazine hydrate at reflux in water for 
three hours.
The ethyl hydrazinoacetate derivative of methyl pyruvate 
(138) was prepared by treatment of methyl pyruvate with ethyl 
hydrazinoacetate hydrochloride and triethylam ine in
dichloromethane under a nitrogen atmosphere. The yield of the 
reaction was 23% after purification using column chromatography.
The 2,4-dinitrophenylhydrazones (2,4-DNPs) of methyl 
pyruvate (139) and pyruvic acid (140) were prepared according to 
the method of Vogel165 in 37% and 18% yields respectively.
CH,
M e02C
^ = N —NH-CH2C02Et
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Scheme 52
Test Results.
The oxime (133) and methyloxime (134) showed no inhibition 
at 0.5 mM with DHDP Synthase. The thiosem icarbazone (136) and 
semicarbazone (135) were both very good inhibitors showing 
approximately 10% inhibition at 0.1 mM. However, by far the best 
inhibition was shown by the ethyl hydrazinoacetate derivative (138). 
This compound showed 62% inhibition at 0.1 mM. Unfortunately due 
to lack of time Kj values have not yet been obtained. It has also not 
yet been established if  (138) is a competitive or a non-competitive 
in h ib ito r.
1 14
The methyl hydrazinocarboxylate derivative (137) sh o w ed  
100% inhibition at 0.5 mM, but at 0.1 mM no inhibition was 
observed. This sudden loss of activity is unusual and further
biochemical experiments must be carried out to establish why this 
h a p p e n s .
The 2,4-DNP derivatives (148) and (149) did not d isso lv e  
particularly well in water/ethanol mixtures. These compounds d id
not show very good inhibition. This may be due to the fact that th e y  
were only poorly soluble and that they might interfere with the 
assay system at 270 nm, due to their extensive conjugation.
Methyl pyruvate has been shown to act as a substrate with 
DHDP Synthase. This compound shows half as good a rate in the 
enyme assay as that of the natural substrate pyruvate (22).
4.2. Synthesis of Bromopvruvate Derivatives.
A range of imine and hydrazine derivatives of ethyl
bromopyruvate and bromopyruvic acid hydrate have also been 
synthesised and tested for inhibitor activity with DHDP Synthase.
The oxime (141), methyloxime (142) and sem icarbazone (143)
derivatives of ethyl bromopyruvate (Schem e 53) were all prepared
in a dichloromethane/water two-phase reaction with the respective 
amine hydrochloride, in the same manner as the methyl pyruvate
derivatives. The respective yields for each of the products were 32%, 
92% and 41%. The 2,4-DNP derivatives (144) and (145) were
prepared according to the procedure of Vogel.1 6 5
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Attempts to prepare the thiosemicarbazone of ethyl 
bromopyruvate (146) using the d ich lo rom ethane /w ater tw o-phase 
system proved unsuccessful. Instead !H NMR analysis of the re a c tio n  
product showed a 1 : 1 mixture of the cyclic products (147) and 
(148) (Schem e 54). The NMR spectrum of the mixture showed 
an AB system for the methylene group at the 2-position in (147) at 
5h 5.33 and 6.28 and the vinyl proton in (148) appeared at 5h 6.97 
(F igure  6 ) .  The l3C NMR spectrum showed all the expected signals 
for the two cyclic products. TLC analysis of the mixture showed one
1 16
spot. Column chromatography proved unsuccessful in separating the 
two products. The mechanism of formation of these cyclic 
compounds presumably proceeds via  the thiosemicarbazone (146) as 
shown in Schem e 54.
Br
H gN -C -N H -N H g
Q p C 0 2Et
HY ^ v "
N'  N T ^ C 0 2Et 
H
(147)
k
NV COoEt
H
(148)
S
> H 2N - C - N H N j
H S dH
Br
C 0 2Et
COoEtH
(146)
Scheme 54
FIGURE 4.
The dimethyl acetal of methyl bromopyruvate (149) w as
prepared in 20% yield from bromopyruvic acid hydrate using
trimethyl orthoformate and cone, sulphuric acid. The diethyl acetal 
of bromopyruvic acid (150) was prepared in 81% yield by similar
treatment of bromopyruvic acid with triethyl orthoformate and conc. 
sulphuric acid.
Test Results.
Bromopyruvic acid hydrate showed very little inhibition at 1
mM with DHDP Synthase. This result is in contrast to the results of 
Kumpaisal et al.s 1 They found that bromopyruvic acid inhibits
1 18
wheat DHDPS considerably at 1 mM using an assay system devised
kinetic studies by Kumpaisal et <z/.8 1 showed that bromopyruvic acid 
hydrate inhibits wheat DHDPS in a competitive manner with re s p e c t  
to pyruvate (22) and in a non-competitive manner with respect to L- 
aspartic acid-0-semialdehyde (21a). They found the Ki value for 
bromopyruvic acid to be 1.82 mM.
The oxime (141) showed very little inhibition at 1 mM. 
However, the methyloxime (142) showed very good inhibition with 
14% at 0.1 mM. Further kinetic studies are required with the 
methyloxime (142). The semicarbazone (143) was a very impressive 
inhibitor showing 50% inhibition at 0.1 mM. Further investigations 
are required with this compound to obtain an accurate Ki value a n d  
to determine whether it is a com petitive or non-competitive 
in h ib ito r.
Like the pyruvate 2,4-DNP derivatives, the bromopyruvate
2,4-DNP derivatives (153) and (154), showed very little inhibition. 
Unfortunately due to lack of time the dimethyl acetal (149) and 
diethyl acetal (150) have not yet been tested for enzyme activity 
with DHDP Synthase.
Commercially available phenylpyruvic acid (151) and sodium 
mercaptopyruvate (152) showed no inhibition with DHDP Synthase.
by Yugari and Gilvarg5 6 involving o-am inobenzaldehyde. Further
(151) (152)
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Conclusions.
A range of pyruvate and bromopyruvate derivatives have b e e n  
synthesised and tested, along with commercially available pyruvates, 
for enzyme activity with DHDP Synthase.
Methyl pyruvate has shown substrate activity with DHDP
Synthase, whereas bromopyruvic acid hydrate, phenylpyruvic acid
and sodium mercaptopyruvate showed no substrate activity. F u r th e r  
investigations are required to obtain an accurate Km value for m e th y l 
pyruvate. Other pyruvate esters should be tested for substrate 
a c tiv ity .
The bromopyruvates were better inhibitors than the pyruvates
i.e. the bromopyruvate oxime (141), methyloxime (142) and 
semicarbazone (143) all showed better inhibition than their 
corresponding pyruvate derivatives, (133), (134) and (135).
In particular, the ethyl hydrazinoacetate derivative of methyl
pyruvate (138) and the semicarbazone of ethyl bromopyruvate (1 4 3 ) 
were very good inhibitors. Accurate Ki values should be calculated 
for these compounds and the nature, competitive or non-com petitive,
of the inhibition should be determined.
Further imine and hydrazone derivatives of pyruvate and
bromopyruvate should be synthesised and tested for inhibitor
activity with DHDP Synthase. The simple hydrazine (153), 
m ethylhydrazine (154) and dimethylhydrazine (155) derivatives of 
ethyl bromopyruvate would be interesting targets which should be 
tested for enzyme activity with DHDP Synthase.
1 2 0
/  Br R = R =H  (153)
N _ N = \  R = H, R' = Me (154)
R  C 0 2Et R = R = Me (155)
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Chapter T51 - Synthesis of Sulphur Analogues of L-2.3-DHDPA (231
and L-2.3.4.5-THDPA (24).
In tro d u c tio n .
1,4-Thiazine (156) was first reported in 1948 by Barkenbus 
and Landis.167 They obtained a 13% yield of 1,4-thiazine (156) by
passing thiodiglycolic acid imide (157) over alumina on pumice at 
450 °C (Schem e 55). Since that early discovery c o n s id e ra b le  
attention has been given to the synthesis of compounds containing a 
tetrahydro-1,4-thiazine (158) or, as it is more commonly known, a
thiam orpholine ring system.1 68* 1 69 In particular, there are many
drugs which are widely used in medicine based on the dibenzo 
derivative of 1,4-thiazine (159). These drugs have the trivial name 
of phenothiazines. They are important in the management of 
psychiatric illness and have other useful properties which enable 
them to be used as sedatives, anti-histamines and in the treatment o f  
nausea. Phenothiazines have also shown good specificity and high
potency as tranquillisers for animals. Burke et <z/.169a have reported 
that 1 0 -(3 -d im e th y la m in o p ro p y l) -2 -( tr if lu o ro m e th y l)-p h e n o th ia z in e  
hydrochloride shows very good tranquillising activity.
Alumina,
0 ^ N^ 0  450°C
H
(157)
(156)
Scheme 55
(158)
Two important phenothiazine drugs are chlorpromazine (1 6 0 ) 
and triflupromazine (161). The synthesis of triflupromazine (161) is 
shown in Schem e 56.
(159)
(CH2)3NMe2
(160) R = Cl
(161) R = CF3
PhHN Sq, I2.
150 C
Me2 NH(CH2 )3 CI,
NahL 
140°(
(CH2)3NMe2
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Scheme 56
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The reaction of diarylamines with sulphur, with iodine being
used as a catalyst,1 70 is one of the oldest and most widely used
methods of synthesis of phenothiazine drugs. A major disadvantage 
of this method is the 1:1 formation of both the 2-(trifluoromethyl)- 
phenothiazine and the 4-(trifluorom ethyl)-phenothiazine isom ers. 
The 2-isomer has a melting point of 187-188 °C, whereas the 4- 
isomer has a melting point of 72-73 °C. The 2-isomer is also less 
soluble than the 4-isomer and so separation can be quite easily 
ach ieved .
The 1,3-thiazole ring system is quite commonly found in
natural products, since it can be produced by the cyclisation of
cysteine residues in peptides. The most important of these is
vitamin Bi (thiamine) (162), which contains both a pyrimidine and a
1.3-thiazole ring system. The bleomycin antibiotics, which have 
antitumour properties, are complex aminoglycosidic structures
containing 1,3-thiazole units. Firefly luciferin (163) is a
benzothiazolyl derivative: the bioluminescence is produced by photo­
oxygenation at the asymmetric centre. Several modern
sem isynthetic 0-lactams, such as cefotaxime (164), contain 2 -am in o -
1.3-thiazole units in the side chain.
The most general synthetic route to 1,3-thiazoles is based on
%
the cyclisation of intermediates formed from the reaction of a-
halocarbonyl compounds and thioamides. This strategy was first
introduced by H an tzsch 1 71 and is commonly known as the 'Hantzsch 
thiazole synthesis'. The reaction has been carried out not only with
thioamides, but also with thioureas, thiosemicarbazides and other 
compounds containing the -N-C=S structural unit. An example of the
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Hantzsch thiazole synthesis to produce 2 ,4 -d ip h e n y l-1,3 -th ia zo le  
(165) is shown in Schem e 57.
NHg
2CI‘
Me
H
(162)
OMe 
N H
H
\  //N^ c °2H
(164)
Ph
Ph
Ph
T NHgBr
S '^ ^ P h
(166)
Ph
Ph
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The mechanism of the reaction goes by way of nucleophilic 
attack by sulphur on the carbon atom bearing the halogen to form an 
acyclic intermediate (166), which has been isolated in a few cases. 
Cyclisation, followed by dehydration, takes place to give the desired
1,3-thiazole (165). The reaction is normally carried out in ethanol.
Another important method of 1,3-thiazole synthesis is th e  
cyclodehydration of a-acylam inoketones (168) with phosphorus 
p e n ta su lp h id e .1 7 2 An example of this method is the synthesis of 4- 
(4-m ethylphenyl)-l,3-thiazole as shown in Schem e 58.
H
4-Me-C6 H4 -COCH2 NH2
HC02H
4"Me-CgH4
/ — N
V - H
O O 
(168)
(167)
Scheme 58
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5.1. Synthesis and Test Results of 1.4-Thiazine Derivatives.
3 .4 -D ih v d ro -2 /M  .4 -T h iaz ines .
3 ,4 -D ihydro-2 //-l,4 -th iazine-3 ,5 -d icarboxy lic  acid (3,4-DHT) 
(169) hydrobromide was first reported by Ricci et a I.* 7 3 in their
studies on the products of L-lanthionine (170) oxidation with snake
venom L-amino acid oxidase (L-AAO). They showed that L-
lanthionine (170) was oxidised by snake venom L-AAO with the
release of one mole of ammonia gas per mole of L-lanthionine (170). 
From spectrophotomeric, chromatographic and analytical data they
identified the mono-keto derivative of lanthionine (171) as the first
enzymatic product of the reaction (Schem e 59). This then cyclised
into 2 ,3 -d ihydro-6 //-l,4 -th iaz ine-3 ,5 -d icarboxy lic  acid (ketimine 
form) (172) which tautomerised to the more stable 3,4-DHT
(enamine form) (169).
Ricci et al.173 prepared authentic 3,4-DHT (enamine fo rm ) 
(169) by stirring equimolar concentrations of bromopyruvic acid 
hydrate and L-cysteine hydrochloride in water (Schem e 60). The
product crystallised in the monomeric form from the aqueous
solution. The properties of the synthetic material were found to be
similar to those exhibited by the enzymatic product.
We prepared 3,4-DHT (169) in 55% yield according to the 
procedure of Ricci et a/.173 (Schem e 60). The 13C NMR sp e c tru m  
showed only the enamine form (169) i.e. there was a signal at 6c 97.7 
for C-6 and at 5c 128.6 for C-5. No signal was observed for th e  
methylene group at C-6 of the ketimine form (172). The !H NMR
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spectrum showed a singlet at 5h 5.94 for the proton at C-6 of the 
enamine form (169). The 13C NMR spectrum of 3,4-DHT (enamine 
form) (169) is shown in F igure  7.
OoC CCV
NH, HUN
(170)
0 2 C.
L-AAO
NB
(171)
(169)
H 0 2 C‘ N ^ ' C O , -
H
(172)
Scheme 59
RO
.SH Br
,C N H,C I- C 0,R '
(169) : r=r*=h
(175) : R=R'=Ethyl
(176) : R=Ethyl, R=H
(177) : R=H, R'=Ethyl
C o n d i t i o n s
H20
CH2 CI2 /E t3N 
CHCI3 /E t3N 
CHCI3  / Et3N
Yield
55%
96%
20%
Scheme 60
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FIGURE 7 : 13C NMR SPECTRUM OF 3.4-DIHYDRO-1.4-THIAZINE DIACID.
There are two possible mechanisms for the formation of 3,4-
DHT (169) from L-cysteine and bromopyruvic acid. One possibility is 
nucleophilic attack by sulphur on the carbon atom bearing th e
bromine to form an acyclic intermediate (173) (Schem e 61). This 
could then undergo cyclodehydration to give 3,4-DHT (169). An
alternative mechanism is to reverse these two steps i.e. first of all
formation of the imine intermediate (174) by attack of the amino
group on the keto group of bromopyruvic acid with the loss of the
elements of water. This could be followed by cyclisation via 
nucleophilic attack by sulphur on the carbon atom bearing th e
bromine (Schem e 61). It has not yet been established which of 
these mechanisms actually occurs.
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-HoO
(174)
R02C‘
ScheaieJii
R02C
1 + 0 ^  PQ O*
n h 3 c o 2r
Br‘
(173)
-HoO
N+ COpR' 
H Br'
(172)
(169)
Diethyl (R )-3 ,4-d ihydro-2£M ,4-th iazine-3 ,5-d icarboxylic  ac id
(175), the diethyl ester derivative of 3,4-DHT, was prepared in 90% 
by treating L-cysteine ethyl ester hydrochloride with ethyl 
bromopyruvate in dichloromethane in the presence of t r ie th y la m in e  
(Scheme 60). The compound exists as a golden brown syrup and 
was first reported by Berges and Taggart1 7 4 from their studies on
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3,4-DHT (169). The mechanism of formation of the diester (175) is
presumably similar to that proposed for the diacid (169).
The !H NMR spectrum of the diester (175) is shown in F i g u r e
8.  The spectrum shows an interesting long range coupling between
the methylene protons at C-2 and the vinyl proton at C-6 with a
coupling constant of 0.7 Hz. There is a well defined ABX splitting
pattern between the methylene protons at C-2 and the ad j acen t
proton at C-3. The diastereotopic protons at C-2 are easily
distinguishable from their coupling with the proton at C-3. The 2a-H
at C-2 has a signal at 5h 2.97 and a coupling constant of 6.7 Hz with
the proton at C-3 whereas the 2b-H at C-2 has a signal at 5h 3.18 and
a coupling constant of 2.9 Hz with the proton at C-3. The coupling
constant between the geminal 2a-H and 2b-H is 12.1 Hz.
t .: :* :  :•* r» i.zurr  • r c i / ;? : i rm x i
%'.% i :  : .»  ;.‘a c s r.'s i . t  i . j  ;.'i  ;.3 s .'t i t •<.% 2.3 : . i  : 'd  .1
r* n
FIGURE 8 : *H NMR SPECTRUM OF 3.4-DIHYDRO-1.4-THIAZINE DIESTER.
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3 -C arb o e th o x y -3 ,4 -d ih y d ro -2 tf-l,4 -th iaz in e -5 -ca rb o x y lic  ac id
(176) (Schem e 6 0 ), the 3,4-DHT derivative containing one free and 
one esterified carboxyl group, was prepared in 20% yield by treating 
L-cysteine ethyl ester hydrochloride and bromopyruvic acid hydrate 
in chloroform in the presence of triethylamine. The work-up for the 
reaction involved extracting the product from chloroform as the 
sodium salt using 5% aqueous sodium bicarbonate solution. The 
aqueous layer was then acidified and the product was extracted into 
organic solvent. Evaporation in vacuo and drying gave the desired 
product as a yellow oil. This extensive work-up may contribute to 
the reaction being low yielding. The spectrophotomeric and 
analytical data of this compound are compatible with those of the 
diester (175).
3 -C a rb o m e th o x y -3 ,4 -d ih y d ro -2 /f-1,4 -th ia z in e -5 -c a rb o x y lic  
acid, the methyl ester derivative of (176), was previously reported 
by Strokov1 7 5 from his studies on the condensation of methyl esters 
of a-am ino-P-m ercaptocarboxylic acids with bromopyruvic acid.
Attempts to prepare 5 -carboethoxy-3 ,4 -d ihydro-2 //-1,4- 
thiazine-3-carboxylic acid (177) (Schem e 60), the other derivative 
of 3,4-DHT (169) containing one free and one esterified carboxyl 
group, proved unsuccessful. Treating L-cysteine hydrochloride with 
ethyl bromopyruvate in chloroform in the presence of triethylamine 
under various reaction conditions gave a dark brown residue which 
showed several spots on TLC analysis and had no vinyl signal for the 
proton at C-6 in the NMR spectrum.
3 ,4 -D ih y d ro -2 //-l,4 -th iaz in e-3 ,5 -d ica rb o x am id e  (1 7 8 )
(Schem e 62), the diamide derivative of 3,4-DHT (169), w a s
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prepared in 37% yield by stirring the diester (175) in a solution of 
methanolic ammonia. The diamide (178) is insoluble in organic 
solvents and precipitated as an orange solid from the methanolic 
so lu tion .
O'TV*'Hb" 1
E tO o C '^ N ^ 'C O a E t  
H 4 H
[77%] (180)
-H20
{77-CPBA,
h 2 c i2,
78°C
C H 2 CI2, \  2
r.t.
H2NOC
MeOH3’
1
.S,
E t02C 4N
/  t o o .  <175>
I T3L \  \ y oxone
E t O ^ ^ ' N ^ C O g E t  vd  4 *  /  \  m-CPBA
[79%] (182) i  (2equiv)
C 0 2Et
Mel,
MF
N 
H 
(178)
X
Et02C
Et02C N C 0 2Et 
H
(185)
CO NH 5
[37%]
N 
I
Me
(179)
C 0 2Et
[31%]
Scheme 62
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Diethyl 3 ,4 -d ih y d ro -4 -m e th y l-2 /f -1,4 -th ia z in e -3 ,5 -
dicarboxylate (179) (Schem e 62), the A-methyl derivative of the
diester (175), was prepared in 31% yield by treating the diester
(175) with methyl iodide in dimethyl formamide (DMF). Excess DMF 
was removed by azeotroping the reaction mixture with two volumes
of water and concentrating the solution in vacuo. Excess methyl 
iodide and hydroiodic acid, formed in situ during the reaction, were 
removed by dissolving the reaction mass in ethyl acetate and then
washing the organic phase with aqueous ammonia solution. The *H 
NMR spectrum of the product showed a signal at 5h 2.70 and the 13C 
NMR spectrum had a signal at 5c 42.3 for the AT-methyl group.
Diethyl f raw s-3 ,4 - di h y d ro - l-o x o -2 tf-  l ,4 - th ia z in e -3 ,5 -
dicarboxylate (180) (Schem e 62), the sulphoxide derivative of the
diester (175), was prepared in 77% yield according to the procedure
of Berges and Taggart.1 7 4 A solution of the diester (175) in
dichloromethane at -78 °C was treated with one equivalent of mc ta -  
chloroperbenzoic acid (m -CPBA). The product was purified on a silica  
gel column eluting with 50% chloroform in methanol to give an 
amber syrup. The spectrophotomeric and physical data of the 
product obtained were identical to those obtained by Berges and 
T ag g art.1 7 4
Berges and Taggart174 assigned the rra/zs-stereochem istry to 
the sulphoxide (180) by comparing the !H NMR spectrum of the 
sulphoxide (180) with the spectra obtained by Kitchen and
S tood ley176 for r ra r ts -3 ,4 -d ih y d ro - l-o x o -2 J /- l ,4 - th ia z in e -3 ,6 -  
dicarboxylates (181). To confirm this assignment they carried out 
NMR aromatic solvent induced studies on the sulphoxide (180).
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It was previously reported by Strom et a/.1 7 7 and Fraser e t  
a /.178 that benzene solvates the positive end of the sulphoxide
Q'
dipole and is therefore closer to the vicinal proton t ra n s  (2a-H) to the
sulphoxide (F igu re  9) and shields it more than the proton cis  (2b-
H) to it. Hence 2a-H (5 h  2.25) has a lower chemical shift than 2b-H
( 5 h  3.41). The large coupling of 3-H to 2a-H and its small coupling to
2b-H indicates that 3-H is t r a n s  to 2a-H and is therefore cis  to the
sulphoxide. Hence the ester group at C-3 must be t ra n s  to the
su lphox ide.
H
(181)
H
FIGURE 9
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Berges and Taggart174 found that the sulphoxide (180) is  
remarkably labile. On standing overnight in dichlorom ethane at
room temperature it was transformed into the 1,4-thiazine (182) 
(Schem e 62). The !H and i3C NMR spectra of the 1,4-thiazine (182) 
were quite different from those of the sulphoxide (180). The lH NMR 
spectrum of the 1,4-thiazine (182) had a doublet at 5h 3.33 for the 
protons at C-2 [7 1.2 Hz] and a triplet at 6 h  7.59 for the proton at C-6
[7 1.2 Hz]. The 13C NMR spectrum had a signal at 5c 20.17 for C-2 and
a signal at 6c 128.22 for C-6. There were also two signals at 6c 
136.92 and 137.57 for C-3 and C-5.
No such precedent for such a mild sulphoxide dehydration was
found in the literature. However, Stoodley and W ilk in s179 reported 
the thermal (ca. 40 °C) racemisation of r r a / j$ -3 ,4 -d ih y d ro -1 -oxo-2 //-
l,4 -th iaz ine-3 ,6 -d icarboxy la tes (181) and provided evidence that 
this reaction involves a cycloelimination to produce an ach ira l 
sulphenic acid (183) which recloses to give back the t ran s -su lp h o x id e  
as a racemate (Schem e 63).
O OH
H
(181)
40°C
H
(183)
Scheme 63
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Since the sulphoxide (180) obtained by Berges and Taggart1 7 4 
was racemic it would be reasonable to conclude that the m ech an ism  
for dehydration of the sulphoxide (180) must go via the sulphenic 
acid (184) (Schem e 64). In addition to being able to reclose to give 
racemised sulphoxide, the ring-opened sulphenic acid (184) can a lso  
undergo 1,4-elimination of water to give the 1,4-thiazine (182). 
Yoshida et a/.180 reported the 1,2-elimination of water from a 
sulphenic acid intermediate. However Stoodley did not report any 
dehydration reactions for his sulphoxides.
r < K
E t02C -  N 
H H
(180)
& COgEt E t02C COgEt
H
(184)
1,4-elimination
of
HgO
(182)
Scheme 64
To confirm that the 1,4-thiazine (182) is the sulphoxide 
dehydration product Berges and Taggart1 7 4 prepared authentic 1,4- 
thiazine (182) by treating a solution of the diester (175) in
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dichlorom ethane with the hydride abstractor, 2,3-dichloro-5,6- 
dicyanobenzoquinone (DDQ) (Schem e 62), They obtained a yellow 
oil which gave *H NMR, IR and UV spectra identical with those
obtained for the sulphoxide dehydration product.
We repeated the synthesis of the 1,4-thiazine (182) in 79%
yield according to the procedure of Berges and Taggart.1 7 4 Both the 
sulphoxide (180) and 1,4-thiazine (182) will be tested for inhibitory 
activity on DHDP Synthase.
Attempts to prepare the sulphone (185) (Scheme 62) from
the diester (175) using oxone (potassium peroxym onosulphate),1 81 
and two equivalents of m-CPBA proved unsuccessful in both cases.
The reason for this may be due to stereochemical bulk at the sulphur 
centre of the 3,4-dihydro- 1,4-thiazines.
3 ,4 -D ih y d ro -2 .2 -d im e th y l-2 ff-1 .4 -th ia z in e s .
D L -3 ,4 -D ih y d ro -2 ,2 -d im e th y l-2 /M ,4 -th ia z in e -3 ,5 -d ic a rb o x y lic  
acid (186) hydrobromide, the 2,2-dimethyl derivative of 3,4-DHT, 
was prepared by treating DL-penicillamine with bromopyruvic ac id  
in glacial acetic acid (Schem e 65). Removal of the solvent in vacuo 
gave a brown solid. The NMR spectrum of this material showed 
two signals at 5h 1.20 and 5h 1.37 for the geminal methyl groups at 
C-2 and a signal at 5h 5.98 for the proton at C-6. Purification of this 
compound proved very difficult. To confirm that this brown solid
was the correct product, the compound was converted into the
dimethyl ester (187) using a solution of diazomethane in ether. The
yield of the dimethyl ester (187) from DL-penicillamine was 61%.
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yield of the dimethyl ester (187) from DL-penicillamine was 61%.
The 13C NMR spectrum of this compound showed two signals at 5c
24.8 and 27.5 for the geminal methyl groups at C-2, two signals at 5c
52.0 and 52.1 for the saturated and unsaturated methyl esters, and a
signal at 5c 102.3 for C-6.
OoC
.SH Br
- +o£NH, 0  C 0,H AcOH
(186)
CH2N2,
EtOAc/Ether
Scheme 65
Ethyl 3 -C a rb o m e th o x y -3 ,4 -d ih y d ro -2 ,2 -d im e th y l-2 //-1,4-
thiazine-5-carboxylate (188) was prepared in 90% yield by treating 
DL-penicillamine methyl ester hydrochloride with ethyl 
bromopyruvate in dichloromethane in the presence of tr ie th y la m in e  
(Schem e 66). This compound had similar and 13C NMR spectra 
to those of the dimethyl ester (187) apart from the ester signals. T h e
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geminal methyl groups at C-2 and a signal at 6h 6.19 for the proton 
at C-6.
Methyl 3 ,4 -d ih y d ro -2 ,2 -d im e th y l-2 H -l ,4 - th ia z in e -5 -c a rb o x y lic  
acid-3-carboxylate (189) (Schem e 66), a derivative o f the di-acid 
(186) containing one free and one esterified carboxyl group, was 
prepared in 24% yield by treating DL-penicillamine methyl e s te r  
hydrochloride with bromopyruvic acid in chloroform in the presence 
of triethylamine. Like the half-acid/half-ester derivative of 3,4-DHT
(176) the yield of this reaction was low presumably due to the 
extensive work-up involved. The *H and 13C NMR spectra of this 
compound were similar to those obtained for the diesters (187) and 
(1 8 8 ).
The mechanism of formation of the 2,2-dimethyl 3,4-DHT 
derivative is presumably the same as that proposed for the 3,4-DHT 
derivatives (Schem e 61).
M e02C NHoCl
H
R = Et [90%1 (188)
R = H [24%] (189)
Scheme 66
3.4-D ihydro-2H -1 .4-th iazine-5-carboxvlic  acids.
3 ,4-D ihydro-2 /M ,4-th iazine-5 -carboxy lic  acid h y d ro ch lo rid e  
(190) (Schem e 67), a derivative of 3,4-DHT (169) with no ca rb o x y l
.SH
Nl-feCr
[R=Et] CH2 CI2,Et3N
Br
C 0 2R
N'
H
C02Et 
(192) [26%]
AcOH  *
[R = H] S. n ; c o 2h 
H2 C r
(190)
s .
(191) I70°/o]
Scheme 67
group at C-3, was prepared by stirring a solution of 2- 
aminoethanethiol hydrochloride and bromopyruvic acid in glacial 
acetic acid at room temperature for 1 hour. Removal of the solvent 
in vacuo gave an off-white solid which showed a signal at 5h 6.25 for 
the proton at C-6 in the *H NMR spectrum. Purification of this 
material proved difficult and, as in the case o f the diacid (186), the 
compound was converted into the methyl ester (191) by adding a 
solution of diazomethane in ether to a solution of the acid (190) in
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ethyl acetate. The yield of the methyl ester (191) from 2- 
aminoethanethiol hydrochloride was 70%. The *H NMR spectrum
showed multiplicities at 5h 2.86 for the protons at C-2 and at 5h 3.62
for the protons at C-3 and a singlet at 5h 6.05 for the proton at C-6. 
The 13C NMR spectrum showed a signal at 6c 40.4 for C-2, a signal at
6c 62.5 for C-3 and a signal at 6c 102.3 for C-6.
Ethyl 3 ,4 -d ih y d ro -2 /M ,4 -th ia z in e -5 -c a rb o x y la te  (192)
(Schem e 67) was prepared in 26% yield by treating 2- 
am inoethanethiol hydrochloride with ethyl bromopyruvate in 
dichloromethane in the presence of triethylamine. The lH and 13C 
NMR spectra of (192) were similar to those obtained for the methyl 
ester (191).
Test Results.
The 3,4-dihydro-l,4-th iazines showed very strong inhibition 
with DHDP Synthase. The diethyl ester (175) and the
dihydrothiazine derivative with one free and one esterified carboxyl 
group (176) both showed approximately 10% inhibition at 0.1 mM 
with DHDP Synthase. Further kinetic studies are required to
determine whether the inhibition is competitive or n o n -co m p e titiv e . 
The diacid (169) showed 88% inhibition at 0.5 mM; however, at 0.1 
mM no inhibition was observed. The reasons for this sudden loss of 
inhibition going from 0.5 mM to 0.1 mM are not fully understood and 
further investigation is required. The diamide (178) has not yet 
been tested for inhibitory activity with DHDP Synthase.
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The N-methyl derivative (179) showed just as good inhibition
as the diester (175) with 11% inhibition at 0.1 mM. However, the
sulphoxide (180) and the 1,4-thiazine (182) were poorer inhibitors. 
The sulphoxide (180) showed no inhibition with DHDP Synthase and 
the 1,4-thiazine (182) only showed 30% inhibition at 0.5 mM.
The 3 ,4-d ihydro-2 ,2-d im ethyl-l,4-th iazines showed slig h tly  
more inhibition than the 3,4-dihydro-1,4-thiazines. The dimethyl 
ester (187) and the half acid/half ester derivative (189) both sh o w ed  
approximately 20% inhibition at 0.1 mM. Further kinetic studies are 
required to determine the type of inhibition involved.
The mono-carboxylate 3 ,4 -d ihydro-1 ,4 -th iaz ine  analogues 
were poor inhibitors with respect to the .dicarboxylate 3,4-dihydro-
1.4-thiazine derivatives. The ethyl ester (192) showed 5% inhibition 
at 0.1 mM with DHDP Synthase.
5.2. Synthesis of 1.4-Thiazepine Derivatives.
4 ,5 ,6 ,7 -T e trah y d ro -4 # -l,4 -th iaz ep in e -3 ,5 -d ic a rb o x y lic  a c id
hydrochloride (193) (Schem e 68), a seven-membered analogue of
3.4-DHT (169), was prepared by treating DL-homocysteine with
bromopyruvic acid in water. The compound was isolated as a yellow 
solid. The *H NMR showed a signal at 5h 6.27 for the proton at C-2.
Purification of this diacid proved difficult and so the compound was
converted into the dimethyl ester (194) by treating a solution of the
diacid (193) in ethyl acetate with a solution of diazomethane in
ether. The diester (194) was easily purified on a neutral alumina
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column eluting with 25% ethyl acetate in hexane to give a yellow oil. 
The yield of the diester (194) from DL-homocysteine was 21%.
The *H NMR spectrum of the dimethyl ester (194) showed a 
m ultiplet at 5h 2.07 for the 6b proton and a multiplet at 5h 2.40 for 
the protons at C-7. There is an interesting signal at 5h 2.72 for the
Br
NH3  (  HzO
I +  ►
o 2 c / ^ ^ v ' s h  o  c o 2h
(193)
CH2 N2,
EtOAc/Ether
7
1
CO2M6M©0?C _5 N
[21%]
(194)
Scheme 68
6a proton. It appears as a doublet of double double doublets (dddd) 
showing a long range coupling with the vinyl proton at C-2 ( /  1.2 Hz), 
a coupling with the proton at C -S (J 3.0 Hz), a coupling with the 
adjacent protons at C-7 (J 5.5 Hz) and a geminal coupling with the 6b 
proton {J 14.2 Hz). The 13C NMR spectrum of this compound shows a 
signal at 5c 29.9 for C-6, a signal at 5c 33.1 for C-7 and a signal at 5c
H 02C
N+ C 02H
h 2  c r
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57.5 for C-5. The vinyl signal at 5c 107.2 corresponds to C-2. The 13C
NMR spectrum of the diester (194) is shown in F igure  10.
The mechanism of formation of the 1,4-thiazepine diacid (193) 
from DL-homocysteine and bromopyruvic acid is presumably similar 
to that proposed for the 1,4-thiazines (Scheme 61). The 4,5,6,7- 
tetrahydro-l,4-thiazepine diacid (193) and dimethyl ester (194) 
have not yet been tested for inhibitory activity with DHDP Synthase.
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FIGURE 1 0 : 1 3C NMR SPECTRUM OF THIAZEPINE DIESTER.
5.3. Synthesis and Test Results of 1.3-Thiazoles.
Ethyl 4-carbom ethoxy-l,3-thiazole-2-carboxylate (195) w a s  
prepared in 40% yield by cyclisation of the mercapto-amide (196) 
(Schem e 69). The cyclisation was induced by treatment of the
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mercapto-amide (196) with phosphorus pentasulphide in 
p y r id in e .172 The product was purified on a silica gel column eluting
with 5% ethyl acetate in hexane to give the desired 1,3-thiazole (1 9 5 ) 
as a yellow oil. The *H NMR spectrum of the 1,3-thiazole (195)
showed a singlet in the aromatic region at 5h 8.40 for the proton at 
C-5 and the 13C NMR spectrum showed a signal at 6c 132.4 for C-5.
The mechanism of the cyclisation presumably involves attack 
of the amide carbonyl group on phosphorus pentasulphide to give 
the intermediate phosphorus complex (197) (Schem e 70). 
Cyclisation then takes place via nucleophilic attack by the mercapto 
group at position 6 on the carbonyl at C-2 to give the 4,5-dihydro-
1,3-thiazole intermediate (198). The driving force for the cyclisation 
is the formation of the strong phosphorus-oxygen double bond in the 
phosphorus complex which is eliminated. The mechanism is
5CH2 CI2, 
— -—£L> -  
Et3N
O
M e02C
H
(196)
r 4°10*
pyridine, A
(195)
Scheme 69
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completed with spontaneous aromatisation of the 4,5-dihydro-1,3- 
thiazole intermediate (198) to the 1,3-thiazole (195) in air.
The mercapto-amide (196) was prepared in 94% yield b y 
treating L-cysteine methyl ester hydrochloride with ethyl oxalyl 
chloride in dichloromethane in the presence of triethylamine. The 
compound was purified on a silica gel column eluting with 25% ethyl 
acetate in hexane to give a clear oil. The NMR spectrum of (196) 
showed a multiplet at 5h 3.07 for the protons at C-5 and a multiplet 
at 5h for the proton at C-4.
M e02C ,N > 2 C 0 2Et 
H 1
(196) (197)
(195) (198)
+
/S —
0 = P \- S - -
s —
Scheme 70
1 4 7
l,3-Thiazole-2,4-dicarboxam ide (199) was prepared in 90% 
yield by treating diethyl l,3-thiazole-2,4-dicarboxylate (200) with a 
saturated solution of methanolic ammonia at room temperature 
(Schem e 71). The 13C NMR spectrum of (199) showed two signals 
at 6c 161.9 and 163.1 for the two amide carbonyls. The IR spectrum 
showed two signals in the carbonyl region at 1680 and 1590 c n r 1.
CONHg
(199)
Scheme.-71
The diethyl ester (200) was prepared in 92% yield by tre a tin g  
ethyl thioxamate with ethyl bromopyruvate in ethanol. The 
compound was purified on a neutral alumina column eluting with 
25% ethyl acetate in hexane to give a yellow oil. The *H NMR and *3C 
NMR spectra of the diethyl ester (200) were similar to those of the 
ester (195). The mechanism of formation of (200) is similar to that 
o f 2,4-diphenyl-1,3-thiazole (165) (Schem e 57). This is an example 
o f the Hantzsch thiazole synthesis.*71
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Test Results.
The 1,3-thiazole derivatives showed strong inhibition with 
DHDP Synthase. The methyl/ethyl ester 1,3-thiazole (195) produced 
21% inhibition at 0.1 mM with DHDP Synthase and the diethyl ester
1,3-thiazole (200) showed 15% inhibition at 0.1 mM. Kinetic studies 
have still to be carried out to determine whether the 1,3-thiazole 
derivatives are competitive or non-competitive inhibitors. The 
diamide (199) has not yet been tested for inhibitory activity with
DHDP Synthase.
5.4. Conclusions and Future Work.
A range of sulphur analogues of L-2,3-DHDPA (25) and L-
2,3,4,5-THDPA (24) have been synthesised and tested for inhibitor
activity with DHDP Synthase.
The 3,4-dihydro-1,4-thiazines displayed good inhibition at 0.1 
mM with DHDP Synthase. In particular the diethyl diester (175) and 
the N-methyl derivative (179) showed 10% inhibition at 0.1 mM. 
Further biochemical experiments must be carried out to determine
whether the inhibition is competitive or non-competitive.
The diamide (178) has not yet been tested for inhibitor activity 
with DHDP Synthase. However, the diacid (169) was not as good an 
inhibitor as the diester (175). This suggests that changes in the 
carbonyl group functionality may have an effect on the level of 
inhibition with DHDP Synthase. Larger diesters - should be
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investigated. The dinitrile (201) and ditetrazole (202) could be 
synthesised from the diamide (178) and the diol (203) and
dialdehyde (204) could be prepared from the diester (175) ( S c h e m e  
7 2 ) .
E t02C N C 02Et 
H \
(175) \
N_H3,_
MeOH
HoNOC
(178)
LiAIH4 \
\DIBALH
Swern  
 ^ oxidation(203)
OHC CHO
H
(204)
\  POCI3> 
\  DMF
NC CN
H
(201)
NaN3,
EtOH/H20
V
(202)
Scheme 72
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The //-m ethyl derivative (179), as previously mentioned, 
showed good inhibition at 0.1 mM with DHDP Synthase. Further N- 
alkyl 1,4-thiazines should be synthesised where the alkyl group is 
sequentially increased in size to see what effect this has on the level 
o f inhibition with DHDP Synthase.
Substitution at the 2-position of the 1,4-thiazine ring caused an 
increase in the level of inhibition observed with DHDP Synthase. The 
2 ,2-dim ethyl-3 ,4-dihydro-l,4-th iazines showed 20% inhibition at 0.1 
mM whereas the 3,4-dihydro-1,4-thiazines showed 10% inhibition at 
0.1 mM. Further substitution at the 2-position and at the 6-position 
should be investigated.
The 1,4-thiazine diester (182) was not as good an inhibitor 
with DHDP Synthase as the 3,4-dihydro-1,4-thiazine diester ( l s75). 
The fully saturated 2,3,4,5-tetrahydro-1,4-thiazine diester (2 0 5 ) 
should be synthesised and tested for inhibitory activity with DHDP 
S yn thase .
(205)
So far only 1,4-thiazines have been investigated for inhibitory 
activity with DHDP Synthase. Further thiazine derivatives should be 
synthesised and tested for inhibition of DHDP Synthase on the basis 
of the good inhibition results obtained with the 1,4-thiazines. These 
include the 4,5-dihydro-l,3-thiazines (206) and the 1,3-thiazine
15 1
( 2 0 7 )  s t a r t i n g  f r o m  D L - h o m o c y s t e i n e  e t h y l  e s t e r  a n d  e t h y l  o x a l y l  
c h l o r i d e  (Schem e 73).
NHj,
E t02C
Et,N.
SH cr co2Et c h 2ci2 ■ rSH°JL ii
E t02C ^ ^  N C 0 2Et 
H
(203)
s  
I,
Et02CT ' N * ^ C 0 2Et 
(207)
DDQ,
CH2CI2
p2 s 5 ,
pyridine
v
E t02C" ' N ^ v'C 0 2Et
(206)
Scheme 73
Replacing the sulphur atom with an oxygen or a nitrogen would
give the respective oxazines and pyrazines. A range of oxazine and
pyrazine analogues should be synthesised and tested for inhibitory 
activity with DHDP Synthase. Possible targets are shown in S c h e m e  
7 4.
The 1,3-thiazoles showed very good inhibition with DHDP
Synthase. The level of inhibition observed was 20% at 0.1 mM. As 
with the 3,4-dihydro-1,4-thiazines, changes in the carboxyl 
functionality produced slight changes in the level of inhibition, i.e. 
the methyl/ethyl ester (195) showed 21% inhibition at 0.1 mM
whereas the diethyl ester (200) showed 15% inhibition at 0.1 mM.
152
Hence, the diacid (208), dinitrile (209), ditetrazole (210), diol (211) 
and dialdehyde (212) should be synthesised and tested for in h ib ito ry  
activity with DHDP Synthase (Schem e 75).
X = 0  
X = N
4.5-dihydro-1,4-oxazine
4.5-dihydro-1,4-pyrazine
R 0 2C C 0 2R'
1.4-oxazine
1.4-pyrazine
X
,  ,  A
r o 2c  N C 0 2R’
X 
R 0 2C '  'N ^ ^ C O g R '
X = 0  
X = N
4.5-dihydro-1,3-oxazine
4.5-dihydro-1,3-pyrazine
1.3-oxazine
1.3-pyrazine
Scheme 74
R = -C 0 2H (208) 
R = -CN (209)
R = - f  N (210)
H N - N  
R = -CH2OH (211) 
R = -CHO (212)
Scheme 75
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The 4,5-dihydro-l,3-thiazole (213) could be prepared by
treating a solution of L-cysteine ethyl ester with ethyl cyanoformate 
in ethanol in the presence of triethylamine (Schem e 76).
SH
E t02C NH3CI'
+ N = C —C 0 2Et -
EtOH,
"e u n " Et02C N 
(213)
C 0 2Et
Scheme 76
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Ch a p t e r  f 61 - E x p e r i m e n t a l
6.1. General Notes.
All melting points were measured with a Kofler hot-stage 
apparatus and are uncorrected. The optical rotations were measured
with an optical Activity Ltd. AA-10 polarimeter. Infra-red spectra
were obtained on a Perkin Elmer 580 spectrometer. Nuclear 
magnetic resonance spectra were recorded with a Perkin Elmer R32 
spectrometer operating at 90 MHz (Sh ) or with a Bruker WP-200 SY 
spectrometer operating at 200 MHz (5 h ) or 50 MHz (5c)* Low 
resolution mass spectra were determined with a VG updated A.E.I.
MS 12 spectrometer and high resolution mass spectra w e re
determined with a VG updated MS 902 spectrometer.
Analytical TLC was carried out on Kieselgel 60 F254 p la s tic  
sheets of 0.25 mm thickness. Spots were viewed under a UV lamp
and developed by iodine vapour. Column chromatography w as 
carried out using 70-230 mesh silica gel.
All solvents and reagents were of analytical grade unless 
otherwise stated. Organic solvents were dried using magnesium 
sulphate and evaporated on a Buchi rotary evaporator under water- 
pump vacuum with slight heating. Dichloromethane was distilled 
from calcium hydride; methanol was distilled from m ag n e s iu m  
turnings and iodine; triethylamine was distilled from potassium
hydroxide; and dimethylformamide was distilled from silica gel.
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Sodium deuteroxide was prepared by adding sodium metal
(115 mg) to a cooled solution of D2O (5 ml). It was stored under 
nitrogen at 0 °C
6.2. Experimental to Chapter (31.
Synthesis of L-Aspartic Acid-fl-semialdehvde and Analogues.
General Procedure T11 - Ozonolvsis o f Protected Allvlglvcine
A nalogues.
A solution of the protected allylglycine analogue (1.0 mmol) in 
dichloromethane (20 ml) was flushed with ozone until a pale blue
colour persisted for 10 min. Excess ozone was removed by flushing 
the reaction flask with nitrogen. The ozonide was decomposed with 
triethylamine (2.0 mmol) at -78 °C with continued stirring for 5h a t
room temperature. Dichloromethane was removed in vacuo  and 
ether (25 ml) was added to precipitate triethylamine JV-oxide. The 
mixture was filtered and ether removed in vacuo to give a gluey oil.
Purification was achieved using a silica gel column eluting with ether
to give the desired aldehyde.
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General Procedure \2\ - Deprotection of Aspartic Acid-fl-
semialdehvde Analogues using Trifluoroacetic Acid.1 4 6
Trifluoroacetic acid (1 ml) was added to a solution of the 
aspartic acid-B-semialdehyde analogue ( 1.0 mmol) in 
dichloromethane (1 ml) under a nitrogen atmosphere. The mixture 
was stirred for 1 h and removal of the solvent in vacuo gave a ye llow  
residue. Trituration with ether precipitated a light yellow solid. The 
solid was filtered and dried under vacuum to give the desired 
p ro d u c t.
The Hydrochloride Salt of DL-Aspartic Acid-6-sem ialdehvde hydrate
a u J °
HO NH,+C1-
JL Xh o ' * x ^ c o 2h
Ozone was bubbled through a solution of DL-allylglycine (0.50 
g, 4.30 mmol) in 1M HC1 (4.3 ml) at 0°C for 3 h to give D L -aspartic  
acid-p-semialdehyde. The product was not isolated or purified as it is 
very unstable. The acidic solution was stored at O °G
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The ozonolysis reaction was repeated in D^ O and DC1 and a XH 
NMR spectrum of the product was taken; Sh (200 MHz) (D2O + DC1) 
1.38 (2H, m, 3-H2) and 3.37 (1H, m, 2-H) and impurities at Sh 2.24 
(m) and 3.51 (m).
Attempted Preparation of DL-W -f-Butoxycarbonylhomoserine (84).
To a cooled solution of DL-homoserine (1.19 g, 10 mmol) in 
dioxan (20 ml) and water (10 ml) was added IN sodium hydroxide 
(10 ml) with stirring. Di-f-butyl dicarbonate (1.1 equiv) was added
to the cooled solution with continuous stirring for 30 min. The
solution was concentrated in vacuo to a volume of 10 ml, cooled in an
ice bath, covered with a layer of ethyl acetate (20 ml) and acidified
to pH 2-3 with a dilute solution of KHSO4. The mixture was extracted
with ethyl acetate (2 x 10 ml) and the combined ethyl acetate
extracts were washed with water. The organic layer was dried, 
filtered and the solvent was removed in vacuo to give a clear oil,
1.97 g (90%). The *H NMR spectrum of the product showed two t-
butoxycarbonyl groups and the spectrum contained many peaks. 
The 13C NMR spectrum had double the expected number of signals.
The IR spectrum had three carbonyl absorptions at 1777 cm-1
(lactone), 1725 cm-1 (acid) and 1705 cm' 1 (broad) (carbam ate).
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DL-Allylglvcine f-Butyl Ester Hydrochloride (861.1 4 6
n h 3+ci-
2-Methylpropene (50 ml) was added to a stirred suspension of 
DL-allylglycine (824 mg, 7.16 mmol) in dichloromethane (50 ml) at 
-78 °C. Cone, sulphuric acid (1 ml) was added dropwise over 1 0 
min. The mixture was stirred for 15 min at -78 °C then gradually 
warmed to room temperature and continually stirred for 24 h. The 
resultant clear solution was carefully basified to pH 8 with sodium 
bicarbonate solution. The organic layer was separated, washed with 
brine solution (2 x 20 ml), dried (Na2SC>4), filtered and concentrated 
to give a yellow oil. A white precipitate resulted on addition of a 
solution of dry HC1 gas in ether (10 ml). The white solid was filtered 
and dried under vacuum, 490 mg (33% yield), mp 134-135°C; Umax 
(KBr disc) 2980, 2880, 1735, 1570 and 1500 cm*1; 5H (200 MHz)
(D2O) 1.32 (9H, s, 7,8 and 9-H3), 2.54 (2H, dd, 3-H2), 3.94 (1H, dd, 2-
H), 5.15 (2H, m, 5 -H 2), 5.60 (1H, m, 4-H); 5C (50 MHz) 28.3 (C-7, 8 
and 9), 35.4 (C-3), 53.8 (C-2), 86.9 (C-6), 122.7 (C-5), 131.2 (C-4) and 
169.6 (C-l); m / z  130, 70 (100%), 57, 43 and 41 (Found: M +, 
172.1342; C, 52.05; H, 8.80; N, 6.74. GjHisNC^ requires AT, 172.1338; 
C, 52.05; H, 8.67; N, 6.75%).
The L-isomer had [cx] d 16 -16.50° (c = 1.4 in H20), mp 133-136 °C.
The D-isomer had [a]o14 +16.07° (c = 1.4 in H20 ), mp 135-138 °C.
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DL-N-f-Butoxycarbonylallvlglycine f-Butvl Ester (87).1 6 3
NH-CO2
10
To a solution of sodium bicarbonate (121 mg) in water (7 ml),
sodium chloride (253 mg) and di-r-butyldicarbonate (0.331 ml, 1 
equiv.) was added a solution of (8  6 ) (300 mg, 1.44 mmol) in  
dichlorom ethane (20 ml) with stirring. The mixture was heated at
reflux for 1.5 h then cooled to room temperature and the organic 
layer was separated. The aqueous layer was extracted with 
dichloromethane (2 x 20 ml) and the combined organic extracts were 
dried (Na2SC>4), filtered, and concentrated in vacuo to give an oil, 35 5 
mg (90% yield), RF 0.42 (25% EtOAc / hexane); i w  (CHCI3) 3425, 
2980, 1710 and 1495 c m '1; 5H (200 MHz) 1.41 (18H, br s, 7-, 8-, 9-, 
12-, 13- and 14-H3), 2.45 (2H, m, 3-H2), 4.20 (1H, m, 2-H), 5.06 (3H, 
m, 5-H2 and NH) and 5.67 (IH, m, 4-H); 6C (50 MHz) 27.9 (C-7, -8 and 
-9), 28.3 (C-12, -13 and -14), 37.0 (C-3), 53.2 (C-2), 79.5 and 81.8 (C- 
6 and -11), 118.7 (C-5), 132.5 (C-4), 155.1 (C-10), 171.0 (C-l); m / z  
230, 170, 130, 114, 70, 57 (100%) and 41 (Found: C, 61.95; H, 9.01; N, 
5.25. Ci 4H25NO4 requires C, 61.91; H, 9.21; N, 5.16%).
The L-isomer had [a]o16 +20.58° (c = 2.2 in CH2CI2).
The D-isomer had [ cc] d 1 4  - 2 0 . 3 2 °  ( c  =  2 . 2  in CH2CI2).
1 60
DL-N-r-Butoxycarbonylaspartic Acid-fl-semialdehvde r-Butvl Ester
£881,
N H -C O ^
'  9  ^
o h (M -  '
1 3
■12
CO. 25
A solution of (8  7 )  (300 mg, 1.106 mmol) in dichloromethane 
was saturated with ozone according to general procedure [1].
Purification was achieved on a silica gel column eluting with ether to 
give a clear oil, 243mg (80% yield), Rf 0.5 (ether); umax (CHCI3)
3425, 2980, 1710 and 1495 c m -i;5 H (200 MHz) 1.44 (18H, br s, 6-,
7-, 8-, 11-, 12- and 13-H3), 2.98 (2H, m, 3-H2), 4.48 (1H, m, 2-H), 
5.40 (1H, br d, NH) and 9.74 (1H, s, 4-H); 5c (50-MHz) 27.9 and 28.2
(C-6 , -7, -8, -11, -12 and 13), 46.3 (C-2), 80.0 and 82.6 (C-5 and -10),
155.3 (C-9), 169.9 (C-l) and 199.4 (C-4); m/z 172, 118, 72, 57
(100%) and 41 (Found: C, 56.92; H, 8.21; N, 5.31. Q 3H23NO5 requires
C, 57.07; H, 8.41; N, 5.12%).
The L-isomer had [a ]D16 +7.97° (c = 2.0 in CH2C12).
The D-isomer had [o]d14 -7.80° (c = 2.0 in CH2C12).
T r i f l u o r o a c e t a t e  S a l t  o f  P L - A s p a r t i c  A c i d - f i - s e m i a l d e h v d e  H y d r a t e
(M L .
HO NH, CF,COO"
JL JL
HO<*nY ^ C 0 2H
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Compound (8  8 ) (100 mg, 0.73 mmol) was deprotected with 
trifluoroacetic acid (1 ml) according to general procedure [2] to give a 
pale yellow solid, 67 mg (74% yield), mp 64-66 °C; umax (KBr disc)
3420 (broad), 2925, 1675 and 1645 cm' dH (200 MHz) (D2O) 1.98
(2H, m, 3-H2), 3.84 (1H, dd, 2-H) and 5.11 (1H, t, 4-H); 5C (50 MHz) 
37.9 (C-3), 52.0 (C-2), 89.4 (C-4) and 173.9 (C-l); m / z  137 ( M H \
13.2%), 120, 92, 69, 44 (100%) and 43 (Found: M H \  137.0435. 
C4H 11NO4 requires Af, 137.0450).
The L-isomer had [a]i>16 +3.33° (c = 1.5 in H2O), mp 63-64 °C.
The D-isomer had {oc]d14 -3.15° (c = 1.5 in H2O), mp 63-65 °C.
Potassium Salt of DL-W -f-Butoxycarbonylallvlglycine (90).1 5 7
N r r  CO2 7
^ 4 > ^ 2 'C 0 2K
To a solution of D L -allylglycine (1 g, 8.69 mmol) in water (25 
ml) was added dioxan (12 ml), potassium bicarbonate (957 mg, 1.1 
equiv) and di-r-butyl dicarbonate (2 ml, 1 equiv) with continuous 
stirring at room temperature for 18 h. The solvents were removed 
with ethanol in vacuo to give a white solid, 2.0 g (91% yield); umax 
(KBr disc) 3360, 2980, 1675, 1595 and 1530 c n r 1; 6H (200 MHz) 
(D20 ) 1.26 (9H, s, 8-, 9- and IO-H3), 2.25 (2H, m, 3-H2), 2.78 (1H, m,
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2-H), 4.97 (2H, m, 5-H2) and 5.60 (1H, m, 4-H); 6C (50 MHz) 28.6 (C- 
8, -9 and -10), 37.3 (C-3), 56.5 (C-2), 81.9 (C-7), 118.9 (C-5), 134.9 
(C-4), 166.5 (C-6) and 180.2 (C-l); m/z 214 (M +, 0.3%), 112, 59
(100%) and 41.
DL-Af-r-Butoxycarbonylallvlglvcine p-M ethoxvbenzvl Ester (91).1 5 7
NH-COI 14
OMe
8 9
To a solution of (90) (1.50 g, 5.92 mmol) in DMF (10 ml) was
added 4-methoxybenzyl chloride (0.9 ml, 1.04 equiv) with 
continuous stirring for 48 h. DMF was removed with xylene / n 
vacuo and the resultant residue was partitioned b e tw e e n
dichloromethane (20 ml) and aq. sodium carbonate solution (20 m l). 
The organic portion was washed with water (2 x 10 ml), dried 
(MgSC>4) and the solvent was removed in vacuo to give a yellow oil.
Purification was achieved on a silica gel column eluting with 60%
ether in hexane to give a clear oil, 1.56 g (79% yield), Rf 0.37 (50%
ether / hexane); umax(CHCl3) 3440, 3020, 2980, 1715, 1620, 1515 
and 1500 cn r^B H  (200 MHz) 1.43 (9H, s, 16-, 17- and I 8-H3), 2.51 
(2H, dd, 3-H2), 3.80 (3H, s, 13-H3), 4.39 (1H, m, 2-H), 5.10 (5H, m, 5- 
H2, 6-H2 and NH), 5.66 (1H, m, 4-H), 6.89 (2H, d, J  8 Hz, 9- and 11-H) 
and 7.29 (2H, d, J  8 Hz, 8- and 12-H); 6C (50 MHz) 28.3 (C-16, 17
163
and 18), 36.8 (C-3), 53.0 (C-2), 55.3 (C-13), 66.9 (C-6), 79.8 (C-15),
113.8 (C-7), 113.9 (C-8 and 12), 119.1 (C-5), 127.5 (C -ll) , 130.2 (C-9 
and 11), 132.2 (C-4), 159.8 (C-14) and 171.9 (C-l); m/z  335 (M +, 
1.0%), 279, 170, 121 (100%), 70 and 57. (Found: M +, 335.1718.
C18H25NO5 requires M , 335.1732).
DL-N-r-Butoxycarbonylaspartic Acid-fl-sem ialdehvde p- 
Methoxybenzvl Ester (92).
OH<x JL ’ ■
> ^ c o 2c h 2- ^ x  A "
A solution of compound (91) (1.20 g, 3.58 mmol) in
dichloromethane was saturated with ozone according to general 
procedure [1]. Purification was achieved on a silica gel column 
eluting with ether to give a clear oil, 900 mg (75% yield), Rf 0.36 
(ether); umax (CHC13) 3440, 3030, 2980, 1715, 1620 and 1515 c m '1;
SH (200 MHz) 1.42 (9H, s, 15-, 16- and 17-H3), 3.03 (2H, t, 3 -H 2),
3.80 (3H, s, I2-H3), 4.58 (1H, m, 2-H), 5.10 (2H, s, 5-H2), 5.42 (1H, br 
d, NH), 6.89 (2H, d, /  8 Hz, 8- and 10-H), 7.26 (2H, d, J  8 Hz, 7- and 
11-H) and 9.69 (1H, s, 4-H); 6c  (50 MHz) 28.2 (C-15, -16 and -17),
46.0 (C-3), 48.8 (C-2), 55.3 (C-12), 67.5 (C-5), 80.2 (C-14), 114.0 (C-7
and -11), 115.1 (C-6), 128.6 (C-9), 130.2 (C-8 and 10), 159.8 (C-13),
171.1 (C-l) and 199.4 (C-4); m/z 337 (M +, 0.7%), 281, 202, 137, 121
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(100%), 72 and 57. (Found: Af+, 337.1538. C17H23NO6 requires M,  
3 3 7 .1 5 2 5 ).
Trifluoroacetate Salt of PL-Aspartic Acid fi-Semialdehvde Hydrate
£89]L
HO NIL C F 3 C O O '
X  X
J 1
A solution of (92) (103 mg, 0.30 mmol) in trifluoroacetic acid
(2 ml) was stirred at room temperature for 2 h. The solvent was 
removed in vacuo to give an oily residue. This was partitioned
between water (10 ml) and ethyl acetate (10 ml). The aqueous layer 
was separated and washed with ethyl acetate (2 x 10 ml). R em oval
of the solvent in vacuo gave a yellow solid, 60 mg (79% yield); Umax
(KBr disc) 3420, 300, 1675, 1630 and 1400 c n r^ S n  (200 MHz) (P 2O)
2.01 (2H, m, 3-H2), 3.80 (1H, dd, 2-H) and 5.18 (1H, m, 4-H); 5C (50 
MHz) 37.8 (C-3), 51.8 (C-2), 89.7 (C-4) and 174.2 (C-l); m / z  137 
{M W ,  17.5%), 119, 107, 93, 86, 69 and 44 (100%). (Found: M W ,  
137.0442. C4H11NO4 requires M,  137.0431).
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NMR Experiments with L-Aspartic Acid-6-semialdehvde 1891 and
Oxaloacetic Acid.
A solution of the trifluoroacetate salt of L-aspartic acid-p- 
semialdehyde (25 mg, 0.1 mol) in D2O (1 ml) in a NMR tube was 
brought to pH 8 with sodium deuteroxide. Oxaloacetic acid (13 mg, 1 
equiv.) was added to the tube with shaking and the reaction was 
followed by !H NMR spectroscopy (200 MHz). After 10 min two new 
signals appeared; a singlet in the vinyl-H region at 5 5.48 ppm and 
an aromatic singlet at 5 8.35 ppm in the integral ratio 3 : 1. Over a 
period of 2 h the strong vinyl signal gradually disappeared and the 
aromatic signal got stronger. The aromatic signal was shown to be 
dipicolinic acid (36) by 13C NMR spectroscopy.
DL-Allvlglvcine Methyl Ester Hydrochloride 194).
n h 3+ci-
• ^ >Y ^ 'C 0 2Me
5  1 ^
A solution of DL-allylglycine (2.46 g, 0.021 mol) in methanol 
(60 ml) at 0 °C was saturated with dry HC1 gas. The solution was 
brought to room temperature with continuous stirring for 1 h. 
Removal of the solvent in vacuo gave a clear oil, 3.2 g (91% yield); 
Umax (CHCI3) 3350, 2980 (broad), 1745 and 1500 c n r *; 5H (200 MHz) 
2.72 (2H, dd, 3-H2), 3.72 (3H, s, 6-H3), 4.17 (1H, dd, 2-H), 5.17 (2H, m,
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5 -H 2), 5.73 (1H, m, 4-H) and 8.37 (2H, br s, NH2); 6c (50 MHz) 34.2 (C- 
3), 49.5 (C-6), 53.1 (C-2), 121.0 (C-5), 130.0 (C-4) and 169.2 (C-l);
m/z 130 (MH+), 129 (M +, 0.1%), 88, 70, 43, 33 and 28 (100%). 
(Found: M +, 129.0779. C6Hi iNC^ requires M , 129.0789).
D L - T V - r - B u t o x v c a r b o n v l a l l v l g l v c i n e  M e t h v l  E s t e r  (95).1 6 3
To a solution of sodium bicarbonate (1.52 g) in water (20 ml), 
sodium chloride (3.17 g) and di-f-butyl dicarbonate (4.16 ml, 1
equiv.) was added a solution of (94) (3.0 g, 0.018 mol) in
dichlorom ethane (40 ml) with stirring. The mixture was heated at
reflux for 1.5 h, cooled to room temperature and the organic l a y e r
was separated. The aqueous layer was extracted w i th
dichloromethane (2 x 20 ml). The combined organic portions were
dried (Na2SC>4), filtered, and the solvent removed in va cu o  to give a 
clear oil, 4.66 g (98% yield), Rf 0.46 (25% EtOAc / hexane); umax
(CHC13) 3430, 3020, 2980, 1805, 1740, 1710 and 1495 cm- *; 6H (200 
MHz) 1.50 (9H, s, 9-, 10- and II-H3), 2.53 (2H, dd, 3-H2), 3.72 (3H, s, 
6 -H 3), 4.30 (1H, dd, 2-H), 5.15 (3H, m, 5-H2 and NH) and 5.60 (1H, m,
4-H); 6C (50 MHz) 27.2 (C-9, -10 and -11), 28.1 (C-6), 36.6 (C-3), 52.8 
(C-2), 85.0 (C-8), 118.9 (C-5), 132.2 (C-4), 146.6 (C-7) and 172.4 (C-
1); m/z 188, 173, 170, 128, 113, 88, 70, 57 (100%) and 41.
ii 1
NH-CO2T “”i0
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DL-7V-/-Butoxycarbonylaspartic Acid-fl-semialdehvde Methvl Ester
£9£L
OH(K ^
10
2 7
8
COoMe
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A solution of compound (9  5 ) (8.17 g, 0.016 mol) in
dichloromethane was saturated with ozone according to general 
procedure [1]. Purification was achieved, on a silica gel column 
eluting with ether to give a clear oil, 934 mg (26% yield), Rf 0.15 
(ether); umax (CHC13) 3440, 3010, 2980, 1710 and 1500 cm’ 1; 5H
(200 MHz) 1.39 (9H, s, 8-, 9- and IO-H3), 3.05 (2H, m, 3-H2), 3.70 
(3H, s, 5-H3), 4.05 (1H, m, 2-H), 5.40 (1H, br d, NH) and 9.68 (1H, s, 
4-H); 6C (50 MHz) 28.2 (C-8, -9 and -10), 45.9 (C-3), 48.5 (C-2), 52.7 
(C-5), 80.2 (C-7), 171.4 (C-l) and 199.4 (C-4); m/z 172, 130, 115, 72, 
59, 57 (100%) and 41.
Trifluoroacetate Salt of PL-Aspartic Acid-fi-sem ialdehyde Hydrate
Methyl Ester (93).
HO NIL CF3COO"
A  AH O ^ V ^ C O o M e  3 1 z s
Trifluoroacetic acid (0.5 ml) was added to a solution of ( 9 6 )  
(90 mg, 0.39 mmol) in dichloromethane at -78 °C with stirring under
1 6 8
a nitrogen atmosphere. The mixture was brought to 0 °C with 
continued stirring for lh. Removal of the solvent in vacuo gave a 
yellow oil, 61 mg (60% yield); umax (KBr disc) 3425 (broad), 2960, 
1750, 1675, 1520 and 1440 cm’ 6H (200 MHz) (D2O) 2.05 (2H, m,
3 -H 2), 3.63 (3H, s, 5-H3), 4.09 (1H, dd, 2-H) and 5.11 (1H, dd, 4-H); 6C 
(50 MHz) 37.5 (C-3), 51.1 (C-2), 54.8 (C-5), 88.8 (C-4) and 171.3 (C-
1); m / z  151, 150 (MH+, 1.4%), 91, 89, 69 and 45 (100%). (Found : 
M H +, 150.0550. C5H12N04 requires M, 150.0555).
DL-AT-Formylallylglvcine r-Butvl Ester (T01T1 5 8
NH-CHO 10
l-(3-D im ethylam inopropyl)-3-ethyl carbodiim ide (911 mg, 2 
equiv.) was added to a solution of formic acid (0.359 ml, 4 equiv.) in 
dichloromethane (15 ml) at 0 °C with stirring for 15 min. A cooled 
solution of (86 ) (570 mg, 2.38 mmol.) and N-methylmorpholine
(0.523 ml, 2 equiv.) in dichloromethane (15 ml) was added and the 
resultant mixture was stirred in a water bath for 20 h. The reaction 
mixture was washed with 5% aq. citric acid (2 x 20 ml), aq. sod iu m  
bicarbonate soln. (2 x 20 ml) and brine soln. (2 x 20 ml). The organic 
portion was dried (MgS04), filtered and removal of the solvent in  
v a cuo  gave a clear oil, 468 mg (98% yield), Rf 0.55 (25% EtOAc /
1 69
hexane); umax (CHCI3) 3405,. 3010, 1725, 1685 and 1490 c m '1; 5h 
(200 MHz) 1.47 (9H, s, 7-, 8- and 9-H3), 2.55 (2H, m, 3-H2), 4.67
(1H, dd, 2-H), 5,14 (2H, m, 5-H2), 5.69 (1H, m, 4-H), 6.63 (1H, 
br d, NH) and 8.21 (1H, s, 10-H); 6C (50 MHz) 27.8 (C-7, -8 and -9),
36.5 (C-3), 50.6 (C-2), 82.3 (C-6), 118.9 (C-5), 131.9 (C-4), 160.5
(C-10) and 170.3 (C-l); m/z 199 (.U +, 0.1%), 158, 143, 126, 98, 70
and 57 (100%). (Found: M +, 199.1202. Q0H17NO3 requires 199.1208).
DL-Af-Form vlaspartic Acid-B-semialdehvde r-Butvl Ester M04’).
OH(iUNH-CHO9CO 92  5 ■” 76
A solution of compound ( 1 0 1 )  (828 mg, 4.16 mmol) in 
dichloromethane was saturated with ozone according to general 
procedure [1]. The ozonide was decomposed with triethylam ine (232 
mg, 4 equiv.) at room temperature with stirring for 12 h. 
Purification was achieved on a silica gel column eluting with 50% 
ethyl acetate in hexane to give a clear oil, 362 mg (43% yield), Rp 
0.50 (ether); umax (CHC13) 3415, 3025, 2985, 1735, 1685 and 15 00  
c n r !; 6H (200 MHz) 1.44 (9H, s, 6-, 7- and 8-H3), 3.08 (2H, dd, 3- 
H2), 4.75 (1H, dd, 2-H), 6.58 (1H, br s, NH), 8.17 (1H, s, 9-H) and 
9.70 (1H, s, 4-H); 5C (50 MHz) 27.8 (C-6, -7 and -8), 45.7 (C-3), 46.7 
(C-2), 83.3 (C-5), 160.6 (C-9), 169.1 (C-l) and 199.1 (C-4); m/z 172, 
158, 128, 100, 72, 57 (100%) and 41.
1 70
DL-N-Formylaspartic Acid-fi-semialdehvde Hydrate (981.
HO NH-CHO
X  X  5H0 " ^ V ^ C 0 2H 
3 1 z
Compound ( 1 0 4 )  (50 mg, 0.25 mmol) was deprotected w i t h  
trifluoroacetic acid (0.5 ml) according to general procedure [2] to give
a yellow syrup, 29mg (80% yield); umax (KBr disc) 3420 (broad),
2920, 1770, 1725, 1665 and 1520 c n r 1^  (200 MHz) (D20) 1.70 (2H, 
m, 3-H2), 4.20 (1H, m, 2-H), 4.70 (1H,- m, 4-H) and 7.68 (1H, s, 5- 
H); 6C (50 MHz) 38.9 (C-3), 49.3 (C-2), 88.8 (C-4), 164.9 (C-5) and
175.5 (C-l); m/z 163 (M +, 0.8%), 144, 135, 119, 118, 44 and 28
(100%). (Found: M +, 163.0488. C5H9NO5 requires M, 163.0481).
Ozonide (107) from DL-Af-Formylallylglvcne r-Butvl Ester.
A solution of compound ( 1 0 1 )  (400 mg, 2.01 mmol) in
dichloromethane was saturated with ozone according to general 
procedure [1]. Reduction of the ozonide using triethylamine (2 
equiv.) at -78 °C was unsuccessful. The ozonide was isolated using 
silica gel chromatography eluting with ethyl acetate to give a white 
solid, 70 mg (14% yield), RF 0.47 (EtOAc); t>max (CHCI3) 3590, 3400,
171
3010, 2980, 1735, 1680 and 1430 cm-1; 6H (200 MHz) 1.49 (9H, s, 7-,
8- and 9-H3), 2.04-2.17 (2H, m, 3-H2), 3.23 (1H, br s, NH), 4.68 (1H, 
dd, 2-H ),-4.93-5.04 (2H, m, 5-H2), 5.36-5.51 (1H, m, 4-H) and 8.23 
(1H, s, 10-H); 5C (50 MHz) 27.9 (C-7, -8 and -9), 31.1 (C-3), 46.7 (C-2),
67.3 (C-5), 82.6 (C-6), 91.2 (C-4), 161.0 (C-10) and 169.3 (C-l); m / z  
146, 130, 100, 84, 72 and 57 (100%).
Trifluoroacetic acid (1 ml) was added to a solution of ( 1 0 7 )  
(15 mg, 0.06 mmol) in dichloromethane (0.5 ml) at -78 °C with 
stirring under a nitrogen atmosphere. The mixture was brought to 0 
°C with continued stirring for 1 h. Removal of the solvent in vacuo 
gave a yellow syrup, 6 mg (54% yield); u max (tbin film) 3400 
(broad), 2940, 2500 (broad), 1725, 1660, 1435 and 1410 cm-1; 5h 
(200 MHz) 2.10-2.41 (2H, m, 3-H2), 4.41-4.62 (1H, m, 2-H), 4.78-5.10 
(2H, m, 5-H2), 5.23-5.34 (1H, m, 4-H) and 8.08 (1H, s, 6-H); m/z 129,  
100, 84 and 55.
Ozonide (108) from deprotection of (107).
0 - 0  NH-CHO
1 7 2
D L -A-Acetvlallvlglvcine f-Butvl Ester (102).1 4 6
NH-COCH3
1 0  U ,9
2-Methylpropene (100 ml) was added to a stirred suspension 
of DL-JV-acetylallylglycine (3.1 g, 19.7 mmol) in dichloromethane 
(100 ml) at -78 °C. Cone. sulphuric acid (2.2 ml) was added 
dropwise to the mixture over 10 min. The mixture was stirred for 
15 min at -78 °C then gradually warmed to room temperature and 
stirred for 24 h. The resultant clear solution was carefully basified 
to pH 8 with aq. sodium bicarbonate solution. The organic layer was 
separated, washed with brine (2 x 20 ml), dried (Na2SC>4), f i l t e red  
and the solvent removed in vacuo to give a yellow oil. Purification 
was achieved on a silica gel column eluting with 15% ethyl acetate in 
hexane to give an oil, 2.0 g (47% yield), Rf 0.2 (25% EtOAc I hexane) ;  
Umax (KBr disc) 3440, 3280, 3080, 2975, 1735, 1650 and 1550 cm” 1; 
5h  (200 MHz) 1.41 (9H, s, 7-, 8- and 9-H3), 1.96 (3H, s, II-H 3), 2 . 47  
(2H, m, 3-H2), 4.52 (1H, m, 2-H), 5.06 (2H, m, 5-H2), 5.66 (1H, m,
4-H) and 6.15 (1H, br s, NH); 6C (50 MHz) 23.1 (C -ll), 27.9 (C-7, -8 
and -9), 36.7 (C-3), 51.9 (C-2), 82.3 (C-6), 118.8 (C-5), 132.3 (C-4),
169.5 (C-10) and 170.9 (C-l); m/z 213 (M +, 0.7%), 172, 157, 140,
116, 114, 112 (100%), 57 and 43. (Found: M \  213.1354; C, 61.86; H, 
8.70; N, 6.52. C11H19NO3 requires M, 213.1365; C, 61.97; H, 8.92; N, 
6.57%).
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D L -A-Acetylaspartic Acid-fi-semialdehvde r-Butvl Ester (105).
N H -C O C H 31 9  10 J
OHCv A  8 
1 6
A solution of compound ( 1 0 2 )  (1.00 g, 4.69 mmol) in
dichloromethane was saturated with ozone according to general 
procedure [1]. Purification was achieved on a silica gel column
eluting with 10% ethyl acetate in ether to give a clear oil, 582 mg 
(57% yield), RF 0.17 (ether); umax (CHC13 ) 3430, 3000, 2980, 1730,
1670 and 1505 cm"*; 6H (200 MHz) 1.41 (9H, s, 6-, 7- and 8-H3),
1.97 (3H, s, IO-H3), 3.01 (2H, m, 3-H2), 4.68 (1H, m, 2-H), 6.48
(1H, br s, NH) and 9.68 (1H, s, 4-H); 5C (50 MHz) 22.9 (C-10), 27.7
(C-6, -7 and -8), 45.8 (C-3), 47.9 (C-2), 82.9 (C-5), 169.6 (C-9),
170.0 (C-l) and !99.4 (C-4); m/z 200, 172, 158, 142, 130, 114, 88, 
72, 57 and 43 (100%).
DL-A-Acetvlaspartic Acid-fi-semialdehvde Hydrate (991.
H O  N H -C O C H 3
i  1 5 ‘
H O ^ Y ^ C O jH
Compound ( 1 0 5 )  (185 mg, 0.86 mmol) was deprotected w i t h  
trfiluoroacetic acid according to general procedure [2] to give a 
yellow oil, llOmg (72% yield); umax (KBr disc) 3400 (broad), 3080,
2980, 1775, 1730, 1650, 1540 and 1435 c m - l ;6H (200 MHz) (D2O)
1.83 (3H, s, 6-H3), 1.91 (2H, m, 3-H2), 4.28 (1H, dd, 2-H) and 4.93 (1H,
1 74
dd, 4-H); 5C (50 MHz) 22.4 (C-6), 38.8 (C-3), 50.6 (C-2), 88.7 (C-4),
174.9 (C-5) and 176.0 (C-l); m/z 134, 132, 119, 116, 100, 87, 73 and 
43 (100%).
D L - A f - T r i f l u o r o a c e t v l a l l v l g l y c i n e  f - B u t v l  E s t e r  (T031.1 5 8
l-(3-D im ethylam inopropyl)-3-ethyl carbodiimide (1.43 g, 2 
equiv.) was added to a solution of trifluoroacetic acid (0.74 ml, 4 
equiv.) in dichloromethane (15 ml) at 0 °C with stirring for 15 min. 
A cooled solution of (86) (500 mg, 2.41 mmol) and N-
methylmorpholine (0.531 ml, 2 equiv.) in dichloromethane (15 ml) 
was added and the resultant mixture was stirred in a water bath for 
20 h. The reaction mixture was washed with 5% citric acid (2 x 20 
ml), aq. sodium bicarbonate solution (2 x 20 ml) and brine solution (2  
x 20 ml). The organic portion was dried (MgSC>4), filtered, and the 
solvent was removed in vacuo gave a yellow residue. Purification 
was achieved on a silica gel column eluting with 20% ethyl acetate in 
hexane to give a light yellow solid, 234 mg (36% yield), Rp 0.57 (25% 
EtOAc / hexane); umax (CHCI3) 3400, 3030, 2980, 1725 and 1530 cm* 
!; 5h  (200 MHz) 1.49 (9H, s, 7,8 and 9-H3), 2.63 (2H, m, 3-H2), 4.55 
(1H, m, 2-H), 5.18 (2H, m, 5-H2), 5.67 (1H, m, 4-H) and 6.90 (1H, br s, 
NH); 5C (50 MHz) 28.0 (C-7, -8 and -9), 36.0 (C-3), 52.3 (C-2), 83.5
NH-COCF3
I 1A H  J
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(C-6), 118.5 (C-l l) ,  120.1 (C-5), 130.9 (C-4), 156.9 (C-10) and 169.2 
(C-l); m/z 202, 173, 166, 159, 121 (100%), 70 and 57.
DL- Af-Trifluoroacetvlaspartic Acid-fi-sem ialdehvde r-Butvl Ester
U 0 6 L .
NH-COCFq
|  9  1 0  J
OHC'  - 0 0 .
[C X4 ^  2 I
8
2 5 " 76
A solution of compound (1 0  3 ) (200 mg, 0.75 mmol) in 
dichloromethane was saturated with ozone according to general 
procedure [1]. Purification was achieved on a silica gel column 
eluting with ether to give a clear oil, 108 mg (54% yield), Rf 0.39 
(ether); umax(CHCl3) 3395, 3030, 2980, 1725 and 1535 ~cm-l ;5H (200 
MHz) 1.47 (9H, s, 6-, 7- and 8-H3), 3.17 (2H, dd, 3-H2), 4.67 (1H, m,
2-H), 5.40 (1H, br s, NH) and 9.73 (1H, s, 4-H); 5C (50 MHz) 27.7 (C-6, 
-7 and -8), 44.6 (C-3), 48.2 (C-2), 84.0 (C-5), 114.9 (C-10), 152.0 (C- 
9), 167.8 (C-l) and 198.6 (C-4); m/z 251, 204, 176, 169, 140 and 57 
( 100%).
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DL-Af-Trifluoroacetvlaspartic Acid-fi-semialdehvde Hydrate (100).
HO NH-COCF3
I 5 6  J
HO 4 2 c o 2h
Compound (106) (124 mg, 0.461 mmol) was deprotected with
trifluoroacetic acid according to general procedure [2] to give 72 mg 
of a yellow syrup, (68% yield); Umax (KBr disc) 3415 (broad), 3050, 
2910, 1770, 1730, 1655 and 1550 cm -l;5H (200 MHz) (D2O) 1.75 (2H, 
m, 3-H2), 4.33 (1H, m, 2-H) and 4.85 (1H, m, 4-H); 5C (50 MHz) 37.9 
(C-3), 49.8 (C-2), 88.1 (C-4), 116.1 (C-6), 155.7 (C-5) and 175.4 (C-l);
m/z 186, 122, 114, 97, 69 (100%), 51 and 44.
A solution of DL-allylglycine (685 mg, 5.95 mmol) in 2M 
sodium hydroxide solution (8 ml) was cooled to 0 °C. Benzyl 
chloroformate (0.927 ml, 1.1 equiv.) and 4M sodium hydroxide 
solution (2 ml) were simultaneously added dropwise over 45 min 
with continued stirring and cooling to 0 °C. After 30 min the re a c tio n  
mixture was washed with ether (3 x 15 ml). The aqueous p o rtio n  
was acidified to Congo Red with conc. hydrochloric acid a n d
DL-AT-Benzyloxycarbonylallylglycine (110).
13 12
NH-CO^B
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extracted with ethyl acetate (2 x 20 ml). The combined organic
extracts were dried (MgSC^), filtered, and the solvent removed in  
vacuo to give a light yellow oil, 1.0 g (71% yield), Rf 0.28 (50% 
EtOAc / hexane); umax (CHCI3) 3440, 3020, 1720 and 1510 c n r l jS n  
(200 MHz) 2.56 (2H, m, 3-H2), 4.48 (1H, m, 2-H), 5.11 (2H, s, 7-H2),
5.17 (2H, m, 5-H), 5.43 (1H, br d, NH), 5.60 (1H, m, 4-H) and 7.33 (5H,
br s, 9-, 10-, 11-, 12- and 13-H); 5C (50 MHz) 36.3 (C-3), 53.0 (C-2),
67.1 (C-7), 119.6 (C-5), 128.0, 128.2 and 128.5 (C-9, -10, -11, -12 
and -13), 131.4 (C-4), 135.9 (C-8), 156.0 (C-6) and 176.1 (C-l); m / z
249 (M +, 2.0%), 208, 204, 108, 91, 79, 51 and 41 (100%). (Found: M \
249.0998. C13H15NO4 requires M, 249.0202).
DL-iV-Benzyloxycarbonvlallvlglvcine Benzyl Ester (11 l l .1 4 8
20
1 6  1 7
A solution of ( 1 1 0 )  (750 mg, 3.19 mmol) in methanol (15 ml) 
and water (2 ml) was titrated to pH 7 with 20% aq. caesium 
carbonate solution. The solvent was removed in vacuo and the 
residue was re-evaporated from DMF (2 x 10 ml). The r e s u l ta n t  
white solid was stirred with benzyl bromide (0.42 ml, 1.1 equiv.) in 
DMF (10 ml) at room temperature for 6 h. The solvent was removed 
in vacuo and on addition of water (50 ml) a white solid started to
178
precipitate. The reaction mixture was taken into ethyl acetate (5 0  
ml), washed with water (2 x 20 ml) and dried (Na2SC>4). The solvent 
was removed in vacuo to give a yellow oil, 900 mg (84% yield), Rf 
0.27 (25% EtOAc / hexane); umax (CHCI3) 3440, 3020, 1720 and 1510 
cm -l;B H (200 MHz) 2.55 (2H, m, 3-H2), 4.50 (1H, m, 2-H), 5.11 (4H, br 
s, 6- and 14-H2), 5.12 (1H, br d, NH), 5.64 (1H, m, 4-H) and 7.35 (10H, 
br s, 8-, 9-, 10-, 11-, 12-, 16-, 17-, 18-, 19- and 20-H); 5C (50 MHz)
36.6 (C-3), 53.3 (C-2), 67.1 and 67.0 (C-6 and -14), 119.4 (C-5),
128.0, 128.1, 128.3, 128.4 ,128.5 and 128.6 (C-8 , -9, -10, -11, -1 2 , 
-16, -17, -18, -19 and -20), 131.8 (C-4), 135.2 and 136.0 (C-7 and 
-15), 155.7 (C-13) and 171.5 (C-l); m/z 399 (M +, 0.3%), 298, 204, 
160, 107 and 91 (100%). (Found: M*, 339.1477. C20H2 iNO4 requires 
M,  339.1471).
PI-A'-Benzvlox vcarbonvlasnartic Acid-6-sem ialdehvde Benzyl Ester
1112).
1 9  1 8
N H - C O j C H j - ^ ^ i r  
>2 “  u , o \ _ /
OHO, Jk « /^ " V 5 “
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A solution of compound ( 1 1 1 )  (850 mg, 2.50 mmol) in 
dichloromethane was saturated with ozone according to general
procedure [1]. Purification was achieved on a silica gel column
eluting with 35% ethyl acetate in hexane to give a clear oil, 494 mg
1 79
(58% yield), RF 0.31 (50% EtOAc / hexane); umax (CHCI3) 3435, 3020, 
1725 and 1510 cm -1; 6h  (200  MHz) 3.07 (2H, m, 3-H2), 4.66 (1H, m,
2-H), 5.10 and 5.16 (4H, 2 x s, 5- and 13-H2), 5.73 (1H, br d, NH),
7.33 (10H, br s, 7-, 8-, 9-, 10-, 11-, 15-, 16-, 17-, 18- and 19-H) and 
9.67 (1H, s, 4-H); 6c  (50 MHz) 45.7 (C-3), 49.1 (C-2), 67.1 and 67.6 (C- 
5 and 13), 128.0, 128.1, 128.2 ,128.5 and 128.6 (C-7, -8, -9, -10, -11, 
-15, -16, -17, -18 and -19), 135.0 and 136.0 (C-6 and -14), 155.8 (C-
12), 170.5 (C-l) and 199.1 (C-4); m/z 341 (M +, 0.1%), 312, 250, 206, 
180, 162, 108 and 91 (100%). (Found: 341.1278. C19H19NO5
requires M,  341.1263).
DL-jV-Benzvloxvcarhonvlaspartic Acid-B-semialdehvde Benzyl Ester
Dimethyl Acetal 11131.1 5 9
19 is
M e O ^ Y * ^  C 02C H ^ >
7  8
A solution of (112) (300 mg, 0.88 mmol), p - to lu e n e su lp h o n ic
acid (42 mg, 0.25 equiv.) and trimethyl orthoformate (0.77 ml, 8 
equiv.) in anhydrous methanol (2 ml) was heated to reflux for 2 h 
under a nitrogen atmosphere. The mixture was cooled to room 
temperature and diluted with ether (20 ml). The organic portion w as
washed with a 1:1 mixture of 5% sodium hydroxide solution and
brine solution (2 x 10 ml), water (2 x 10 ml) then brine solution (2 x
180
10 ml) and dried (Na2SC>4). The solvent was removed in vacuo to  
give an oil. Purification was achieved on a silica gel column eluting 
with ether to give a clear oil, 280 mg (82% yield), Rf 0.36 (ether); 
Umax (CHC13) 3420, 3010, 2950, 1720 and 1505 c m '•; 5H (200 MHz)
2.11 (2H, br t, 3-H2), 3.24 and 3.26 (6H, 2 x s, 20- and 21-H3), 4.34 
(1H, t, 4-H), 4.46 (1H, m, 2-H), 5.11 and 5.16 (4H, 2 x s, 5- and 13-H2) 
and 7.35 (10H, br s, 7-, 8-, 9-, 10-, 11-, 15-, 16-, 17-, 18- and 19-H);
6C (50 MHz) 34.6 (C-3), 51.0 (C-2), 53.5 and 53.7 (C-20 and -21),
66.9 and 67.1 (C-5 and -13), 102.2 (C-4), 127.7, 128.1, 128.4, 128.5,
128.6 and 128.8 (C-7, -8, -9, -10, -11, -15, -16, -17, -18 and -19),
135.3 and 136.2 (C-6 and -14), 155.9 (C-12) and 171.6 (C-l); m / z  
356, 325, 252, 220, 143, 107, 91 (100%) and 75.
m.-Asnartic Acid-fi-semialdehvde Dimethyl Acetal ( 1141.1 6 0
MeO NH,
X  XMeO 4
A solution of (113) (206 mg, 0.53 mmol) and 10% Pd-charcoal
(40 mg) in anhydrous methanol (10 ml) and glacial acetic acid (1 ml) 
was left in a sonic bath under a hydrogen atmosphere for 20 h. The 
resultant black mixture was filtered through celite and the so lv e n t 
was removed in vacuo to give an oil. Azeotroping with toluene 
removed traces of acetic acid. Trituration of the resultant oil w ith
1 8 1
ether gave a white solid, 50 mg (58% yield); Umax (KBr disc) 3 4 4 0 , 
3080, 2950, 2830, 2560, 1595 and 1505 cm -1; 6H (200 MHz) (D2O)
2.00 (2H, m, 3-H2), 3.23 and 3.24 (4H, 2 x s, 5- and 6-H3), 3.65 (1H, 
dd, 4-H) and 4.34 (1H, t, 2-H); 5C (50 MHz) 34.0 (C-3), 52.1 (C-2), 55.5 
(C-5 and 6), 104.3 (C-4) and 174.5 (C-l); m/z 148, 132, 118, 102, 86 , 
75 (100%), 59 and 47.
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Z- (115) and E-PL-N -f-Butoxvcarbonvlaspartic Acid-fl-sem ialdehvde
f-Butvl Ester Oxime (116).
H  N H - C O f
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1 3 13'
■12
C O 2 5
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2 56’
O H
(Z) (E)
To a solution of hydroxylamine hydrochloride (74 mg, 1 equiv.) 
and triethylamine (0.15 ml, 1 equiv.) in dichloromethane (8 m l)
under a nitrogen atmosphere was added dropwise a solution of (8  8 )
(290 mg, 1.06 mmol). The mixture was stirred at room temperature 
for 12 h. Removal of the solvent in vacuo left an oily residue. Ether 
(10 ml) was added with stirring to precipitate triethylam ine 
hydrochloride. The mixture was filtered and the solvent WAS 
removed in vacuo  to give a clear oil. Purification was achieved on a
silica gel column eluting with 5% ethyl acetate in ether to give a clear
oil, 214 mg (73% yield), Rf 0.39 (20% EtOAc I hexane); um ax (CHCI3) 
3590, 3430, 3020, 2985, 1715 and 1500 cm -1; lH NMR and 13C NMR 
analysis showed that both the geometric isomers of the oxime had
1 82
been formed in the ratio (117) (Z) 2 : (118) (£) 1; 5h (200 MHz) 1.45,
1.46, 1.47 and 1.52 (4 x s, 6- and 6'-, 7- and 7'-, 8- and 8'-, 11- and
11'-, 12- and 12'-, 13- and 13'-H3), 2.69 and 2.81 (2 x t, 3- and 3'-
H2), 4.35-4.45 (m, 2- and 2'-H), 5.40 and 5.60 (2 x br d, 2 x NH), 6.80 
and 7.39 (2 x t, 4- and 4'-H) and 9.03 (h, 2 x N-OH); 6C (50-MHz) 27 .8 ,
28.2 and 28.6 (C-6 and -6’, -7 and -7', -8 and -8', -11 and -11', -12
and -12', -13 and -13’), 32.9 (C-3 and -3'), 51.5 and 51.7 (C-2 and
-2'), 80.0 and 82.5 (C-5 and -5', -10 and -10'), 147.2 (C-4 and -4'),
170.9 and 171.3 (C-l and -1', -9 and -9'); m/z 230, 187, 172, 159,
131, 87 and 57 (100%).
Trifluoroacetate Salt of Z- 11171 and E-PL-Aspartic Acid-fi- 
semialdehvde Oxime (1181.
H NH, CF3COO‘ H NH, CF3COO
1 1  H(X J  1
N r > ^ C 0 2H | 1 3 1' ^
OH
(Z) (E)
The mixture of (115) and (116) (125 mg, 0.456 mmol) was
deprotected with trifluoroacetic acid (2 ml) according to general
procedure [2] to give an amber syrup, 77 mg (69% yield); umax (thin
film) 3350, 2980, 2520, 1730, 1670 and 1430 c m - ^ b n  (200 MHz)
2.68-2.82 (m, 3- and 3’-H2), 4.00-4.08 (m, 2- and 2’-H), 6.78 and
7.35 (2 x t, 4- and 4’-H); 6C (50 MHz) 30.6 and 34.5 (C-3 and -3 ’),
51.4 and 51.5 (C-2 and -2’), 148.0 and 148.6 (C-4 and -4’), 172.5 and
183
174.4 (C-l and -1’); m/z 1 3 2 ( M \  1.0%), 116, 98, 87, 69 a n d  
57(100%). (Found: M +, 132.0540. C4H8N203 requires M,  132.0535).
r-Butvl DL-2-r-Butoxycarbonylamino-4-oxopentanoate (1191 and_____
Butyl DL-2-r-B utoxvcarbonvlam ino-4-epoxypentanoate  (1201 .1 6 1
n  NH- COf
1 4
1 1
2
3 12
-1 3
CO 1 2 6
NH- C 02-ha ” 1 41123 12-132 CO
A solution of diazomethane in ether was added dropwise to a
solution of (8  8 ) (230 mg, 0.84 mmol) in ethyl acetate (5 ml) with
stirring and cooling to 0 °C until a yellow colour persisted for 15 min.
The resultant mixture was stirred at room temperature for 12 h.
Removal of the solvent in vacuo gave a clear oil. TLC analysis
showed 2 main spots. Separation was achieved on a silica gel column
eluting with 50% ether in hexane to give two compounds 119 a n d
1 2  0.
(119) : 188 mg of a clear oil, (77% yield), Rf 0.18 (50% ether /
hexane); umax (CHCI3) 3440, 3030, 2980, 1715 and 1500 cm-1; 5h
(200 MHz) 1.44 (18H, s, 7-, 8-, 9-, 12-, 13- and 14-H3), 2.17 (3H, s, 5- 
H3), 3.01 (2H, ddd, 746 Hz, 7 18 Hz, 7 4.4 Hz, 3-H2), 4.36 (1H, dd, 7 18 
Hz, 74.4 Hz, 2-H) and 5.46 (1H, br d, NH); 5C (50 MHz) 27.8 and 28.3
184
(C-7, -8, -9, -12, -13 and -14), 29.9 (C-5), 45.6 (C-3), 50.1 (C-2), 79.8 
and 82.1 (C-6 and 11), 155.6 (C-10), 170.3 (C-l) and 206.6 (C-4); m / z  
287 (M+, 0.2%), 231, 186, 130, 86, 57 (100%) and 41. (Found: M \
287.1722. C14H25NO5 requires M,  287.1733) and
(120) : 21 mg of a clear oil, (8% yield), Rf 0.08 (50% ether /
hexane); i)ma„ (CHCI3) 3500, 3430, 3020, 2985, 2940, 1715, 1500 and 
910 c m -l;8H (200 MHz) 1.42 (18H, s, 7-, 8-, 9-, 12-, 13- and 14-H3), 
2.11-2.19 (2H, m, 3-H2), 2.45-2.63 (2H, m, 5-H2), 2.91-3.00 (1H, m, 4-
H), 4.42 (1H, m, 2-H) and 5.52 (1H, br d, NH); 5C (50 MHz) 27.2 and
28.1 (C-7, -8, -9, -12, -13 and -14), 38.3 (C-3), 48.1 (C-5), 49.8 (C-4),
52.2 (C-2), 80.1 and 82.0 (C-6 and -11), 154.9 (C-10) and 171.7 (C-l); 
m / z  216, 186, 160, 130, 116, 86 , 57 (100%) and 41.
Trifluoroacetate Salt of DL-2-Amino-4-oxopentanoic Acid (1211.
„ N it CF3COO'
JL JL5 3 SC02H
Compound (119) (60 mg, 0.21 mmol) was deprotected with
trifluoroacetic acid (1 ml) according to general procedure [2] to give a
yellow syrup, 40 mg (80% yield); um ax (thin film) 3430 (broad), 
2995, 2550, 1680, 1635 and 1400 c m - 6H (200 MHz) (D2O) 2.06 (3H, 
s, 5-H3), 3.05-3.07 (2H, m, 3-H2) and 3.93 (1H, dd, J  6.1 Hz and J  4.9
185
Hz, 2-H); 5C (50 MHz) 30.3 (C-5), 43.6 (C-3), 50.2 (C-2), 173.9 (C-l) 
and 211.4 (C-4); m/z 13 1(M +), 114, 87, 69, 56 and 45. (Found: M +, 
131.0719. C5H9NO3 requires M, 131.0727).
Benzyl D L -2-(B enzyloxycarbonv n a m in o -4 -e p o x y p e n ta n o a te
(1231.1 62
20
1 6  1 7
A solution of (111) (50 mg, 0.147 mmol) in dichloromethane
(1 ml) was added dropwise to a solution of m -CPBA (31 mg, 1.2 
equiv.) in dichloromethane (2 ml) at 0 °C with stirring under a 
nitrogen atmosphere. Na2HPC>4 buffer was added to bring the pH of 
the mixture to 8 and stirring was continued at room temperature for 
3 h. The resulting mixture was diluted with dichloromethane (10 
ml), washed with 5% sodium bicarbonate solution (2 x 10 ml), dried 
(MgSC>4), and the solvent was removed in vacuo to give an oily 
residue. Purification was achieved on a silica gel column eluting with 
30% ethyl acetate in hexane to give a clear oil, 39 mg (76% yield), Rp 
0.12 (50% EtOAc / hexane); umax(CHCl3) 3430, 3010, 2955, 1620 a n d  
1505 and 1245 c n r^ d n  (200 MHz) 1.81-2.17 (2H, m, 3-H 2), 2.40 (1H, 
dd, J  2.6 Hz and J  4.8 Hz, 5b-H), 2.60 (1H, dd, 7 4.8 Hz and J  8.7 Hz, 
5a-H), 2.88-3.02 (1H, m, 4-H), 4.46-4.64 (1H, m, 2-H), 5.11 and 5 .1 9  
(4H, 2 x s, 6- and 14-H2), 5.62 (1H, br d, NH) and 7.35' (10H, br s, 8-,
1 86
9-, 10-, 11-, 12-, 16-, 17-, 18-, 19- and 20-H); 6C (50 MHz) 35.4 (C-
3), 46.7 (C-5), 48.9 (C-4), 52.4 (C-2), 67.1 and 67.5 (C-6 and -14),
-18, -19 and -20), 135.1 and 140.8 (C-7 and -15), 156.0 (C-13) and
171,5 (C-l); m / z  355(M+, 3.2%), 220, 176, 107 and 91(100%).
(Found: M +, 355.1404. C2oH2 iN05 requires Af, 355.1418).
A solution of ( 1 2 3 )  (30 mg, 0.08 mmol) and 10% Pd-charcoal 
(6 mg) in anhydrous methanol (2 ml) and glacial acetic acid (0.5 ml) 
was left in a sonic bath under a hydrogen atmosphere for 20 h. The 
resultant black mixture was filtered through celite and the so lv e n t 
was removed in vacuo to give a clear oil. Azeotroping with toluene 
removed traces of acetic acid. Trituration of the resultant oil w ith  
ether gave an off-white solid, 7 mg (63% yield); umax (KBr disc) 3025 
(broad), 300, 2980, 1595, 1500 and 1240 c n r i;  5H (200 MHz) (E^O) 
2.10 (2H, m, 3-H2), 2.41-2.44 (1H, m, 5b-H), 2.59-2.64 (1H, m, 5a-H), 
3.01-3.03 (IH, m, 4-H) and 4.34-4.41 (1H, m, 2-H); 5C (50 MHz) 35.1  
(C-3), 46.1 (C-5), 50.1 (C-4), 52.1 (C-2) and 173.9 (C-l); m / z  114, 86, 
74, 45 (100%).
128.1, 128.2, 128.4, 128.5 and 128.6 (C-8 , - 9 ,  -10, -11, -12, -16, -17 ,
DL-2-Amino-4-epoxvpentanoic Acid (124).
W 2
6.3. Experimental to Chapter T41.
Synthesis of Derivatives of Pyruvate and Bromopvruvate.
General Procedure \ 11 - Preparation of Imine Derivatives of
Pyruvate and Bromopvruvate.
A solution of the amine hydrochloride (1 equiv.) in water (5 
ml) was added to a solution of the pyruvate analogue (6.00 mmol) in 
dichloromethane (3 ml) and the 2-phase mixture was rapidly stirred 
at room temperature for 48 h. The resultant mixture was then
extracted with dichloromethane (2 x 10 ml) and the combined 
organic extracts were dried (MgSCU), filtered and the solvent 
removed in vacuo to give the desired products (20-70% yield).
General Procedure T21 - Preparation of 2.4-D initrophenylhvdrazone
(DNP1 Derivatives of Pvruvates and Bromopvruvates.1 6 5
Cone, sulphuric acid (0.5 ml) was added to a solution of 2,4-
dinitrophenylhydrazine (1.5 mmol) in methanol (5 ml) with s tirr in g . 
The resultant orange precipitate was filtered and to the filtrate a 
solution of the pyruvate analogue (1 equiv) in methanol (2 ml) was 
slowly added with stirring. The mixture was cooled and a solid 
precipitated immediately. Filtration and drying under vacuum g av e
the desired 2,4-DNP derivative (20-50% yield).
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Preparation of Thiosemicarbazide.
Sii
h 2n h n -  c -  n h 2
A solution of ammonium thiocyanate (2.20 g, 0.03 mol) a n d  
98% hydrazine hydrate (0.54 ml, 0.01 mol) in water (10 ml) was 
heated to reflux for 3 h. After cooling the mixture was filtered to 
remove small traces of sulphur. The filtrate was then allowed to cool 
to room temperature over 10 h and thiosemicarbazide p re c ip ita te d . 
The solid was filtered and washed with cold water to remove any 
unreacted ammonium thiocyanate. Drying under vacuum gave 500 
mg of a white solid (47% yield), mp 178-181 °C (EtOH/KkO); umax 
(KBr disc) 3485, 3370, 3265, 1645, 1620, 1533, 1286 and 100 c n r 1;
Methyl pyruvate (867 mg, 8.50 mmol) was reacted with 
hydroxylamine hydrochloride (607 mg, 1 equiv) according to general 
procedure [1] to give a white solid, 380 mg (38% yield), Rf 0.62 
(50% CHCl3/ether); umax (Nujol mull) 1730, 1460 and 1370 cm- *; 5h 
(200 MHz) 2.10 (3H, s, 3-H3), 3.84 (3H, s, 4-H3) and 9.90 (1H, br s, N-
m/z 91 (M+, 69.8%), 60, 42 and 32 (100%). (Found: C, 13.09; H, 5.42; 
N, 46.06; S, 35.21. CH5N3S requires C, 13.19; H, 5.49; N, 46.15; S, 
35.16% ).
Methyl Pyruvate Oxime (1331.
1 89
OH); 5C (50 MHz) 10.5 (C-3), 52.7 (C-4), 149.2 (C-2) and 164.0 (C-l);
Methyl pyruvate (0.90 ml, 9.98 mmol) was reacted with
methoxylamine hydrochloride (4 g, 1 equiv.) according to general
procedure [1] to give a yellow oil, 220 mg (17% yield) Rf 0 .45
(EtOAc); Umax (thin film) 2950, 1730, 1440 and 1330 cm-1; 6h (200
MHz) 1.99 (3H, s, 3-H3), 3.80 and 4.00 (6H, 2 x s, 4- and 5-H3); 5C (50
MHz) 11.1 (C-3), 52.6 (C-4), 63.0 (C-5), 148.6 (C-2) and 164.0 (C-l);
m/z 131 (M + , 21%), 101, 84, 72, 59 and 42 (100%). (Found: M + ,
131.0585. CsHqNC^ requires M , 131.0582).
m / z  117 (M +, 29.6%), 85 (100%), 58 and 42. (Found: C, 40.92; H, 6.06; 
N, 11.82. C4H7N 03 requires C, 41.05; H, 6.03; N, 11.96%).
Methyl Pyruvate Methvloxime (1341.
Methyl Pyruvate Semicarbazone (1351.
H
Methyl pyruvate (0.56 ml, 6.17 mmol) was reacted with 
semicarbazide hydrochloride (850 mg, 1 equiv.) according to general 
procedure [1] to give a white solid, 110 mg (11% yield), mp 197-201
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°C, Rf  0.19 (EtOAc); umax (Nujol mull) 1710, 1590, 1400 and 1380 
c m-1; 6h  (200 MHz) (D6-DMSO) 1.74 (3H, s, 3-H3), 2.67 (2H, br s, NH2), 
3.49 (3H, s, 4-H3) and 5.83 (1H, br s, C-NH-N); 5C (50 MHz) 11.3 (C-3), 
51.5 (C-4), 135.9 (C-2), 155.9 (C-5) and 164.2 (C-l); m/z 159 (M+, 
3.6%), 128, 116, 100, 83, 57 and 44 (100%). (Found M+, 159.0635.
C s^N sC ^ requires M, 159.0644).
Methyl pyruvate (0.12 ml, 1.35 mmol) was reacted with
thiosemicarbazide (150 mg, 1 equiv.) according to general procedure
[1] to give a white solid, 141 mg (60% yield), Rf 0.48 (EtOAc); om ax 
(KBr disc) 3520, 3440, 3240, 3160, 1725, 1630, 1610 and 1500 c a r l ;  
5h  (200 MHz) (De-DMSO) 2.08 (3H, s, 3-H3), 3.71 (3H, s, 4-H3), 7.68 
(1H, br s, NH) and 8.66 (2H, br s, NH2); 5C (50 MHz) 13.2 (C-3), 52.4 
(C-4), 138.8 (C-2), 164.8 (C-l) and 179.9 (C-5); m/z 175 (M +, 38.4%),
116 (100%), 75, 57 and 43.
Methvl Pvruvate Thiosemicarbazone 11361.
H
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Methyl Hvdrazonocarboxvlate 11371 of Methvl Pvruvate.
x
Methyl hydrazinoacetate (200 mg, 2.22 mmol) was reacted
with methyl pyruvate (0.2 ml, 1 equiv.) according to general 
procedure [1] to give a white solid, 270 mg (69% yield), Rp 0.30
(EtOAc); Umax (KBr disc) 3240, 1750, 1730, 1710, 1615 and 1500 cnr
(200 MHz) 2.15 (3H, s, 7-H3), 3.86 and 3.89 (6H, 2 x s, 6- and 8- 
H3) and 8.96 (1H, br s, NH); 6c (50 MHz) 11.5 (C-7), 52.9 and 53.7 (C- 
6 and 8), 140.9 (C-2), 154.3 (C-l) and 164.8 (C-5); m / z  174 (M +l.l% ), 
83, 55 and 42. (Found: C, 41.19; H, 6.04; N, 15.97%. C6HioN204 
requires, C, 41.38; H, 5.79; N, 16.08%).
Ethyl Hvdrazonoacetate (1381 of Methvl Pvruvate.
To a solution of ethyl hydrazinoacetate hydrochloride (200 mg,
1.29 mmol) and triethylamine (131 mg, 1 equiv.) in dichloromethane 
(5 ml) under a nitrogen atmosphere was added methyl pyruvate 
(132 mg, 1 equiv.) at room temperature with stirring. After 12 h 
stirring the resultant yellow solution was washed with water (3 x 10 
ml), dried (Na2SC>4) and the solvent removed in vacuo to give an off- 
white solid. Purification was achieved on a silica gel column eluting
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with ethyl acetate to give a white solid, 61 mg (23% yield), Rp 0.69 
(EtoAc); i)max (KBr disc) 3350, 2950, 1730, 1705, 1585 and 1450 cnr 
! ;5 h  (200 MHz) 1.28 (3H, t, J  7.2 Hz, 8-H3), 2.03 (3H, s, 6-H3), 3.82
(3H, s, IO-H3), 4.22 (2H, q, J  7.2 Hz, 7-H2), 4.23 (2H, m, 2-H2) and 5 .9 7
(1H, br s, NH); 5C (50 MHz) 10.5 (C-6), 14.1 (C-8), 51.8 (C-10), 52.4 (C-
2), 61.4 (C-7), 134.8 (C-5), 153.6 (C-9) and 170.8 (C-l); m/z 202 (M +,
11.6%), 143, 129, 115, 97, 69 (100%) and 59. (Found: C, 47.79; H, 
6.83; N, 13.93%. C8H i4N20 4 requires C, 47.52; H, 6.93; N ,13.86%).
2.4-DNP Derivative (1391 of Methvl Pvruvate.
NO,
OjN N -N  £ 0 2CH3 
H
Methyl pyruvate (0.46 ml, 5.05 mmol) was reacted with 2 ,4- 
dinitrophenylhydrazine ( 1.00 g, 1 equiv.) according to general 
procedure [2] to give a yellow solid, 520 mg (37% yield), mp 144-146 
°C (EtOH), Rp 0.85 (50% CHCI3 / ether); um ax (KBr disc) 3306, 3080, 
2360, 1730, 1620, 1590, 1550, 1510 and 1450 cm -[; 5H (200 MHz)
2.30 (3H, s, 3-H3), 3.91 (3H, s, 4-H3), 8.15 (1H, d, /  9.5 Hz, 10-H), 8.41 
(1H, dd, J  9.5 Hz and J  2.5 Hz, 9-H), 9.15 (1H, d, J  2.5 Hz, 7-H) and
11.23 (1H, br s, NH); 5c (50 MHz) 12.1 (C-3), 53.0 (C-4), 117.6 (C-7),
123.0 (C-9), 130.3 (C-10), 131.2 (C-5), 139.9 and 143.2 (C-6 and 8),
144.1 (C-2) and 164.4 (C-l); m/z 282 (M+, 31.2%), 222, 181, 152,
131, 72 and 43 (100%). (Found: Af+, 282.0599. CioHioN40fe re q u ire s  
M, 282.0601).
2.4-DNP Derivative (1401 of Pyruvic Acid.
NO2<5 5,
kOjN—3 / V - N - N  £ 0 2H
Pyruvic acid (0.35 ml, 5.05 mmol) was reacted with 2,4- 
dinitrophenylhydrazine ( 1.00 g, 1 equiv.) according to general 
procedure [2] to give an orange solid, 240 mg (18% yield), mp 203- 
206 °C; umax (KBr disc) 3350, 3290, 3100, 1725, 1615, 1590, 15 15 
and 1425 cm" l; 6H (200 MHz) (D6-DMSO) 2.19 (3H, s, 3-H3), 3.40 (1H, 
br s, NH), 8.09 (1H, d, J  9.5 Hz, 9-H), 8.48 (1H, dd, J  9.5 Hz and J  2.5
Hz, 8-H) and 8.87 (1H, d, J  2.5 Hz, 6-H); 5C (50 MHz) 11.8 (C-3), 117.2 
(C-6), 122.7 (C-8), 130.4 (C-9), 131.4 (C-4), 138.9 and 143.8 (C-5 and 
7), 144.7 (C-2) and 165.1 (C-l); m/z 268 (M +, 20.3%), 222, 152, 122, 
91, 78 and 43 (100%). (Found: M \  268.0433. C9H8N4O6 requires AT, 
2 6 8 .0 4 4 3 ).
Ethyl Bromopvruvate Oxime (1411.
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Ethyl bromopyruvate (0.64 ml, 5.13 mmol) was reacted with 
hydroxylamine hydrochloride (320 mg, 1 equiv.) according to g e n e ra l 
procedure [1] to give a white solid, 900 mg (83% yield), mp 77-79 °C,
RF 0.62 (50% CHC13 / ether); umax (KBr disc) 3290, 3060, 2980, 1725,
1470 and 1445 cnr l ; 5H (200 MHz) 1.35 (3H, t, J  7.2 Hz, 5-H3), 4.23
(2H, s, 3 -H 2) and 4.35 (2H, q, J  7.2 Hz, 4-H2); 5c (50 MHz) 13.9 (C-5),
15.1 (C-3), 62.5 (C-4), 147.6 (C-2) and 161.6 (C-l); m/z 210 (M +, 
37.5%), 183, 165, 138, 129 (100%), 121, 93, 81 and 73. (Found: M +, 
210.9665; C, 28.61; H, 3.79; N, 6.42%. C5H8BrN03 requires M,
210.9668; C, 28.59; H, 3.84; N, 6.67%).
Ethyl Bromopvruvate Methvloxime (1421.
Ethyl bromopyruvate (0.64 ml, 5.13 mmol) was reacted with 
methoxylamine hydrochloride (520 mg, 1 equiv.) according to 
general procedure [1] to give a yellow oil, 1.06 g (92% yield), RpO.30 
(EtOAc); umax (thin film) 3440, 2980, 2940, 1720, 1590 and 1460 
c n r 1; 5h  (200 MHz) 1.29 (3H, t, J  7 3  Hz, 5-H3), 4.09 (3H, s, 6-H3), 4.11 
(2H, s, 3 -H 2) and 4.29 (2H, q, J  7.3 Hz, 4-H2); 5C (50 MHz) 13.9 (C-5),
15.8 (C-3), 62.1 (C-4), 64.0 (C-6), 147.1 (C-2) and 161.5 (C-l); m / z  
224 (M +, 50.4%), 179 (100%), 150, 144, 122, 101 and 72. (Found: M \  
224.9835. CeHioBrNCb requires M, 224.9825).
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Ethyl Bromopyruvate Semicarbazone fl43).
H2N- C- n -  n ‘ ^ o 2c h 2c h 3
Ethyl bromopyruvate (0.64 ml, 5.13 mmol) was reacted with 
semicarbazide hydrochloride (470 mg, 1 equiv.) according to general 
procedure [1] to give a white solid, 530 mg (41% yield), mp 142-143 
°C,RF 0.13 (30% MeOH / CHC13); umax (Nujol mull) 3500, 3340, 3160, 
1700, 1610, 1585 and 1455 cm" 1; 5H (200 MHz) 1.24 (3H, t, 7 7.1 Hz,
5 -H3), 4.19 (2H, q, 7 7.1 Hz, 4-H2), 4.35 (2H, s, 3-H2), 6.32 (2H, br s, 
NH2) and 10.36 (1H, br s, NH); 5C (50 MHz) 13.7 (C-5), 18.7 (C-3), 61.1 
(C-4), 132.6 (C-2), 155.8 (C-6) and 162.4 (C-l); m/z 252 (M +, 0.6%), 
209, 178, 172, 129 (100%), 101 and 83. (Found: 252.9870; C,
28.22; H, 4.20; N, 16.25%. C6H i0BrN3C>3 requires M, 252.9887; C, 
28.59; H, 4.00; N, 16.67%).
Ethyl bromopyruvate (0.16 ml, 1.28 mmol) was reacted with
2,4-d in itrophenylhydrazine (240 mg, 1 equiv.) according to general
2.4-DNP Derivative (1451 of Ethyl Bromopyruvate.
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procedure [2] to give a yellow solid, 235 mg (49% yield), mp 87-89 
°C, RF 0.66 (50% CHC13 / ether); umax (CHCI3) 3260, 3100, 3015, 2990, 
1710, 1615, 1585, 1525, 1505 and 1430 c m '1; 6H (200 MHz) 1.42
(3H, t, 7 7.1 Hz, 5-H3), 4.38 (2H, s, 3-H2), 4.41 (2H, q, 7 7.1 Hz, 4-H 2),
8.18 (1H, d, 7 9.4 Hz, 11-H), 8.46 (1H, dd, 79.4 Hz and 7 2.5 Hz, 10-H),
9.16 (1H, d, 72.5 Hz, 8-H) and 11.56 (1H, br s, NH); 6c  (50 MHz) 14.2
(C-5), 16.8 (C-3), 62.6 (C-4), 117.9 (C-8), 122.8 (C-10), 130.3 (C -ll) ,
132.0 (C-6), 139.3 and 140.7 (C-7 and 9), 143.4 (C-2) and 162.1 (C-
1); m/z 375 (M +, 0.8%), 295, 195, 99 and 79.
2-4-DNP Derivative M441 of Bromopvruvic Acid.
Bromopyruvic acid (210 mg, 1.26 mmol) was reacted with 2,4- 
dinitrophenylhydrazine (240 mg, 1 equiv.) according to general 
procedure [2] to give a yellow solid, 132 mg (38% yield), mp 115- 
117 °C, Rp 0.57 (50% CHCI3 / ether); uraax (KBr disc) 3440, 3190,
3110, 2940, 1720, 1690, 1620, 1590, 1500 and 1420 c m -l;5 H (2 0 0  
MHz) (D6-DMSO) 4.33 (2H, s, 3-H2), 8.12 (1H, m, 9-H), 8.35 (1H, m, 8- 
H),and 9.08 (1H, m, 6-H); 6c  (50 MHz) 29.7 (C-3), 117.6 (C-6), 122 .6  
(C-8), 130.7 (C-9), 134.4 (C-4), 139.4 and 143.2 (C-5 and 7), 144.1 (C-
2) and 165.1 (C-l); m/z 266, 180, 98, 78 and 64.
197
Attempted Preparation of Ethvl Bromopvruvate Thiosemicarbazone
Ethyl bromopyruvate (500 mg, 2.56 mmol) was reacted with 
thiosemicarbazide (233 mg, 1 equiv.) according to general procedure 
[1] to give a yellow oil, 310 mg (64% yield). TLC analysis (25% EtOAc 
/ hexane) with iodine visualisation showed one main spot. 
Purification was achieved on a silica gel column eluting with 25% 
EtOAc in hexane. and 13C NMR spectroscopic analysis showed that 
a 1:1 mixture of the cyclic products (147) and (148) had been 
fo rm ed .
(147) (148)
The spectroscopic data for these cyclic products is as follows; umax 
(CHC13) 3010, 2400, 1725, 1710, 1585 and 1510 c m ' ^ b u  (200 MHz)
1.30 and 1.41 (6H, 2 x t, 77.14 Hz, 9- and 9’-H3), 4.23 (2H, dq, J  7.14
Hz and J  1.00 Hz, 8’-H2), 4.40 (2H, ddq, 7 7.14 Hz and /  5.18 Hz, 8-H2),
5.33 (1H, d, J  13.38 Hz, 2-H), 6.28 (1H, d, J  13.38 Hz, 2-H) and 6.97
(1H, s, 2’-H); 5C (50 MHz) 14.1 (C-9 and -9’), 42.0 (C-2), 61.5 and 61.7
(C-8 and -8’), 113.3 (C-3’), 115.1 (C-21), 132.2 (C-3), 148.2 (C-6),
159.1 (C-6’), 165.2 (C-7) and 170.7 (C-7').
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M ethyl 3-Brom o-2.2-dim ethoxypropanoate (1491.1 6 6
Br
CH3O f ° 2 C H 3
6
A solution of bromopyruvic acid hydrate (500 mg, 3.0 mmol), 
trim ethylorthoform ate (2 ml) and c. H2SO4 (0.03 ml) was stirred at 
room temperature for 18 h. The resultant mixture was diluted with 
dichloromethane (6 ml) and washed with water (2 x 10 ml) and 
brine solution (2 x 10 ml). The organic portion was dried (MgS04 ), 
filtered and the solvent removed in vacuo to give a clear oil, 132 mg 
(20% yield), Rp 0.78 (50% EtoAc / hexane); Umax (CHCI3) 3500, 3020, 
2950, 1730 and 1430 c n r^ b H  (270 MHz) 3.38 (6H, s, 5- and 6-H3), 
3.63 (2H, s, 3-H2) and 3.97 (3H, s, 4-H3); m/z 168, 163, 120, 104 and 
80 ( 100%).
A solution of bromopyruvic acid hydrate (500 mg, 3.0 mmol), 
triethylorthoformate (2 ml) and c. H2SO4 (0.03 ml) was stirred a t  
room temperature for 18 h. The resultant mixture was diluted with 
dichloromethane (6 ml) and washed with water (2 x 10 ml) and 
brine solution (2 x 10 ml). The organic solution was dried (MgSC>4), 
filtered and the solvent removed in vacuo to give a white solid, 499
3-Brom o-2.2-diethoxypropanoic Acid (150).1 6 6
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mg (81% yield), Rf 0.33 (50% EtoAc / hexane); umax (CHCI3) 3495, 
3400, 3020, 2980, 1780, 1730 and 1440 cm-1; 5H (270 MHz) 1.28 
(6H, 2 x t, 7 6.7 Hz, 5 and 7-H3), 3.60 (4H, dq, 7 11.2 Hz and 7 6.7 Hz,
4- and 6-H2) and 3.63 (2H, s, 3-H2); 6c (50 MHz) 13.8 and 14.9 (C-5 
and -7), 30.8 (C-3), 58.5 and 63.1 (C-4 and 6), 99.7 (C-2), 159.2 (C-l).
6.3. Experimental to Chapter T51.
Synthesis of Sulphur Analogues of L-2.3-DHDPA (231 and L-2.3.4.5-
THDPA (241.
3 .4-D ihvdro-2H -1.4-th iazine-3 .5-dicarboxylic Acid Hvdrobrom ide
(1 59),
1
To a solution of bromopyruvic acid (190 mg, 1.139 mmol) in 
water (1 ml) was added a solution of L-cysteine hydrochloride (200 
mg, 1 equiv.) with stirring for 1 h. The resultant precipitate was 
filtered, washed with cold water and dried to give a white solid, 119 
mg (55% yield); umax (KBr disc) 3343 (broad), 3090, 2361, 1691,
1626, 1601, 1468 and 1417 c m '1; 6H (200 MHz) (D6-DMSO) 3.01 (2H, 
m, 2-H2), 4.25 (1H, dd, 3-H), 5.17 (2H, br s, NH2) and 5.94 (1H, s,
2 0 0
6-H); 6C (50 MHz) 25.7 (C-2), 52.2 (C-3), 97.7 (C-6), 128.6 (C-5), 168.4 
(C-7) and 171.7 (C-8); m/z 189 (M +, 35.6%), 145, 126, 100, 54 and 
44 (100%). (Found: M+, 189.0094; C, 37.93; H, 3.70; N, 7.33; C6H7NO4S 
requires M,  189.0095; C, 38.09; H, 3.70; N, 7.41%).
Diethvl (,R1-3.4-Dihvdro-2H-1.4-thiazine-3.5-dicarhoxvlate 1175 V
K J s
* 1 Xc h 3c h 2o 2c  - n 4 5 c o 2c h 2c h 3 
9 3 8 2 27 H h  10 12 3
To a solution of L-cysteine ethyl ester hydrochloride (200 mg, 
1.077 mmol) and triethylamine (0.16 ml, 2 equiv.) in 
dichlorom ethane (5 ml) under a nitrogen atmosphere was added 
dropwise a solution of ethyl bromopyruvate (0.135 ml, 1 equiv.) in 
dichloromethane (5 ml) with stirring. The mixture was stirred at 
room temperature for 12 h, washed with water (2 x 10 ml) and the 
organic portion was dried (Na2SC>4). The solvent was removed in  
vacuo to give a yellow oil. Purification was achieved on a silica gel 
column eluting with 20% ethyl acetate in hexane to give a yellow oil, 
145 mg (90% yield), RF 0.36 (25% EtOAc / hexane); i w  (CHC13) 3 4 0 5 , 
2980, 1740, 1700, 1605, 1475 and 1465 cnr*; 6H (200 MHz) 1 .26  
and 1.27 (6H, 2 x t, /  7.1 Hz and J  7.2 Hz, 9- and 12-H3), 2.97 (1H,
ddd, J  12.1 Hz, J  6.7 Hz and J  0.7 Hz, 2a-H), 3.18 (1H, ddd, J  12.1 
Hz, J  2.9 Hz and J  2.9 Hz, 2b-H), 4.30 (5H, 2 x q + m, /  7.1 Hz and /
7.2 Hz, 8- and 11-H2) and 6.14 (1H, t, /  0.7 Hz, 6-H); 5C (50 MHz) 14 .0
201
and 14.1 (C-9 and -12), 26.8 (C-2), 53.0 (C-3), 61.2 and 61.8 (C-8
and -11), 101.2 (C-6), 128.0 (C-5), 162.3 (C-10) and 170.2 (C-7); m / z
245 (M +, 43.6%), 201, 172 (100%), 154, 139, 101, 98 and 73. (Found: 
M +, 245.0731. C10H 15NO4S requires M, 2 4 5 .0 7 2 2 ).
3-C arboethoxy-3.4-dihydro-2H -1.4-th iazine-5-carboxvlic  Acid (1761.
To a solution of L-cysteine ethyl ester hydrochloride (100 mg,
0.54 mmol) and bromopyruvic acid (90 mg, 1 equiv.) in anhydrous
chloroform (6 ml) under a nitrogen atmosphere was added 
triethylamine (0.21 ml, 2 equiv.) with stirring and cooling to 0 °C  
The mixture was continuously stirred for 16 h then washed w ith  
water ( 2 x 5  ml) and 2M hydrochloric acid ( 2 x 5  ml). The organic 
portion was extracted with 5% sodium bicarbonate solution (10 ml).
The aqueous portion was carefully acidified to pH 2 with c. HC1 then
extracted with chloroform (3 x 10 ml). The combined o rgan ic  
extracts were dried (MgSC>4) and removal of the solvent in vacuo
gave a yellow oil, 20 mg (20% yield), Rp 0.32 (ether); umax (CHCI3) 
3400, 3020, 2410, 1740, 1690 and 1420 c m '1; 5h (200 MHz) 1.29
(3H, t, /  7.2 Hz, 8-H3), 3.01 (1H, dd, /  12.4 Hz and J  6.7 Hz, 2a-H), 3.24
(1H, dd, J  12.4 Hz and J  2.3 Hz, 2b-H), 4.25 (3H, q + m, /  7.2 Hz, 7-H2
and 3-H) and 6.36 (1H, s, 6-H); 5C (50 MHz) 14.1 (C-9), 26.9 (C-2),
2 0 2
52.9 (C-3), 62.0 (C-8), 104.7 (C-6), 127.2 (C-5), 166.6 (C-10) and
170.1 (C-7); m/z 217 (M+, 37.9%), 189, 172, 144, 126 (100%), 98 and 
45.
A solution of (175) (250 mg, 1.02 mmol) in methanolic
ammonia (10 ml) was stirred at room temperature for 16 h. The 
resulting orange precipitate was filtered to give an orange solid. 
Recrystallisation from methanol gave a white solid, 71 mg (37%
yield); um a* (KBr disc) 3400, 3340, 2950, 1690, 1650, 1595, 1485
and 1435 cm -l;8H (200 MHz) 2.54 (1H, dd, J  12.3 Hz and J  3.3 Hz, 2- 
H), 3.37 (1H, ddd, J  12.3 Hz, J  3.3 Hz and J  1.8 Hz, 2-H), 4.42 (1H, m,
3-H), 5.93 (2H, br s, NH2), 6.33 (1H, d, J  1.8 Hz, 6-H) and 6.52 (2H, br
s, NH2); 5c  (50 MHz) 24.8(C-2), 52.4 (C-3), 103.2 (C-6), 126.8 (C-5),
162.6 and 163.1 (C-7 and -8); m/z 172, 158, 142, 126 (100%), 98, 72 
and 54.
3 .4-D ihvdro-2H -i .4 -th iazine-3 .5 -d iam ide  (1781.
H2NOC 3 N4 5 CONH2
H
2 0 3
Diethyl 3 .4-Di hvdro-4-methyl-2H-1.4- thiaz ine-3 .5-dicarboxvla te
(17 9 )..
CH
9 8 7 irl '
Ml
13
H
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Methyl iodide (0.76 ml, 10 equiv.) was added to a solution of 
(175) (300 mg, 1.22 mmol) in DMF (3 ml) with stirring. The mixture 
was heated at reflux for 1 h then cooled to room temperature, 
diluted with water (3 ml) and the solvents were removed in vacuo t o 
give an oily residue. Traces of DMF were removed by azeo tro p in g  
the mixture with further volumes of water. The resulting oil was 
dissolved in ethyl acetate (5 ml) and washed with aq. ammonia 
solution. The organic layer was dried (MgSC>4), filtered and 
concentrated in vacuo to give a yellow oil. Purification was achieved 
on a silica gel column eluting with 50% ethyl acetate in hexane to 
give a yellow oil, 100 mg (31% yield), Rp 0.45 (EtOAc); um ax (CHCI3) 
3000, 1750, 1710, 1580 and 1465 c n r 1^  (200 MHz) 1.23 and 1.31 
(6H, 2 x s, 7 7.1 Hz, 9- and 12-H3), 2.70 (3H, s, 13-H3), 2.93 (1H, dd, 7
12.7 Hz and 7 3.3 Hz, 2a-H), 3.19 (1H, ddd, 7 12.7 Hz, 73.7 Hz and 7 1 .7  
Hz, 2b-H), 4.19 (5H, m, 8- and 11-H2 and 3-H) and 6.86 (1H, d, 7 1.7 
Hz, 6-H); 5C (50 MHz) 14.1 and 14.3 (C-9 and -12), 21.8 (C-2), 42.3 (C-
13), 60.1 (C-3), 60.9 and 61.5 (C-8 and -11), 116.6 (C-6), 132.4 (C-5),
163.3 (C-10) and 168.6 (C-7); m/z 259 (M+, 21.6%), 186 (100%), 158, 
113, 86 and 42. (Found: M +, 259.0865. C11H17NO4S requires M,
2 5 9 .0 8 7 8 ).
2 0 4
Diethyl t r a n s - 3 A - D i h y d r o -  l -o x o -2 H -  1.4- th iazine-3 .5-
dicarboxvl  atef 180).
O'
K i ls i
3L "5"c h 3c h 2o 2c  n ;  3 c o 2c h 2c h 3
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To a solution of (175) (490 mg, 2 mmol) in dichloromethane
(10 ml) at -78 °C under a nitrogen atmosphere was added dropwise a 
solution of m -chloroperbenzoic acid (414 mg, 2.4 mmol) in 
dichloromethane (2 ml). The mixture was stirred at -78 °C for 2 0 
min then warmed to room temperature and stirred for a further 30 
min. The resultant yellow solution was washed with 5% sodium 
bicarbonate solution ( 2 x 5  ml), water ( 2 x 5  ml) and dried (Na2SC>4). 
The solvent was removed in vacuo  to give an amber syrup. 
Purification was achieved on a silica gel column eluting with 50% 
chloroform in methanol to give an amber syrup, 400 mg (77% yield), 
Rf  0.22 (50% CHC13 / MeOH), [<x]D = 0; i w  (CHCI3) 3405, 3000, 1740, 
1595, 1200 and 1025 cm -1;5 H (200 MHz) 1.32 (6H, 2 x t, 9- and 12- 
H3), 2.25 (1H, dd, J  13.3 Hz, 2b-H), 3.41 (1H, br d, J  13.5 Hz, 2a-H), 
4.25 (5H, 2 x q + m, 8- and II-H 2 and 3-H), 6.24 (1H, br s, 6-H) and
6.38 (1H, br s, NH); 6C (50 MHz) 14.0 and 14.2 (C-9 and -12), 44.2 
(C-3), 44.3 (C-2), 62.8 and 62.9 (C-8 and -11), 97.4 (C-6), 137.1 (C-
5), 161.9 (C-10) and 169.8 (C-7); m/z 261 (M +, 1.0%), 245, 143, 70, 
45 and 29 (100%).
2 0 5
Diethyl 2H-1.4-Thiazine-3.5-dicarboxylate (182).
1
To a solution of 2,3-dichloro-5,6-dicyanobenzoquinone (120 
mg, 0.53 mmol) in dichloromethane (5 ml) was added a solution of
(175) (115 mg, 0.47 mmol) in dichloromethane (2 ml) at room
temperature with continuous stirring for 1 h. The resultant reddish 
brown precipitate was filtered through celite, washed with 5% 
aqueous sodium bicarbonate solution (3 x 15 ml) and dried (MgSCU). 
The solvent was removed in vacuo to give a yellow oil. Purification 
was achieved on a silica gel column eluting with 50% chloroform in 
ether to give 102 mg (79% yield), Rf 0.46 (50% CHCI3 / ether); umax 
(KBr disc) 3420, 2960, 1735, 1710 and 1465 cm -1;5 H (200 MHz) 1.35 
(6H, 2 x t, 9- and 12-H3), 3.33 (2H, d, J  1.2 Hz, 2-H2), 4.30 (4H, 2 x q, 
8- and 11-H2) and 7.59 (1H, t, J  1.2 Hz, 6-H); 5C (50 MHz) 14.1 and
14.2 (C-9 and -12), 20.6 (C-2), 63.0 and 63.4 (C-8 and -11), 128.2 (C-
6), 137.2 and 137.9 (C-3 and -5), 167.5 and 168.8 (C-7 and 10); m / z  
243 (M+, 47.0%), 215, 169, 141, 97, 45 and 29 (100%).
2 0 6
3 .4 -D ihydro -2 .2 -d im ethy l-2H -1 .4 -th iazine-3 .5 -d icarboxv lic  Acid 
Hvdrobromide (186) and Dimethyl 3.4-Dihydro-2.2-dimethvl-2H- 
1 .4-th iazine-3 .5-d icarboxvlate  (187).
A solution of DL-penicillamine (500 mg, 3.35 mmol) in glacial
acetic acid (2 ml) was added to a solution of bromopyruvic acid (559
mg, 1 equiv.) in glacial acetic acid (1 ml) with stirring. The m ix tu re
was stirred for 16 h at room temperature. The solvent was removed
in vacuo to give a brown solid (186); 5h (90 MHz) (D6-DMSO) 1.20
and 1.37 (6H, 2 x s , 9 and 10-H3), 3.70 (1H, s, 3-H), 5.98 (1H, s, 6-H),
and 7.60 (2H, br s, NH2); A solution of the brown solid in e th y l  
acetate (20 ml) was cooled to 0 °C then saturated with ethereal 
diazomethane and stirred at room temperature for 18 h. The 
resultant mixture was washed with water (2 x 20 ml), dried (Na2SC>4) 
and the solvent was removed in vacuo to give a brown oil. 
Purification was achieved on a neutral alumina column eluting with 
25% ethyl acetate in hexane to give an amber oil (187) 505 mg (61% 
yield), Rf 0.56 (25% EtOAc / hexane); Umax (CHCI3) 3400, 3010, 2950, 
1735, 1700, 1605 and 1435 cm-1; 6H (200 MHz) 1.23 and 1.40 (6H, 2 
x s, 11- and 12-H3), 3.73 (6H, s, 8- and IO-H3), 3.81 (1H, d, J  3.8 Hz, 
3-H), 4.75 (1H, br s, NH) and 6.20 (1H, s, 6-H); 5C (50 MHz) 24.8 and
27.5 (C -ll and -12), 40.4 (C-2), 52.0 and 52.1 (C-8 and -10), 62.5 (C-
2 0 7
3), 102.3 (C-6), 125.8 (C-5), 162.6 (C-9) and 170.2 (C-7); m/z 245 
(M +, 45.0%), 186, 154 (100%), 126, 112 and 82. (Found:
245.0723; C, 49.02; H, 6.39; N, 5.50. Q 0H 15NO4S requires M,
245.0721; C, 48.79; H, 6.12; N, 5.71%).
E thvl 3 -C arbom ethoxy-3 .4 -d ihydro -2 .2 -d im ethv l-2H -1 .4 -th iaz ine-5 -
carboxvlate (188).
c h 3o 2c ^ 3 n 4 5 c o 2c h 2c h 3
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To a solution of DL-penicillamine methyl ester hydrochloride 
(200 mg, 1.0 mmol) and triethylamine (0.28 ml, 2 equiv.) in  
dichlorom ethane (5 ml) under a nitrogen atmosphere was added 
dropwise a solution of ethyl bromopyruvate (0.13 ml, 1 equiv.) in 
dichloromethane (5 ml) with stirring. The mixture was stirred for 12
h at room temperature then washed with water (2 x 10 ml). The 
organic portion was dried (Na2S0 4 ) and the solvent was removed in  
vacuo to give a yellow oil. Purification was achieved on a neutral
alumina column eluting with 30% ethyl acetate in pet. ether (40-60
°Q  to give a yellow oil, 234 mg (90% yield), Rf 0.61 (EtOAc); umax 
(CHCI3) 3390, 3005, 2965, 1730, 1690, 1500, 1450 and 1425 c n r ^ H  
(200 MHz) 1.22 (3H, s, 12- or 13-H3), 1.25 (3H, s, /  7.1 Hz, II-H 3),
1.39 (3H, s, 12- or 13-H3), 3.71 (3H, s, 8-H3), 3.80 (1H, d, J  3.7 Hz, 3- 
H), 4.18 (2H, q, J  7.1 Hz, 10-H2), 4.75 (1H, br s, NH) and 6.19 (1H, s, 6-
2 0 8
H );SC (50 MHz) 14.1 (C-l 1), 24.7 and 27.5 (C-12 and -13), 40.3 (C-2),
52.1 (C-3), 61.0 (C-10), 62.5 (C-8), 101.8 (C-6), 126.0 (C-5), 162.1 (C- 
9) and 170.2 (C-7); m/z 259 (M+, 44.0%), 200, 186, 154 (100%), 126, 
112, 82 and 45. (Found: M +, 259.0871. C11H 17NO4S requires Af,
2 5 9 .0 8 7 8 ).
Methyl 3 .4-D ihvdro-2 .2-dim ethvl-1.4-thiazine-5-carboxvlic acid-3-
carboxvlate (1891.
To a solution of DL-penicillamine methyl ester hydrochloride
(200 mg, 1.00 mmol) and bromopyruvic acid (167 mg, 1 equiv.) in 
anhydrous chloroform (10 ml) under a nitrogen atmosphere was 
added triethylamine (0.418 ml, 2 equiv.) with stirring and cooling to
0 °C. The mixture was continuously stirred for 16 h then washed 
with water ( 2 x 5  ml) and 2M HC1 (2 x 10 ml). The organic portion 
was extracted with 5% sodium bicarbonate solution (2 x 10 ml) then
carefully acidified to pH 2 with conc. HC1. The aqueous portion was
extracted with chloroform (3 x 15 ml), dried (Na2SC>4) and the so lv e n t 
was removed in vacuo to give a yellow oil, 55 mg (24% yield); um ax
(CHCI3) 3405, 3020, 2960, 1740, 1680, 1600, 1440 and 1425 c m '1; 
5h  (200 MHz) 1.29 and 1.46 (6H, 2s, 10 and II-H 3), 3.78 (3H, s, 8 -H 3), 
3.87 (1H, d, 77.4 Hz, 3-H) and 6.45 (1H, s, 6-H); 6C (50 MHz) 25.0 and
27.7 (C-10 and 11), 40.9 (C-2), 52.9 (C-3), 62.5 (C-8), 105.7 (C-6),
2 0 9
129.3 (C-5), 148.5 (C-9) and 170.2 (C-7); m/z 231 (M +, 30.6%), 186, 
172, 154 (100%), 126 and 82.
3.4-D ihydro-2H -1.4-thiazine-5-carboxylic Acid Hvdrobromide (1901 
and Methyl 3.4-Dihydro-2H-1.4-thiazine-5-carboxvlate fl911.
A solution of 2-aminoethanethiol hydrochloride (1.23 g, 0.011
mol) in glacial acetic acid (4 ml) was added to a solution of
bromopyruvic acid hydrate (1.80 g, 1 equiv.) in glacial acetic acid (4
ml) at room temperature with stirring for 1 h. The resulting white
precipitate was filtered, washed with ether and dried to give an off- 
white solid (190); bH (90 MHz) (D6-DMSO) 2.45 (2H, m, 2-H2), 2.93
(2H, m, 3-H2), 6.25 (1H, s, 6-H) and 6.40 (2H, br s, NH2); A solution of
the white solid in ethyl acetate (30 ml) was cooled to 0 °C then
saturated with ethereal diazomethane and stirred at room
temperature for 16 h. The resultant mixture was washed with water
(2 x 20 ml), dried (Na2SC>4) and the solvent was removed in vacuo to  
give a yellow oil. Purification was achieved on a neutral alumina 
column eluting with 20% ethyl acetate in hexane to give 1.22 g of a
yellow oil (191), (70% yield), Rf 0.64 (20% EtOAc / hexane); Umax
(CHC13) 3415, 3005, 2995, 2910, 1720, 1700 and 1625 c n r^ S H  (200
H 7 8
(190) (191)
MHz) 2.86 (2H, m, 2-H2), 3.62 (2H, m, 3-H2), 3.80 (3H, s, 8-H3), 4.98
2 10
(1H, br s, NH) and 6.05 (1H, s, 6-H); 6C (50 MHz) 27.1 (C-2), 41.4 (C- 
3), 51-3 (C-8), 102.9 (C-6), 128.5 (C-5) and 159.8 (C-7); m/z 159 
(M +, 23.5%), 144, 100, 72, 61 and 44 (100%).
Ethvl 3.4-D ihydro-2H -1.4-thiazine-5-carboxvlate (1921.
Ethyl bromopyruvate (0.552 ml, 1 equiv.) was added to a 
solution of 2-aminoethanethiol hydrochloride (500 mg, 4.40 mmol) 
and triethylamine (1.22 ml, 2 equiv.) in dichloromethane (15 ml) 
under a nitrogen atmosphere at room temperature with continuous 
stirring for 1 h. The resultant brown mixture was washed with 
water (3 x 15 ml), dried (Na2SC>4) and the solvent was removed in  
vacuo to give a brown residue. Purification was achieved on a 
neutral alumina column eluting with 15% ethyl acetate in hexane to 
give a yellow oil, 200 mg (26% yield), Rf 0.73 (25% EtOAc / hexane); 
Umax (CHC13) 3420,3020, 2980, 2920, 1715, 1695 and 1600 cm' 1; 5H
3-H 2), 4.20 (2H, q, 7 7.1 Hz, 8-H2) and 6.17 (1H, s, 6-H); 5C (50 MHz)
H 7 9
(200 MHz) 1.28 (3H, t, 7 7.1 Hz, 9-H3), 2.97 (2H, m, 2-H2), 3.53 (2H, m,
14.2 (C-9), 25.8 (C-2), 41.2 (C-3), 61.0 (C-8), 101.9 (C-6), 129.1 (C-5) 
and 162.7 (C-7); m/z 173 ( M \  44.7%), 145, 132, 99, 72, 61, 45 and
29 (100%).
2 1 1
4 .5 .6 .7 -T etrahydro -1 .4 -th iazep ine-3 .5 -d icarboxy lic  Acid 
Hydrochloride (193) and Dimethyl 4.5.6.7-Tetrahvdro-1.4- 
th iazep ine-3 .5-d icarboxvlate  (194).
c o 2h  
h ° 2c  h 2 c r  8
(193)
T-N43
(194)
A solution of DL-homocysteine (1.19 g, 8.80 mmol) in water (2  
ml) and 2M HC1 (1 ml) was added to a solution of bromopyruvic acid 
(1.63 g, 1 equiv.) in water (3 ml) with continued stirring at room 
temperature for 1 h. The solvent was removed in vacuo to give a 
yellow solid (193); 5H (90 MHz) (D6-DMSO) 2.15 (2H, m, 6-H2), 2.75
NH2); A solution of the yellow solid in ethyl acetate (20 ml) was
cooled to 0° C then saturated with ethereal diazomethane and stirred 
at room temperature for 18 h. The resultant mixture was w a sh e d
with water (2 x 20 ml), dried (Na2S0 4 ) and the solvent was removed
in vacuo to give a yellow residue. Purification was achieved on a 
neutral alumina column eluting with 25% ethyl acetate in hexane to 
give a yellow oil (194), 425 mg (21% yield), Rf 0.54 (25% EtOAc /
hexane); umax(CHCl3) 3360, 3020, 2950, 1735, 1705, 1595 and 1435 
c m -1;6 H (200 MHz) 2.07 (1H, m, 6b-H), 2.40 (2H, m, 7-H2), 2.72 (1H, 
dddd, 714.2 Hz, 7 5.5 Hz, 7 3.0 Hz and 7 1.2 Hz, 6a-H), 3.75 and 3.76 
(6H, 2 x s, 9- and 11-H3), 4.77 (1H, ddd, 714.2 Hz, 7 5.5 Hz and 7 1.2 
Hz, 5-H), 4.97 (1H, br s, NH) and 6.09 (1H, s, 2-H); 5C (50 MHz) 29.9 
(C-6), 33.1 (C-7), 52.5 and 52.6 (C-9 and -11), 57.7 (C-5), 107.2 (C-
(2H, m, 7-H2), 3.95 (1H, m, 5-H), 6.27 (1H, s, 2-H) and 8.10 (2H, br s,
2 12
2), 135.1 (C-3), 163.7 (C-8) and 172.7 (C-10); m/z 231 (M+, 23.4%), 
172, 140, 112 (100%), 85 and 59. (Found: M +, 231.0566. C9H 13NO4S 
requires M, 231.0567).
Ethyl 4-Carbom ethoxy-1.3-thiazole-2-carboxvlate ( 195).
A solution of (196) (7.26 mg, 3.09 mmol) and phosphorus 
pentasulphide (1.37 g, 1 equiv.) in pyridine (20 ml) was heated to  
reflux with stirring for 4 h. Pyridine was removed in vacuo and the 
resultant residue was partitioned between water (100 ml) and ethyl 
acetate (40 ml). The organic portion was separated and the aqueous 
layer was extracted with ethyl acetate (2 x 20 ml). The combined 
organic layers were washed with water (3 x 20 ml), dried (MgSC>4), 
filtered and the solvent removed in vacuo to give a dark yellow 
residue. Purification was achieved on a silica gel column eluting with 
5% ethyl acetate in hexane to give a yellow oil, 265 mg (40% yield), 
Rf  0.60 (50% EtOAc / hexane); umax (CHCI3) 3120, 3000, 2960, 1720
and 1465 c m ' 5 H (200 MHz) 1.42 (3H, t, J  7.1 Hz, 8-H3), 3.95 (3H, s, 
IO -H 3), 4.48 (2H, q, J  7.1 Hz, 7-H2) and 8.40 (1H, s, 5-H); 5C (50 MHz)
14.2 (C-8), 52.6 (C-10), 63.0 (C-7), 132.4 (C-5), 148.5 (C-4), 159.3 (C- 
2), 159.5 and 161.2 (C-6 and 9); m/z 215 (M +, 9.2%), 184, 170, 156, 
143 (100%), 111, 84 and 57.
2 1 3
Ethyl 3-A za-4-carbom ethoxv-5-m ercapto-2-oxopentanoate (196)
6
SHf °
c h ,o ,c  '  4'  n 3^  c o ,c h ,c h ,
10 9 H 1 7 8
Ethyl oxalyl chloride (0.651 ml, 1 equiv.) was added to a
solution of L-cysteine methyl ester hydrochloride (lg , 5.83 mmol) 
and triethylamine (1.62 ml, 2 equiv) in dichloromethane (20 ml) at 
room temperature with stirring. The resultant white suspension was 
stirred for 3 h, washed with water (3 x 20 ml), dried (MgSC>4) and 
filtered. The solvent was removed in vacuo to give an oily residue. 
Purification was achieved on a silica gel column eluting with 25%
ethyl acetate in hexane to give a clear oil, 1.29 g (94% yield), Rf 0.48
(50% EtOAc / hexane); umax (CHC13) 3395, 3020, 1740, 1705 and
1515 cm -l;5 H (200 MHz) 1.40 (3H, t, J  7.1 Hz, 8-H3), 3.07 (2H, ddd, J
9.2 Hz, J  4.3 Hz and J  1.6 Hz, 5-H2), 3.83 (3H, s, IO-H3), 4.39 (2H, q, J
7.1 Hz, 7-H2), 4.89 (1H, m, 4-H) and 7.94 (1H, br s, NH); 6C (50 MHz)
13.8 (C-8), 26.2 (C-5), 52.9 (C-10), 54.0 (C-4), 63.3 (C-7), 159.7 (C-l),
169.3 (C-9) and 184.6 (C-2); m/z 235 (M+, 2.5%), 234, 176, 162, 134,
102, 86 and 59.
2 14
Diethyl 1.3-Thiazole-2.4-dicarboxvlate (200^.
c h 3c h 2o 2c11 Jio z
jdkN'
3
c o 2c h 2c h 3
6 ^ 7  J
A solution of ethyl thioxamate (1.12 g, 8.41 mmol) and e th y l  
bromopyruvate (3.17 ml, 3 equiv.) in ethanol (20 ml) was heated a t  
reflux for 2 h. The solvent was removed in vacuo and ether (20 ml) 
was added to precipitate triethylamine hydrobromide. Filtration and 
removal of the solvent in vacuo g a v e . a yellow oily residue. 
Purification was achieved on a neutral alumina column eluting with 
25% ethyl acetate in hexane to give a yellow oil, 1.80 g, (92% y ield ), 
RF 0.39 (50% EtOAc / hexane); umax (CHC13) 3120, 3010, 1715, 1485
and 1460 c n r ^ H  (200 MHz) 1.35 and 1.38 (6H, 2 x t, 7 7.1 Hz, 8- 
and II-H 3), 4.38 and 4.43 (4H, 2 x q, 7  7.1 Hz, 7- and 10-H2) and
8.36 (1H, s, 5-H); 6C (50 MHz) 14.0 and 14.1 (C-8 and -11), 61.7 and
62.9 (C-7 and -10), 132.1 (C-5), 148.8 (C-4), 159.1 (C-2), 159.4 and 
160.6 (C-6 and 9); m/z 229 ( M \  5.0%), 200, 184, 157, 156, 129,111 
and 83.
2 15
1.3-T hiazole-2.4-diam ide (1991,
5 4
j f kh 2n o c ^  n  ^  c o n h 2
A solution of (200) (220 mg, 0.96 mmol) in methanol (15 ml)
saturated with ammonia was stirred at room temperature for 18 h. 
The resultant precipitate was filtered, washed with cold water and
dried in vacuo to give a white solid, 124 mg (90% yield); um ax (KBr
disc) 3400 (broad), 3270, 3200, 1680, 1590 and 1485 cm -1; 6 H (2 0 0
MHz) 7.76 (2H, br s, NH2), 8.21 (2H, br s, NH2) and 8.46 (1H, s, 5-H); 
6C (50 MHz) 128.9 (C-5), 150.4 (C-4), 160.5 (C-2), 161.9 and 163.1 (C- 
6 and 7); m/z 171 (M+, 100%), 154, 128, 112, 84 and 70.
6.4. Test Data for Chapters T31. T41 & T51.
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B orthw ick 1 21 has set up a standard assay screen for DHDP
Synthase by monitoring the rate of formation of dipicolinic acid (36)
at 270 nm. The product of the reaction, in vivo, is L-2,3-DHDPA (23) 
which is unstable and could not be the product absorbing at 270 nm. 
L-2,3-DHDPA (23) is oxidised in air to DPA (36) which absorbs at 270 
nm (Schem e 9).
The standard assay consisted of 100 mM imidazole buffer, 1
mM L-aspartic acid-P-semialdehyde (89a), 1 mM pyruvate (22) and
16 units of DHDP Synthase. Three concentrations of compound were 
studied, 1 mM, 0.5 mM and 0.1 mM, unless other dilutions were
required. Each result shown is an average over three assay runs.
The level of inhibition was measured by a percentage of the
standard rate as shown in the following equation and graph :
a - x
x 100 = Inhibition (%)a
a = rate of standard assay
x = rate of assay plus compound
time
2 17
Significant inhibition was taken to be about 10% inhibition at 0.5 
mM of the compound being tested.
Test Data for Chapter T31.
Compound No. 
or Name
Experimental 
Page No.
Concentration of Inhibitor
1 mM 0.5 mM 0.25 mM 0.1 mM
DL-Allylglycine 14% 0 - -
(8 6 ) 158 0 - - -
(87) 159 0 - - -
(96) 167 1 1 °/p 5% - -
(93) 168 14% 0 -
(104) 169 1 1 % 0 - -
(98) 170 7% 0 - -
(107) 170 0 - - -
( 1 2 1 ) 184 0 - - -
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Test Data for Chanter 141.
Compound No. 
or Name
Experimental 
Page No.
Concentration of Inhibitor
1 mM 0.5 mM 0.25 mM 0.1 mM
(133) 188 0 - - -
(134) 189 8% 0 - -
(135) 189 100% - - 8%
(136) 190 100% 96% - 8%
(137) 191 100% 100°/c 0
(138) 191 100% | roo°/\ 62%
(140) 193 100% | 92% | 0
(141) 194 3% - - -
(142) 194 100% - - 14%
(143) 195 100% 100°/c - 51%
(145) 196 65% 50% - 38%
(144) 196 100% 78% - 0
Phenylpyruvate 0 - - -
Mercaptopyruvate 0 - - -
Bromopyruvate 2 0 - -
2 19
Test Data for Chapter T51.
Compound No. 
or Name
Experimental 
Page No.
Concentration of Inhibitor
1 mM 0.5 mM 0.25 mM 0.1 mM
(169) 199 100% 88% - 0
(175) 200 87% 26% - 13%
(176) 201 63% 37% - 8 %
(180) 204 78% 0 - -
(182) 205 94% 31% - 0
(188) 2 0 7 100% 7 9 % - 13%
(189) 208 100% 97% - 19%
(192) 210 67% 25% - 8 %
(195) 212 100% 86% - 21%
(200) 215 100% 100% 100% 15%
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